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Abstract
In almost all organisms on Earth, many behavioral, physiological, and biochemical activities
oscillate with a circadian rhythm, a rhythm with a period of about 24 hours. This oscillating
behavior is the result from a combined influence of the external day-night-cycle and an internal
timekeeping system.
In gene expression, the 24-hour-rhythm can be found on all stages: from transcription initiation
to protein degradation. On the transcript level, circadian mRNA production and mRNA abundance
are comprehensively charted through numerous genome-wide high throughput studies from various
model organisms and tissues. Circadian post-transcriptional regulation, however, comprising many
different processes, is less well understood. In this thesis, I will investigate how unobserved post-
transcriptional processes influence rhythmic properties of gene expression. To this end, I quantify
the life-stages of biomolecules using one modeling motif, a simple ordinary differential equation de-
scribing production and degradation with time-dependent rhythmic rates. This basic modeling motif
is systematically varied to examine and discuss various influences of post-transcriptional regulation
(PTR) on circadian mRNA expression.
First, the influence of PTR on the circadian transcriptome is theoretically investigated, specifically,
the effects on phase and amplitude of transcript abundance. Constant PTR dictates restrictions on
phase and amplitude relations between transcript production and abundance: mRNA can peak at
most 6 hours (in circadian context) after its production, the mRNA amplitude is smaller than the
production amplitude. However, genome-wide studies of production and abundance show many
genes where these relations do not hold true, and thus an oscillation also in a post-transcriptional
process must be assumed. A careful discussion of known post-transcriptional processes suggests
that only rhythmic mRNA degradation, rhythmic mRNA export or rhythmic alternative splicing
are able to explain measured circadian expression profiles.
The model provides the basis for a statistical test to quantify the extent of rhythmic PTR in
genome-wide studies. Analyzing two data sets on mouse liver and kidney, I find that 18% of circadian
genes in kidney and 34% in liver are under rhythmic post-transcriptional control. The untranslated
regulatory regions (UTR) of circadian mRNAs are longer in liver compared to kidney and phase
analysis points to a peak in mRNA degradation around CT12 for liver and around CT0 in kidney.
In a second part, I analyze more specific aspects of PTR in a hypothesis-driven approach. Firstly,
I find that splicing with a rhythm of 24 hours is able to generate 12-hour rhythms in abundance
of mature mRNA, and I further characterize the requirements for this phenomenon. Secondly, I
propose and analyze a model to investigate rhythmic degradation of core clock genes. And finally,
I extend the core modeling motif to a partial differential equation (PDE) model that accounts for
the “aging” process of molecules. I first use the PDE to investigate oscillations in oxidized proteins:
Long-lived proteins tend to “forget” their production history and – although rhythmically produced
– proteins have a constant total abundance. However, the production rhythm is still observable in
fractions of damaged proteins and this might have biological implications. As a second application
of the PDE, I describe the time course of poly(A) tail length distributions. The Poly(A) tails is a
stabilizing element of mRNA. This description is motivated by novel methods to measure poly(A)
tails genome-wide (e.g. “TAIL-seq”) and can be used to predict poly(A) tail deadenylation rates
from such data. Here, the original modeling motif finds a new and independent application apart
from describing circadian gene expression.
In this thesis, I varied a minimal modeling motif to query large datasets for evidence of specific
hypotheses on underlying mechanisms. This is essentially an Occam’s razor approach: only very
minimal assumptions are made and rigorously tested. The approach offers a promising general
solution, unifying the disparate scientific approaches of data-driven vs. hypothesis-driven research
in molecular biology.
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Zusammenfassung
Viele biologische Prozesse im Verhalten von ganzen Organismen, aber auch in den Prozessen
und der biochemischen Zusammensetzung von Zellen zeigen einen zirkadianen Rhythmus, also einen
Rhythmus mit einer Periode von etwa 24 Stunden. Diese Oszillationen sind das Resultat vom
äußeren Tag-Nacht-Rhythmus und einer inneren biologischen Uhr.
Diese 24-Stunden-Rhythmen sind in der Genexpression auf allen Ebenen zu finden: von der Tran-
skriptionsinitiation bis zur Proteindegradation. Auf Transkriptebene, zirkadiane mRNA-Produktion
und mRNA-Abundanz ist umfassend durch zahlreiche genomweite Hochdurchsatzstudien in mehre-
ren Modellorganismen und Geweben gemessen. Auf der anderen Seite, zirkadiane posttranskrip-
tionelle Regulation, die verschiedenste Prozesse umfasst, ist weit weniger verstanden. In dieser
Arbeit untersuche ich, wie bisher ungemessene, posttranskriptionelle Prozesse die rhythmischen
Eigenschaften von Genexpression beeinflussen. Dazu beschreibe ich die Lebensstadien eines beliebi-
gen Bio-Moleküls mit einem Modell-Motiv, einer einfachen Differentialgleichung mit zeitabhängigen,
rhythmischen Raten. Diese Differentialgleichung wird variiert um systematisch den Einfluss von
posttranskriptioneller Regulation (PTR) auf zirkadiane Genexpression zu untersuchen.
Als erstes untersuche ich theoretisch den Einfluss von PTR auf das zirkadiane Transkriptom,
speziell den Effekt auf Phase und Amplitude. Konstante PTR setzt Einschränkungen für die Phasen-
und Amplitudenbeziehung zwischen mRNA-Produktion und mRNA-Abundanz fest: mRNA kann
höchstens 6 Stunden (im Kontext der zirkadianen Uhr) nach der Produktion ihren Hochpunkt
erreichen, die mRNA-Amplitude ist kleiner als die Produktionsamplitude. Genomweite Studien
zeigen jedoch, dass für viele Gene diese Beschränkungen nicht erfüllt sind. Diese Eregbnisse können
nur erklärt werden, wenn es auch eine Oszillation in einem posttranskriptionellen Prozess gibt.
Eine sorgfältige Diskussion bekannter posttranskriptioneller Prozesse zeigt, dass nur rhythmischer
mRNA-Abbau, rhythmischer mRNA-Export und alternatives Spleißen die gemessenen zirkadianen
Expressionsprofile erklären können.
Das Modell liefert die Grundlage für einen statistischen Test um das Ausmaß von rhythmischer
PTR in genomweiten Studien zu quantifizieren. Durch die Analyse zweier Datensätze von Mausle-
ber und -niere finde ich, dass 18% aller zirkadianen Gene in Niere und 34% in Leber rhythmisch
posttranskriptionell reguliert sind.
Im zweiten Teil analysiere ich weitere Aspekte von PTR in einem Hypothesen-getriebenen Ansatz.
Als erstes weise ich nach, dass Spleißen mit einem Rhythmus von 24 Stunden 12 Stunden-Rhythmen
in der Abundanz von reifer mRNA erzeugen kann, das heißt die Abundanz hat zweimal pro Tag
einen Hochpunkt. Zusätzlich charakterisiere ich die Bedingungen für dieses Phänomen. Als näch-
stes schlage ich ein Modell vor, das rhythmische Degradation von Mitgliedern der zentralen in-
neren Uhr, der zirkadianen Uhr, beschreibt, und charakterisiere dieses. Schließlich erweitere ich das
Modell-Grundmotiv zu einer partiellen Differentialgleichung (PDG), die das “Altern” von Molekülen
beschreibt. Ich schlage zwei Beispiele für die Anwendung vor. Als erstes benutze ich die PDG um
Oszillationen in oxidierten Proteinen zu untersuchen: Langlebige Proteine “vergessen” ihre Produk-
tionsgeschichte und weisen trotz rhythmischer Produktion ein konstantes totales Proteinlevel auf.
In Anteilen von beschädigten Proteinen können aber die Produktionsrhythmen noch beobachtet
werden, was biologische Auswirkungen haben kann. Als zweites Beispiel beschreibe ich die Län-
genentwicklung von Poly(A)-Schwänzen, ein stabilisierendes Element von mRNA-Molekülen. Diese
Beschreibung ist motiviert durch eine neue Messmethode, die genomweit die Längenverteilung von
Poly(A)-Schwänzen misst (“TAIL-seq”), und dazu benutzt werden kann, von solchen Daten die
Poly(A)-Schwanz-Deadenylierungsrate vorherzusagen.
In dieser Arbeit variiere ich ein minimales Modellierungsmotiv um große Datensätze nach Hin-
weisen von darunterliegenden Mechanismen zu untersuchen. Damit folge ich im Wesentlichen
dem Ockhams-Rasiermesser-Prinzip: Es werden nur minimale Annahmen gemacht und gründlich
getestet. Dieser Ansatz bietet eine vielversprechende, generelle Lösung, die die ungleichen wis-
senschaftlichen Ansätze von datengetriebener vs. hypothesengetriebener Forschung in der Moleku-
larbiologie vereinigt.
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Abandon the urge to simplify everything, to look for
formulas and easy answers, and to begin to think
multidimensionally, to glory in the mystery and paradoxes
of life, not to be dismayed by the multitude of causes and
consequences that are inherent in each experience –
to appreciate the fact that life is complex.
M. Scott Peck
Everything must be made as simple as possible.
But not simpler.
Albert Einstein
The scatter of the experimental data contrasted with the
convincing clarity of the theoretical model.
Matthias Beuse et al. [1]
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1 Introduction
1.1 Biological 24-Hour Rhythms
For more than three billion years, the organisms on this planet have known, just like Little
Orphan Annie, that “The sun’ll come out tomorrow”, and many have honed their biochemistry
to exploit this knowledge.1 At this time Cyanobacteria, one of the oldest clades on Earth, started
to use water as the electron-donor for photosynthesis, releasing oxygen, and thus slowly building
up the earth’s atmosphere. About 1 billion years ago these bacteria developed an internal time-
keeper. With this internal “clock” they were able to synchronize the timing of their metabolic
events with the predictable turning of the earth and its implications for daily changes in light,
temperature and humidity. Such clocks are nearly ubiquitous among existing higher organisms,
plants, fungi and animals [3].
Such inner clocks regulate a diverse range of cellular and organismic processes, the so-called
“circadian behavior”. For a process to be considered as circadian it must possess three charac-
teristic properties [4]:
• It oscillates with a period of around 24 hours (“circa dies” - about a day) even in the
absence of environmental cycles.
• The phase can change or “be reset” upon environmental cues such as light or temperature.
The behavior is “entrainable”.
• The period does not change for different temperatures, i.e. it does not run faster in higher
temperatures or slow at lower temperatures. The behavior is “temperature-compensated”.
In mammals, the internal time keeping system is complex and comprises of hierarchical struc-
ture, reviewed in Section 1.1.4. On the cellular level, this hierarchical system results in 24-hour-
oscillations in the abundance of thousands of transcripts, see also Section 1.1.5. Genome-wide
studies also found oscillating abundances in nascent RNA [5, 6]. However, these findings sug-
gest that many of the rhythmic RNA levels cannot originate solely from their production. Many
RNAs were found to oscillate on the level of mature transcript concentration, although they were
not rhythmically produced, in other cases production oscillated with a smaller amplitude than
the final transcript abundance; or, in some case both, production rate and transcript abundance
oscillated, but the phase difference between production and transcript abundance was greater
than 6 hours. In all these cases, post-transcriptional processes must play an important role
1I stole this sentence from Susan Golden’s review on Cyanobacterial circadian clocks [2]. The song comes from
a musical “Annie” composed by Charles Strouse and lyrics by Martin Charnin. The musical is based on a
comic strip series which was published from the 1920s until mid 1970s. It was created by Harold Gray.
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in shaping the circadian abundance profile of the biomolecule. These results were the start-
ing point for our investigation of rhythmic post-transcriptional regulation in more depth. The
weapon of choice when tackling the diverse scientific questions that arise was mathematical mod-
eling. Specifically, I described rhythmic processes with ordinary differential equations or partial
differential equations. The results of this journey are concentrated in this doctorial thesis.
Before we start our exploration of the varied aspects of rhythmic post-transcriptional reg-
ulation, I will first give an introduction to the circadian clock, in particular the mammalian
clock, review what current knowledge of rhythmic post-transcriptional regulation gained from
experimental studies. I will then introduce the central theoretical concepts, such as amplitude
and phase, which will be employed throughout this thesis.
1.1.1 A Brief History of Chronobiology
The existence of internal time keepers was originally proposed in the year 1729. De Mairan [7]
noticed that the plant Mimosa pudica lowers its leaves and folds them away during night. He
also found that this behavior continues in constant darkness. This opened the question on the
existence of internal timekeepers. Almost 200 years later, the search for clocks started to spread.
Several studies were undertaken (in chronical order) into: primates [8] (1906), rodents [9, 10, 11],
insects [12], birds [13], single-cell eukaryotes [14], 1962 by Aschoff et al. [15] humans, fungi [16]
and finally, 1986, also bacteria [17]. All these studies tested various behaviors which continued
to oscillate with a period of around 24 hours in darkness or in different light environments,
strengthening the inital idea of the existence of internal time-keepers in all domains of life.
1959, Franz Halberg introduced the term “circadian” derived from the two Latin words “circa”
and “dies” accounting for oscillations with a period of “about a day”.
Evidence for a genetic base of the internal time keeper was presented in 1935 by Bünning [18]
who showed that period length is inheritable in bean plants. A genetic component, however,
was first identified in the late 20th century. Here, Konopka et al. [19] identified a gene locus
in Drosophila Melanogaster where mutations resulted in either longer or shorter periods of
pupal eclosion and locomotor activity. The encoded gene Per (Period) was characterized 10
years later [20]. In mice, a large mutant screen in the laboratory of J. Takahashi lead to the
discovery of the first clock gene, named Circadian Locomotor Output Cycles Kaput (Clock) in
the mid 90s [21]. Only 5 years later, the main components of the clocks in mammals, Drosophila
melanogaster, Neurospora crassa and Synechococcus were characterized [3].2
1.1.2 “Evolutionary Why” Clocks?
The first circadian clocks are thought to have evolved 1 billion years ago [23] in cyanobacteria,
one of the oldest clades on earth. In these bacteria, cycles in the phosphorylation state of
the protein KaiC drive alternation between periods of nitrogen fixation and photosynthesis [2].
Additionally, a circadian cycle of genome compaction, potentially driven by changes in the extent
of DNA supercoiling, has been observed in a variety of species [24, 25]. In the early days of Earth
2Of course, these two paragraphs are a very condensed summary and can only provide a glimpse on the devel-
opment of research of the circadian clock. For further reading, I highly recommend the comprehensive and
entertaining introduction to chrono-history in the book “Circadian Physiology” by Roberto Refinetti [22].
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ultra-violet (UV) irradiation from the sun - not yet filtered by the Earth’s atmosphere and its
ozone layer - was both a threat and the main energy source. One theory for the emergence of
clocks in cyanobacteria is the “escape from light” hypothesis. This hypothesis states that clocks
evolved to temporally separate cellular processes that are sensitive against UV radiation, such
as DNA replication, from other, UV-insensitive processes. Hence, the DNA may be compacted
during daytime in order to protect the genomic information. Records of DNA compaction and
decompaction, however, show that, in modern cyanobacteria, compaction occurs at night, not
during the day [26]. Hut et al. [27] hence argue that clocks have evolved in order to store ATP
for periods where no photosynthesis is possible. To date it is unclear which of the two theories
holds true.
Clocks in plants, fungi, and animals are quite distinct from each other and have no apparent
homologies with KaiC from cyanobacteria [3, 28, 29]. This indicates that clocks have evolved
more than once. It is interesting to note that cryptochrome, a light-sensitive protein and main
component of the circadian clock in mammals [30, 31] and D. Melanogaster [32, 33], has a close
relationship to photolyases, an ancient enzyme family that uses light to repair UV-induced DNA
damage [34]. Further, it has been observed that despite their different clocks in all domains of
life oxidation-reduction cycles of peroxiredoxin proteins oscillate with a circadian period [35].
Peroxiredoxin proteins protect cells from excessive amounts of reactive oxygen species (ROS),
which are produced during respiration and photosynthesis. These observations fit with the “es-
cape from light” hypothesis and may suggest a primordial role of DNA damage in the evolution
of circadian clocks in eukaryotes [36, 37].
Other lessons may be learned from another exisiting clock. Budding yeast has evolved a
metabolic cycle which is tightly coupled to the cell division cycle [38, 39, 40, 41]. The cycle
shares a variety of features with the circadian clock, discussed in Causton et al. [42], and both
clocks might even share a common ancestor [43, 44]. The metabolic oscillations were first ob-
served in a synchronous oscillation in the pH value and dissolved oxygen levels in continuously
growing cultures of budding yeast [45, 38], but could recently be observed in single cells growing
in a microfluidic system [41]. Akin to the “escape from light” hypothesis, it was proposed that
this metabolic cycle may serve to protect DNA from ROS during replication [39]. However,
oscillations were also observed in non-growing cells [46], and it was recently shown that phases
of high oxygen consumption, where ROS are produced, are not strictly separated from DNA
replication [40, 47]. These results put forward original interpretations of this cycle from the
1960s [38, 48], that initiation of cell division (in budding yeast: “budding”) and DNA replica-
tion occur only after accumulation of sufficient carbohydrate reserves to supply the increased
energy demand during these time-critical cellular processes. Machne et al. [49] proposed the
existence of a global mechanism of growth regulation, where a direct feedback exists between
energy metabolism, ATP-dependent remodeling of chromatin structure, and large groups of
differentially expressed genes in budding yeast. They further suggested a similar system to
be tightly integrated with the circadian clock of cyanobacteria, where DNA structure (“DNA
supercoiling” and DNA compaction) were previously observed to oscillate in a circadian manner.
However, energy metabolism is a major source of ROS. With this in mind, it can be argued,
that protection from ROS- or UV-induced DNA damage, or gating replication for times of high
energy supply may be two sides of the same came coin and hence both “evolutionary whys” are
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compatible.
1.1.3 Architecture of Cellular Clocks
Circadian clocks in multi-cellular organisms consists of several intertwined transcriptional-trans-
lational feedback-loops. A genome-wide small interfering RNA (siRNA) screen showed that more
than 200 genes affect properties of mammalian circadian gene expression, such as period and
amplitude of mRNA abundance [50]. Hence, a clock network is large and complex becoming eas-
ily incomprehensible. The consensus view focuses therefore on small sets of a few transcriptional
(co-)regulators, so-called core clock proteins, that operate in most cell types and necessary for
a functioning cellular clock.
In plants, fungi, and animals these core-clock genes act as transcriptional activators and re-
pressors, mutually regulating each other in negative transcriptional-translational feedback loops,
as has been shown in several key experiments [51, 52, 53]. A negative feedback loop is one major
ingredient to produce oscillations, also comprehensively understood from the modeling perspec-
tive [54, 55, 56]. The other two ingredients for oscillation production are delay and a sufficient
non-linearity in the describing equations. A delay results from the inclusion of intermediate
steps within the negative feedback loop. While a single transcriptional auto-repressor acts too
quickly on its own transcription, a chain of cross-regulating transcription factors can easily cause
oscillatory expression patterns [57, 58]. Non-linearity is introduced by cooperativity in transcrip-
tional activation or suppression, i.e. more than one protein at a time is required to activate or
inhibit transcription. Because of this, the e.g. inhibition of transcription, which is dependent
on the concentration of inhibitory proteins, follows a step function, which is highly nonlinear.
Delay and non-linearity are inversly dependent on each other. If the delay is large, less non-
linearity is needed to produce oscillations [56]. In many cases, circadian clocks are equipped
with additional positive feedback loops. These might weaken the requirements on nonlinearity
and provide robustness with regards to degradation parameters [59].
In mammals, the proteins BMAL1 and CLOCK form a dimer activating the transcription of -
among others - the transcriptional co-repressors PER1/2 and CRY1/2 which in turn inhibit the
activation of BMAL1/CLOCK and thereby exert a negative feedback on their own expression,
see Figure 1.1. The consensus view considers this to be the main negative feedback loop in
the mammalian circadian clock [60, 28] supported by the fact that a knock-out of either one
of its components, namely BMAL1 [61], CLOCK and its substitute NPAS2 [62], PER1 and
PER2 [63, 64] or CRY1 and CRY2 [65, 66], completely stops the clock. However, a very recent
computational approach pointed to a different main negative feedback-loop. Here, Pett et al. [67]
systemically substituted oscillations of core-clock members by their mean mRNA concentration
in a comprehensive, already published mathematical model of the circadian clock [68] and inves-
tigated if circadian-like oscillations still persist. With this approach Pett et al. [67] were able to
reduce the circadian network structure to essential parts. A motif appeared in this systematic
analysis was the “repressilator”, a network motif consisting of a serial inhibition [69], and origi-
nating in Goodwin’s model of cellular oscillators [57]. The identified repressilator motif Pett et
al. [67] represented the serial inhibition of the clock genes Cry1→ RevErbα→ Per2→ Cry1,
see Figure 1.1. It is interesting to see, that PER2 and CRY1 in the model described previ-
ously form a dimer acting as one transcriptional co-repressor, but their DNA binding profiles
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BMAL1
CLOCK
CRY1/2
PER1/2
Cry1
Per2RevErbα
Figure 1.1: Two models of the core negative feedback loop in the circadian clock. The
consensus view favors the idea shown in the left. The proteins BMAL1 and CLOCK
form a dimer which activates the transcription of the transcriptional co-repressors
PER1/2 and CRY1/2 which in turn inhibit the activation of BMAL1/CLOCK. Re-
cently, Pett et al. [67] identified a repressilator (right) as core negative feedback of
the circadian clock.
tend to support sequential DNA binding [70] of both proteins. These binding profiles favor the
repressilator model over the consensus feedback-loop. Knock-out studies further support the
repressilator motif as the core negative feedback loop, see [67] and references therein. However,
the model and hence finding a repressilator as a possible main negative feedback-loop is based
on mRNA expression profiles and does not take protein levels into account. Including protein
levels might, yet again, alter the picture.
In summary, the overall architecture of the mammalian core clock is well understood and the
details are currently worked out in an exemplary loop between theoretical modeling and wet lab
experimentation.
1.1.4 Time-Keeping in Higher Organisms
Every cell with a nucleus is equipped with the core clock described above. However, even
cells without nucleus, i.e. blood cells show sustained 24-hour-oscillations in their peroxiredoxin
protein levels [71] indicating the existence of additional oscillators within single cells [72]. Hence,
most, if not all, cells show oscillations, even in the absence of transcription. To function as a
proper time-keeper these oscillators must transmit their information about time to other cellular
processes and they must listen to their environment in order to synchronize to the external cues
(“entrainment”). How is this achieved?
In mammals - highly complex organisms - single cell oscillators are organized in a hierarchical
structure. Single cells group together to form larger structures. It is believed that these larger
structures divide in so-called “peripheral oscillators”, associated with whole organs such as
liver or kidney, and “master oscillators”, which respond to environmental cues. The peripheral
oscillators listen to the master oscillators.
A master oscillator, or central pacemaker, is able to restore complex rhythmic behavior in
modified, arrhythmic animals and is connected to the environment [73]. There are three knwon
master oscillators, the suprachiasmatic nuclei (SCN), the food entrainable oscillator (FEO) and
the methamphetamine sensitive circadian oscillator (MASCO).
From these three, the SCN is best understood. It is a small organ in the hypothalamus
and consists of about 20,000 neurons [74]. The individual clocks of these neurons are tightly
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coupled such that each neuron in the SCN oscillates with almost exactly the same period [75]
and therefore with a fixed phase relationship. The SCN receives information directly via light
reaching the retina of the eye [76]. The SCN reacts upon different photoperiods, accounting
for long or short days, with modulated phase distributions of its neurons [77, 78], also which
has also been investigated from a modeling perspective [79]. The SCN transmits its timing
information via neuronal and humoral signals [76], which are yet incompletely understood [73].
SCN lesioned animals have arrhythmic locomotor activity [80]. A transplant of an intact SCN
restores rhythmicity [81], with the original period of the transplanted SCN [82]. All this together,
the coupling to the environment and the capability to induce rhythms in complex behavior,
support the role of the SCN as a pacemaker and rhythm provider.
The two other pacemakers, FEO and MASCO, investigated and put forward by Michael
Menaker and colleagues, are less well understood. Evidence for their existence is based on exper-
iments where rhythms in locomotor activity, body temperature and gene expression profiles can
be restored in SCN-lesioned animals by restricted feeding [83, 84, 85, 86] or methamphetamine
exposure [87, 85, 86]. In SCN-intact animals a phase de-synchrony between food-dependent
and food-independent tissues is induced by restricted feeding [88]. In genetically modified mice
lacking a functional transcriptional-translational clock, rhythmic locomotor-activity is induced
both by methamphetamine administration [89] and restricted feeding [90], suggesting that the
molecular mechanisms that generate these oscillations are fundamentally different from those
that generate SCN rhythmicity. However, neither the anatomical location nor the molecular
mechanisms of the FEO or the MASCO are yet known. They might even be two aspects of
the same mechanism [73]. However, these experiments strongly support the idea that oscillators
other than the SCN can act as pacemakers.
Peripheral oscillators on the other hand are rhythm listeners. Individual organs are thought
to have their own clock which coordinates tissue-specific behavior and which is induced by cues
from the SCN and other pacemakers [91, 92, 93]. Every organ shows its own specific circadian
transcriptome profile [94] accounting for different organ-specific functions, see also Sec. 1.1.5. If
peripheral organs, i.e. organs beside the SCN, are explanted they show damped oscillations [95].
This is in contrast to SCN explants which were reported to oscillate indefinitely [95]. Theoret-
ically, the observed dampening could either arise from attenuated oscillations in single cells or
from increasing de-synchrony among clocks in adjacent cells. Bio-luminescent or fluorescent
recordings of fibroblasts cells in culture [96, 97] and of different tissue explants [98] supports
the latter hypothesis: Single cells show long-lasting oscillations - each with a slightly different
period - but fail to synchronize without external stimuli. Westermark et al. [99] compared time
series of SCN neurons and fibroblasts to two models, firstly a damped oscillator driven by noise,
secondly a self-sustained noisy oscillator. These two models account for a “weak” and a “strong”
oscillator, comparable to the concept of peripheral (weak) oscillator and (strong) pacemaker.
However, it was found that single cell time series from fibroblasts and SCN neurons were both
described by the two oscillators, indicating that both cell types contain similar clocks. Since
SCN and peripheral organs are similar at the single-cell level, the differing behavior of tissue ex-
plants, non-dampened versus dampened rhythms, most likely arises from a missing intercellular
coupling in peripheral organs. Consequently, there is no experimental evidence that peripheral
organs form one meta-oscillator. They rather consist of single-cell oscillators which are inde-
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pendently entrained by the pacemakers. Different cell types in heterogeneous tissues might be
entrained by different input-pathways. These results would suggest that the concept of one clock
per organ, e.g. “liver clock”, may be misleading.
Furthermore, there is evidence for a secondary hierarchical structure within peripheral organs.
For example, the adrenal gland which “listens” to the SCN [100, 101], produces hormones which
in turn influence rhythmicity in other organs such as liver or kidney [102, 103, 104, 105]. It may
even be possible that several more layers exist within this hierarchy.
Consequently, an oscillating transcriptome measured in a peripheral tissue reflects the in-
fluence of a myriad of inputs from different levels of organization: from the transcriptional-
translational negative feedback loop, the core clock, to hormonal and neuronal inputs of the
pacemakers, and environmental cues such as metabolic activity upon feeding or locomotor ac-
tivity. The transcriptome of cell lines, a system where inputs from pacemakers do not exist,
showed rhythms in about only a dozen transcripts, in liver tissue however rhythms in over 3000
transcripts could be detected [106]. This indicates the large majority of circadianly expressed
genes in tissues is directly influenced by systemic cues from the pacemakers.
1.1.5 Circadian Output
Depending on tissue, experiment and analysis (see next section) 5% to 50% of transcripts show
a circadian rhythm in their abundance. Depending on protein half-lives and cell growth, many
cellular processes could thus be modulated by a circadian rhythm. This includes both basic
cellular processes, which are needed for a functioning cell, and functions specific for certain cell
types and organs. Additionally, as outlined above, transcription-independent oscillations further
point to autonomous metabolic or physiological clock-like systems. However, very little is known
about the mechanics and main actors in these systems.
Basic cellular functions are under circadian control Cellular metabolism and the core cir-
cadian clock are interlocked. Most of cellular metabolism oscillates with a circadian rhythm
and it is influenced by members of the core clock. This includes glycolysis [107], gluconeogen-
esis [108, 109, 110], fatty acid oxidation [111] and lipid biogenesis [112]. Thus, both build-up
and consumption - anabolism and catabolism - of the main cellular energy sources are con-
trolled by the clock. It has also been shown that mitochondrial respiration activity [113, 114]
is circadianly regulated, both by controlling rate-limiting enzymes [115, 114] and mitochondrial
dynamics [113], i.e. fusion and fission of the mitochondrial network, which is connected to
the mitochondrial activity [116]. Consequently, ATP levels are circadian in a multitude of tis-
sues [117]. The metabolic state of a cell feeds back to the core clock via the NAD+-NADH axis,
reviewed in [118].
Cellular maintenance processes, often connected to the bioenergetic state of the cell [119,
120, 121], are under circadian control, such as autophagy [122] and the cellular redox state,
exquisitely reviewed by Putker et al. [120]. Thus, probably the whole bioenergetic state of most
- if not all - cells oscillates with a diurnal rhythm, reminiscent again of the metabolic oscillations
in budding yeast cells outlined above. And just like in these metabolic oscillations, the other
large oscillator in the cell, the cell cycle, and the circadian clock are coupled [123, 124].
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But cells do not simply exist, they must also fulfill a function in a complex organism. How
does the clock affect tissue specific functions, especially in liver and kidney, the two organs I
analyze in this thesis with regard to their post-transcriptional regulation? According to Zhang
et al. [94] liver and kidney are the two organs with the highest fraction of circadianly expressed
genes, i.e. 16% and 13% of expressed genes in liver and kidney, respectively, have a circadian
rhythm in their transcript abundance. What does this mean for organ function?
Liver - virtually all processes oscillate The liver is the second largest organ in our body after
the skin and mainly consists of hepatocytes. It is a metabolic organ that performs numerous
functions in the human body, including regulation of glycogen storage, decomposition of red
blood cells, plasma protein synthesis, hormone production, and detoxification. The liver is
considered the prototypic experimental model tissue for circadian research in peripheral organs.
Hence, numerous studies have covered the circadian transcriptome [125, 126, 127, 128, 129, 130,
131, 5, 6, 132, 133, 94], proteome [134, 135, 136, 137] and metabolome [130, 138, 139, 140, 141] of
the liver. Many key findings for the global regulation of circadian gene expression were generated
using mouse liver as modelling system [6, 5, 123, 135]. But the data also served for elucidating
circadian hepatic processes. Virtually all hepatic processes appear to be under control of the
circadian clock, including detoxification, cholesterol and bile acid metabolism, glucose and lipid
homeostasis, thyroid hormone metabolism, and many more (reviewed in [142]).
Kidney function is modulated with diurnal rhythm The kidneys are two bean-shaped organs,
which function to filter water soluble waste products of metabolism from the blood, maintain
fluid and ion homeostasis and regulate blood pressure. In contrast to the liver, a kidney is a
very heterogeneous organ and consists of many different cell types. The functional filtering unit
in kidney is the tubular structured nephron. Each kidney contains about 1 million nephrons.
Blood enters the nephrons and is filtered through the glomerulus, a ball-shaped structure within
the nephron. The filtrate flows through the nephron, and the many specialized cell types in each
segment of the nephron reabsorb or secrete solutes according to the needs of the body. The final
filtrate flows into the ureter to eventually become the urine.
The overall kidney function seems to exhibit circadian fluctuations. For example, the glomeru-
lar filtration rate, i.e. the flow rate of filtered fluid through the kidney [143], and the renal blood
flow [144] show diurnal oscillations.
Urinary sodium excretion oscillates with a diurnal rhythm [145]. This might be explained by
clock-mediated regulation of several renal sodium transport genes [146, 147, 148]. Several key
pathways in the kidney are affected by core clock knock-outs (reviewed in [149]).
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1.2 Rhythmic Post-Transciptional Regulation
Let’s start this introduction by investigating the statement below:
Messenger RNAs (mRNAs) are the central conduits in the flow of information from
DNA to protein. In eukaryotes, mRNAs are first synthesized in the nucleus as pre-
mRNAs that are subject to 5’-end capping, splicing, 3’-end cleavage, and polyadeny-
lation. Once pre-mRNA processing is complete, mature mRNAs are exported to the
cytoplasm, where they serve as the blueprints for protein synthesis by ribosomes and
then are degraded.
This text snippet, taken from the excellently written review by Melissa Moore [150]3, contains
most of the key words which one needs to discuss about post-transcriptional regulation and serves
its purpose of introducing the topic. However, in this review it is given as a counter example
which is not capable to reflect, in reality, vast and fascinating complexity of post-transcriptional
regulation.
Another example for this complexity is provided by the beautiful figure of Gerstberger et
al. [151]4 where post-transcriptional regulation of both mRNA and non-coding RNA is shown.
In this paper, the authors derive a census of about 1500 RNA binding proteins (RBP). The
subsequent analysis reveals that most RBP are ubiquitously expressed, typically at higher levels
than average proteins, and almost all of them are involved in protein synthesis (692 mRNA
binding proteins, 169 ribosomal proteins, 130 proteins in biogenesis and delivery of charged
tRNAs to the ribosome).
In principle, any abundance or activity of proteins involved in post-transcriptional regulation,
any depicted step in the figure, or any processing rate could exhibit circadian rhythms affecting
single mRNAs, groups of mRNA or even all expressed mRNAs in specific cell types. In the
following, I will briefly review what is already known regarding rhythmic post-transcriptional
regulation in mammals and Drosophila.
Post-transcriptional regulation is affected by mRNA-associated factors, such as RNA binding
proteins (RBP) and micro-RNAs (miRNAs). The mRNA-associated factors act as trans-factors
that recognize cis-acting binding sites on (pre)mRNA. Rhythmic post-transcriptional regulation
can be generated either by a time-dependent activity or abundance of trans-factors or by dynamic
changes of cis-elements on the (pre)mRNA achieved e.g. by alternative splicing.
3Reprinted by permission from Macmillan Publishers Ltd: Science, “From Birth to Death: The Complex Lives
of Eukaryotic mRNAs”, Melissa J. Moore, copyright 2005.
4Reprinted by permission from Macmillan Publishers Ltd: Nature, “A census of human RNA-binding pro-
teins”,Stefanie Gerstberger, Markus Hafner, Thomas Tuschl, copyright 2014.
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Overview of the main post-transcriptional gene regulation pathways in eukary-
otes. An overview is given for the biogenesis, decay and function of the most abundant RNAs:
tRNAs, ribosomal RNAs, small nuclear RNAs (snRNAs), small nucleolar RNAs (snoRNAs), mR-
NAs, microRNAs (miÂRNAs), PIWI-interacting RNAs (piRNAs) and long non-coding RNAs
(lncRNAs). Processes are described from left to right. a tRNAs are transcribed by RNA poly-
merase III (Pol III); the 5’ leader and 3’ trailer sequences are removed, introns are spliced, and
the ends are joined. CCA nucleotides are added to 3’ ends, and nucleotide modifications - such
as methylation (M), pseudouridylation (ψ) and deamination of adenosines to inosines (I) - are
introduced before tRNA aminoacylation195 . b The 5S rRNA is transcribed by Pol III, whereas
28S, 18S and 5.8S rRNAs are transcribed as one transcript by Pol I. The precursor is processed
by RNA exonucleases, endonucleases and the ribonucleoprotein (RNP) RNase MRP, guided
by U3 small nucleolar RNP (snoRNP). Nucleotide modifications are introduced by snoRNPs.
rRNAs are assembled together with ribosomal proteins into ribosomal precursor complexes in
the nucleus and transported to the cytoplasm, where they mature to functional ribosomes. c
Most snRNAs are transcribed by Pol II, capped and processed in the nucleus. When exported
to the cytoplasm, they undergo methylation and assemble with LSM proteins into small nuclear
ribonucleic particles (snRNPs) in a process aided by the survival motor neuron 1 (SMN1). These
snRNPs are re-imported into the Cajal body (CB) within the nucleus, where they undergo final
maturation and snRNP assembly. U6 and U6atac snRNAs are transcribed by Pol III and are
alternatively processed in the nucleus and the nucleolus. Mature snRNPs form the core of the
spliceosome. d snoRNAs and small Cajal body-specific RNAs (scaRNAs) are processed from
mRNA introns, capped and modified before they assemble into snoRNPs or scaRNPs in the CB.
snoRNPs and scaRNPs carry out methylation and pseudouridylation of rRNAs, snoRNAs and
snRNAs, or function in rRNA processing (for example, processing of U3 snoRNA). e mRNAs are
transcribed by Pol II, capped, spliced, edited and polyadenylated in the nucleus. Correctly ma-
tured mRNAs are exported into the cytoplasm. Regulatory RNA-binding proteins (RBPs) con-
trol correct translation, monitor stability, decay and localization, and shuttle mRNAs between
actively translating ribosomes, stress granules and P bodies. f miRNAs are either transcribed
from separate genes by Pol II as long primary miRNA (pri-miRNA) transcripts or expressed
from mRNA introns (mirtrons) and processed into hairpin pre-miÂRNAs in the nucleus. After
transport into the cytoplasm, they are processed into 21-nucleotide-long double-stranded RNAs.
One strand is incorporated into Argonaute (AGO) proteins (forming miRNA-containing RNPs
(miRNPs)) and guides them to partially complementary target mRNAs to recruit deadenylases
and repress translation. g piRNAs are ∼28-nucleotides-long, germline-specific small RNAs.
Primary piRNAs are directly processed and assembled from long, Pol II-transcribed precursor
transcripts, whereas secondary piRNAs are generated in the “ping pong” cycle by the cleav-
age of complementary transcripts by PIWI proteins. Mature piRNAs are 2’-O-methylated and
incorporated into PIWI proteins. The piRNA-PIWI complexes (piRNPs) silence transposable
elements (TEs) either by endonucleolytic cleavage in the cytoplasm or through transcriptional
silencing at their genomic loci in the nucleus. h Most lncRNAs are transcribed and processed in
a similar way to mRNAs. Nuclear lncRNAs play an active part in gene regulation by directing
proteins to specific gene loci, where they recruit chromatin modification complexes and induce
transcriptional silencing or activation. Other non-coding RNAs (for example, 7SK RNA) reg-
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ulate transcription elongation rates or induce the formation of paraspeckles (PS). Cytoplasmic
non-coding RNAs can modulate mRNA translation. i Incorrectly processed RNAs are recognized
by several complexes in the nucleus and cytoplasm that initiate and execute their degradation.
CPSF, cleavage and polyadenylation specificity factor; EJC, exon junction complex; hnRNP,
heterogeneous nuclear RNP; NGD, no-go decay; NMD, nonsense-mediated RNA decay; NSD,
non-stop decay; PABP, poly(A)-binding protein.
1.2.1 First Advances and Investigation of Trans-Factors
The complement of possible trans-factors is large. 1500 RBPs [151] and more than 5500 mi-
RNA [152] in humans have been identified, each one of them targeting groups rather than
single mRNAs. It is predicted that mi-RNA affect ∼50% of all protein-coding genes [153] by
downregulating gene expression via either inhibition of translation or mRNA degradation [153].
Additionally, some non-coding RNA are shown to inhibit translation [154].
The first observation of a rhythmic post-transcriptional regulation was made by Robinson et
al. [155] who found that the mRNA encoding for SCN vasopressin had two different poly(A) tail
lengths whose relative abundance varied throughout the day. They hypothesized that this is the
underlying mechanism for rhythmic protein abundance in the SCN. Sol et al. [156] discovered a
rhythmic stability for the Per transcript in Drosophila. Cheng et al. [157] found that the 3’UTR
of this gene is alternatively spliced and results in two isoforms. Later, it was shown that the mode
of splicing depended on temperature and photoperiod and contributed to locomotor-activity in
long and hot days[158], which may help to avoid desiccation of the fly.
In subsequent studies, single core clock transcripts were the focus, with the aim to find the
trans-acting factors. For the mouse transcripts of per3 [159], per2 [160] and cry1 [161] rhythmic
half-lives have been noted. In each of these cases the trans-factor, a known RBP, binds to
the 3’UTR of the transcript in a rhythmic manner which leads to a time-dependent mRNA
destabilization.
Another RBP known to affect the circadian clock is RBM4. RBM4, also known as LARK, has
a circadian abundance in mouse SCN and Drosophila [162]. LARK is involved in diverse cellular
processes that include alternative splicing of pre-mRNA, translation, and RNA silencing [163].
Altering the endogenous abundance of LARK in mice leads to an altered core clock period most
likely by changing translational efficiency of the per1 transcript [162].
Different deadenylases attack the poly(A) tail, a stabilizing element at 3’end of each mRNA,
and thereby affect transcript stability and translational efficiency. Nocturnin, one of the mam-
malian deadenlysases, exhibits circadian rhythms at the transcript level in the retina of Xeno-
pus [164] and in several mouse tissues with an especially high amplitude in mouse liver [165].
The targets of Nocturnin are not yet known [166]. However, Nocturnin knocked-out mice stay
lean under a high-fat-diet indicating an altered lipid metabolism, accompanied by changes in
glucose and insulin sensitivity [167].
With the advances of sequencing techniques it was possible to characterize the complement
of RNAs bound by specific RBPs. To date this has been done for two RBPs with a circa-
dian abundance, the cold-inducible RNA binding protein (CIRBP) and RNA binding protein
3 (RBM3). Both proteins are rhythmically expressed upon temperature cycles [168, 169] due
to temperature-dependent splicing efficiency [170]. This expression behavior possibly enables
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a synchronization of peripheral tissues via the body temperature. Identification of the binding
sites of both proteins resulted in genome-wide listings of possible target mRNAs. More than
8500 binding sites for CIRBP and over 9500 for RBM3 were assigned to annotated transcript
regions [169].
The importance of miRNAs for the circadian output is not clear. Gatfield et al. [171] in-
vestigated miR-122, a highly abundant, hepatocyte-specific microRNA [172]. Transcription of
miR-122 is under circadian control, however due to a long half-live (see also Section 2.1) the
miR-122 level is constant throughout the day [171]. Downregulation of miR-122 revealed that
this miRNA affects a disproportionately large range of RNA with a circadian abundance and
consequently, a knock-down results in reduction of lipid and cholesterol metabolism [173, 174],
processes known to have diurnal rhythms. In line with this, a recent genome-wide study found 57
miRNA, all originating from primary transcripts of clock-controlled genes [175]. Consequently,
the pre-miRNA levels oscillated, but the mature miRNA did not. An overexpression of one of
these miRNA, miR-378, again revealed that this miRNA regulates many circadian genes.
Genome-wide screenings identified only a very small number of miRNA with oscillating abun-
dances, six in Drosophila head [176] and 54 in mouse liver [129]. Du et al. [177] investigated
the circadian transcriptome within a global disruption of miRNA biosynthesis. Here, 30% of
circadian 1630 transcripts changed their mean abundance, however only 20 transcripts showed
alterations in rhythmicity. Very few cycling miRNA and almost no alteration in mRNA abun-
dance rhythms may indicate that miRNA generally do not induce circadian rhythms. This is
supported by results showing that the kinetics of miRNA interactions are too slow to affect circa-
dian rhythms in mRNA levels [178]. This is further supported by our study [179], where mRNA
predicted to be under rhythmic post-transcriptional regulation show no over-representation of
target sites for the rhythmic miRNAs suggested in above studies [129].
A very recent study suggests that long non-coding RNA may be involved in rhythmic post-
transcriptional regulation. Torres et al. [180] investigated the content of paraspeckles, struc-
tures that are formed by a long non-coding RNA molecule and a number of RNA binding
proteins [181, 182]. Paraspeckles are thought to prevent certain mRNAs from leaving the nu-
cleus and, therefore, stop them from being decoded to proteins [183]. Both, the composition
and the abundance of paraspeckles changed with a circadian rhythm in cells of the rat pituitary
glands [180]. Disruption of the paraspeckles resulted in rhythm-loss of cytosolic mRNA levels
known to be recruited by paraspeckles.
1.2.2 Investigation of Cis-Acting Elements
Charting of trans-factors is one way of investigation post-transcriptional regulation. However,
insight can also be gained through methods: by investigating the modifications of cis-acting
elements on the (pre)mRNA regardless of the mediating molecule. Such cis-acting motifs can
be mediated by alternative splicing, poly(A) deadenylation and RNA methylation.
Alternative splicing in mammals is widespread, affecting 94% of genes in humans [184]. It does
not only result in different proteins by, e.g., exon-skipping, but can also affects the regulatory
regions of mRNA, the 5’ and 3’UTRs [185]. It is estimated that 20% of expressed genes in
mouse liver contain a circadian exon [186]. McGlincy et al. [186] also demonstrated that certain
splicing factors have clock-controlled transcript expression. Gotic et al. [170] observed that
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temperature-dependent splicing efficiency of cold- and heat-inducible proteins lead to a circadian
accumulation of mature mRNA. Only properly spliced mRNA can serve as a protein template,
unspliced mRNA is degraded in the nucleus. Gotic et al. [170] found that a regulatory element
in the first intron of Cirbp mRNA is responsible for changes in splicing efficiency.
The poly(A) tail is a stabilizing element of about 250 adenosides at the 3’end of mRNAs. Its
length is connected to mRNA stability and translational efficiency. Once the mRNA is in the
cytosol, the poly(A) tail length is attacked by different deadenylases [187]. But this shortening
is not constant: It can slow down, stop, and even re-lengthening is possible to accommodate
different mRNA fates [188]. Kojima et al. [189] investigated the poly(A) tail length of transcripts
over the course of a day and find 230 transcripts with oscillating poly(A) tails. Surprisingly, most
of them are not affected by a knock-out of Nocturnin, the only known rhythmic deadenylase [190].
m6A RNA methylation is the post-transcriptional addition of a methyl group to an adenosine.
Dominissini et al. [191] identified RNA methylation in more than 7000 human genes, typically
around stop codons and within long internal exons. Fustin et al. [192] identified RNA methyla-
tion on many clock gene transcripts and demonstrated that upon inhibition of m6A methylation
the core clock period was longer.
1.2.3 Quantifying the Extent of Post-Transcriptional Regulation
If interested in rhythmic post-transcriptional regulation one may not simply ask and investigate
the specific situations and players, but also how many of all expressed genes are affected by
post-transcriptional regulation.
Since post-transcriptional regulation comes in many different flavors, as the previous section
demonstrated, no single experiment can capture every possible post-transcriptional regulation
at once. Hence, the problem is tackled the other way around by charting production and
abundance of mRNA. If production and abundance “match” each other, there is no reason to
assume rhythmic post-transcriptional regulation. For this approach it is crucial to find a clear
and statistically sound definition of such a “match”.
Charting of the mRNA abundance is achieved by common RNA-sequencing or hybridization-
based (“micro-arrays” or “tiling arrays”) studies. However, monitoring of production in a
genome-wide manner is not as straight-forward. Different approaches have been developed,
both experimental [193] and computational [70, 194], also employed to characterize the extent
of rhythmic post-transcriptional regulation.
Experimental approaches to characterize transcriptional activity based on sequencing in-
clude ChIP-seq of polymerase II, GRO-seq and Nascent-seq. ChIP-seq (Chromatin Immuno-
Precipitation & DNA-Sequencing) is used to examine the DNA binding sites of specific proteins.
Proteins are cross-linked to DNA, followed by DNA fragmentation and immunoprecipitation by
antibodies specific to polymerase II (Pol II). The sequencing of DNA fragments bound by Pol
II allow the identification of Pol II enriched regions [195], however this covers all stages of
transcription, including sites of Pol II pausing, where there is no active transcription. Global
Run-On Sequencing (GRO-seq) [196] attempts to chart engaged polymerases. Here, nuclei with
artificially halted transcription are isolated, the transcription is restarted in vitro and newly
synthesized RNA fragments are isolated and sequenced. NascentSeq [197] is based on isolation
of chromatin together with bound Pol II and transcribed RNA followed by RNA extraction.
14
1.2 Rhythmic Post-Transciptional Regulation
This RNA is then depleted of poly(A) tails and rRNA and subsequently sequenced. Hence, all
these three experimental approaches attempt to capture current transcriptional activity.
An established computational approach estimates RNA transcription from RNA sequencing
data. Here, exons and introns are annotated separately accounting for mature RNA and pre-
RNA, respectively. Exons reads can originate from both mRNA and pre-RNA, while intron reads
can only stem from pre-RNA. However, most transcripts are spliced co-transcriptionally [198].
Hence, the complete set of introns is not part of the sequencing library. This leads to reduced
mean level of pre-RNA quantification. A reduced mean level does not necessarily effect rhyth-
micity, and the data can still be used for qualitative interpretation (phase) of oscillations in
transcriptional activity. However, to enrich for mRNA, the sequencing libraries are commonly
generated via Poly(A) tails. These are added after completing the transcript. This means,
firstly, that the moment we capture with this computational approach is after the completed
transcription in contrast to the experimental approaches where transcription is “caught in the
act”. Secondly, due to co-transcriptional splicing transcripts may already be properly spliced
and we cannot detect any pre-RNA levels for some transcripts. Despite these limitations, the
quantification of pre-RNA and mRNA from one RNA sequencing run is an established method
and seems to give useful insight also in data concerning the circadian transcriptome [70, 194].
To estimate the extent of rhythmic post-transcriptional regulation Koike et al. [70] and Menet
et al. [5] divide their findings in 3 classes of genes: first, genes with rhythmic transcriptional ac-
tivity and rhythmic mRNA abundance; second, genes with rhythmic transcriptional activity but
an arrhythmic or flat mRNA abundance; and third, genes with arrhythmic transcriptional ac-
tivity, but rhythmic mRNA abundance. They conclude, that the first class (rhythmic-rhythmic)
is not under control of rhythmic postranscriptional regulation; in the second class (rhythmic-
arrhythmic) rhythms are lost due to long mRNA half-lives; and only the third class (arrhythmic-
rhythmic) contains genes under rhythmic post-transcriptional control. Although not completely
wrong, these conclusions do not hold for every examined gene. For example, even if both, tran-
scriptional activity and mRNA abundance are rhythmic, there are cases where transcriptional
activity cannot explain mRNA abundance, for example if the phase difference between both is
large or mRNA abundance oscillates with a larger relative amplitude than the corresponding
transcriptional activity. This can be comprehensively understood using a simple ordinary dif-
ferential equation model, see also Section 2.1. The detailed analysis of Le Martelot et al. [6] is
based on this model.
In our study [179] we reexamined the data of Le Martelot et al. [6]. We developed a sta-
tistical test to precisely estimate how likely it is for a given mRNA to be under rhythmic
post-transcriptional control. The main advantages of this test is, firstly, to overcome potentially
misleading assignments of binary categories, either rhythmic or arrhythmic, and secondly, to
handle every gene separately whilst dealing with its specific measurement noise. Using this test
we were able to estimate that about one third of the circadian transcriptome in mouse liver
(data from [6]) is under rhythmic post-transcriptional control. A very similar result was found
for Drosophila head (data from Rodriguez et al. [199]) where 34% of circadian genes showed
evidence of rhythmic post-transcriptional control.
In the last section of my introduction, I will briefly outline the ideas behind this modeling
approach. This thesis is based mostly on these ideas, as published in [179], but I will present
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significant extensions of the model and show its versatility by applying it to a series of hypotheses
on rhythmic regulation on various of above outlined levels in the complex life of genetically
encoded macromolecules.
1.3 Modeling Idea and Detection of Rhythms
In this last section I will briefly comment on the modeling technique I have implemented. First
of all, I concentrate on describing deterministic behavior and, with that, exclude any stochastic
variation. Almost all models described in this thesis, except for the partial differential equation
from section 3.3, are compartment models with time-dependent rates.
The compartments emplyed are not physical spaces but pools of molecules. With applying
compartment models I assume that
• There is an instant homogeneous distribution of molecules within a “compartment.”
• The cell volume is constant, that is, effects of cell growth are not accounted for.
In many cases I describe only a single compartment with a time dependent input, molecule
production, and time dependent output, generally molecule degradation. This rather simple
description does not account for the underlying biochemistry, for example molecular interaction,
inhibition etc., in any detail. This makes the models universally applicable. Although I focus on
RNA production and degradation, many conclusions hold true for other molecules, e.g. proteins,
orthophosphate proteins, nuclear import/export, etc., see Section 4 for more examples.
1.3.1 Rhythms in Time Series and Rates
Any sustained oscillation can be characterized by four features, see also Figure 1.3A:
• magnitude: the mean value
• period: the time it needs to complete one oscillation
• phase: the peak (or trough) of an oscillation with reference to an external point such as
time
• amplitude: the difference between peak (or trough) and magnitude
For circadian behavior the period is fixed to about 24 hours and will not be of great interest. In
this thesis I also will rarely mention the mean value since I will not concentrate on comparison
of absolute expression levels but on comparison of their dynamics, their rhythmicity. Of specific
interest are the phase of the signal (when does molecular abundance or activity peak) and
amplitude (how strong does it vary over one cycle).
Here, it is convenient to introduce a normalized amplitude, the so-called relative amplitude.
The dimensionless, relative amplitude is defined by the absolute amplitude normalized by the
mean and is a measure for rhythmicity. It can take values between 0, no rhythmicity, and 1,
maximally possible oscillation.
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The rhythms in time series and rates are then characterized by a phase and a relative ampli-
tude.
I will describe most time-dependent rhythmic rates r(t) as cosine functions, if not stated
otherwise, with magnitude M , phase φ and relative amplitude Arel, see Figure 1.3A.
R(t) = M (1 +Arel cos(ωt− φ)) (1.1)
The angular frequency is set to ω = 2pi/(24h) ≈ 0.26 h−1 throughout this thesis to reflect
circadian biology. The extreme values of the relative amplitudes, 0 and 1, indicate for 0, rate is
constant, and 1, rate oscillates between 0 and twice its mean.
1.3.2 Vector Model to Describe Rhythms
To visualize rhythmic properties of cosine functions it is convenient to use a vector description.
Here, one vector represents one cosine function. Its length represents the oscillation strength or
relative amplitude and the vector’s direction the oscillation phase, see Figure 1.3B. If we want to
describe processes with a circadian rhythm the phase can take values between 0 and 2pi, which
represent values between 0 and 24 hours in the circadian time frame. Although, all calculations
are done in angular frequency I will display and write about the corresponding values in the
circadian time frame. As with the rates also rhythmic time series can also be approximated with
cosine functions. Here, a linear model, e.g.
x(t) = a cos(ωt) + b sin(ωt) (1.2)
is fitted to a time series, estimating the parameters a and b. Since both models, Equation 1.1 and
1.2 are equivalent, we can calculate from the parameters a and b phase φ and relative amplitude
Arel with
Arel =
√
a2 + b2 (1.3)
φ = arctan 2
(
a
b
)
, (1.4)
where the function arctan2 maps the two arguments a and b onto the whole phase plane, see
Appendix A.1.2. With this the time series is described as a cosine function and can be displayed
as a vector as previously described. The derivation between fit and time series, the residuals of
the fit, are displayed as a so-called confidence ellipses in this graph, see Figure 1.3C. For most
experimental designs, namely fully measured periods, the ellipse is a circle, see Appendix C.1.3.
The circle covers a very small proportion of possible phase values compared to possible amplitude
values. This has the consequence that phase can be estimated by much greater accuracy than
the relative amplitude.
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1.3.3 Statistics of Rhythmicity Detection
Numerous high-throughput studies on the circadian transcriptome obviously ask for the num-
ber of cycling genes compared to the overall expression. Often it is implicitly assumed that
rhythmicity in transcript abundance implies rhythmicity in biological function. To be biologi-
cally functional rhythms should exhibit a sufficient amplitude, oscillations must be strong. In
contrast, when, for example, asking for principal regulatory mechanisms of the circadian clock
one might also be interested in rhythmic gene expression with low amplitude regardless if the
rhythm has a function or not. Hence, different scientific questions pose different demands on
rhythmicity detection. I argue it is useful to test for rhythmicity and amplitude independently,
although both are related, as I will outline in the following. With this I follow the suggestion
by Thaben et al. [200].
To find circadian rhythms in time series often a statistical hypothesis testing is employed
which tests for rhythmicity against a null hypothesis as some sort of random noise without any
rhythmicity. There are statistical tests based on both parametric [201, 202] and non-parametric
methods [203, 204, 200] available, reviewed in [205], with non-parametric often being more robust
against biological outliers.
In the literature, fixed percentages or numbers of genes are often given, as I also reported
in Section 1.1.5. These are almost always based on applying a p-value cut-off of e.g. 0.05,
chosen arbitrarily. However, testing thousands of genes for rhythmicity is a multiple testing
problem and hence asks for correcting the p-values, for example by using the Benjamini-Hochberg
procedure [206].
In this thesis, in order to detect rhythms in time series I apply RAIN [200] together with a
false-discovery rate of 25%. RAIN is a further development of a non-parametric method to detect
not only symmetric, but also asymmetric wave-form rhythms. This yields very high numbers of
rhythmic transcripts, e.g. applying this method to the liver data set by Zhang et al.[94], we find
that at least 49% of transcripts are rhythmic, much more than the published number of 16%.
However, most of these detected rhythms have a very low amplitude. Hence, this detection
method is accompanied by an amplitude cut-off. This amplitude cut-off can be motivated
biologically. For example, as it is well established and as I also outline in Section 2.1, rhythms
are lost easily due different processing steps. Accordingly, if I want to deduce from rhythmicity
in transcript abundance to rhythmicity in protein I should choose a high amplitude cut-off. On
the other hand, if I am rather interested in basic regulatory principles in RNA processing, a low
amplitude cut-off is sufficient.
Using this approach to search for rhythmic transcripts I first find a reliable set of cycling time
series and then chose a motivated, in contrast to arbitrary, amplitude cut-off which serves best
for my scientific question.
1.4 Outline of the Thesis
This thesis aims to elucidate the effect of post-transcriptional, especially rhythmic post-transcrip-
tional regulation on the circadian transcriptome. How can the circadian clock tune its output
to specific times and keep a desired oscillation strength? I investigate the main properties of
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rhythmicity, phase, relative amplitude and period.
First, in Section 2.1 I look at constant, i.e. not time-dependent, post-transcriptional regu-
lation, and how it affects amplitude and phase of a transcript. This is the starting point to
developing different tests which estimate the extent of rhythmic post-transcriptional regulation
in Section 2.3 and 2.4. I apply these tests to two data sets on mouse liver and kidney, revealing
34% of circadian genes in mouse liver and 18% in mouse kidney for which a rhythmic post-
transcriptional regulation must be assumed. In Section 2.5 I introduce a model for rhythmic
mRNA degradation and show that rhythmic degradation could account for the measurements.
In Section 2.6 I ask if rhythmicity in other stages of mRNA processing could equally explain
the data. In Section 2.7 I finally search for additional evidence of rhythmic post-transcriptional
regulation in mouse liver and kidney.
The second part of this thesis complements this general investigation of the prevalence of mul-
tiple rhythmic processes with more specific questions. First, I ask if and when higher harmonics
in time series could be induced by rhythmic post-transcriptional regulation (Section 3.1). I fur-
ther inspect rhythmic post-transcriptional regulation of core clock genes in Section 3.2. Finally,
in the last section I introduce a partial differential equation model, which describes an “aging”
molecule. This model is applied to damaged proteins and shortening of poly(A) tails.
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The transcriptome of clock controlled genes in different mouse organs show a phase distribu-
tion throughout the day. It seems different genes require different phases in order to properly
fulfill their function. This requires for a fine adjustment of phases and amplitudes of mRNA
abundances. Transcript levels are tightly regulated via different steps, starting with the tran-
scription initiation, followed by splicing and other post-processing and finally the degradation
of the mature transcript. Genome-wide diurnal profiles of mRNA abundances are obtained by
next generation sequencing technology. A genome-wide approach for transcriptional activity
can be achieved by different techniques such as “nascent-seq” [197], “GROseq” [207], ChIPSeq
of Polymerase II or identification of introns in RNA sequencing data. However, for the diverse
range of most PTR steps a genome-wide approach has not yet been established.
In this work I aim to elucidate the importance of post-transcriptional regulation (PTR) for
circadian gene expression with a focus on rhythmic PTR. With ordinary differential equation
(ODE) models I will characterize the limits of constant PTR, how rhythmic PTR affects mRNA
levels and how rhythmic PTR can be detected without direct experimental evidence. I will use
2 data sets on mouse liver and kidney to test this. In the second part I will extend these models
to characterize other interesting aspects of rhythmic PTR. I will investigate if rhythmic PTR
can produce higher harmonics in mRNA abundance, briefly characterize rhythmic PTR in the
core clock and lastly describe the life cycle of a molecule as an “aging” process by a partial
differential equation (PDE) model.
Part of this work has been published in “Rhythmic degradation explains and unifies circadian
transcriptome and proteome data” [179], in particular the solution and stability discussion of
the model in Section 2.5, and the test which uses half-lives presented in Section 2.4. This test I
developed in collaboration with Paul Thaben and Pål Westermark. Apart form this, the work
I present here is completely my own.
2.1 Time Matters
The kinetics of mRNA processing are crucial for generating rhythms in mRNA abundance. They
dictate strict boundaries for maintaining oscillations. In the following I will use an ODE model
to show what determines the oscillation strength (amplitude) and how oscillations are passed
during mRNA processing steps.
Rhythmicity or oscillation refers to relative amplitude. The relative amplitude defines how
strong the rhythm is. A loss in amplitude means a loss of rhythmicity.
How is a rhythm in transcription initiation passed on to the mature transcript? Since we are
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interested in oscillation only, we can describe several life stages of an mRNA by one model equa-
tion. This is then a global description without taking into consideration underlying molecular
mechanisms. In this equation a species x is rhythmically produced and constantly degraded:
dx
dt = prod(t)− γx
prod(t) = k (1 +Aprod cos (ωt− φprod)) .
(2.1)
The time dependent production rate prod(t) is a cosine function with period ω = 2pi24h−1, mean
k, relative amplitude Aprod and phase φprod. γ is a constant degradation rate characterizing the
removal of the molecule out of the described system. This rate is related to the species’ half-life
or processing time τ1/2 by the relationship
γ = ln(2)
τ1/2
. (2.2)
The different interpretations for the different life stages are achieved by interpreting the variable
and rates differently. For example, let x stand for nascent, unspliced RNA. Then the rhythmic
production rate describes a rhythmic transcription initiation. In this interpretation, splicing
destroys nascent RNA, hence the splicing rate constitutes the degradation rate. The degradation
rate is defined by the processing time, here, how long it takes for splicing. The subsequent
species spliced RNA is rhythmically produced due to rhythmic pre-RNA abundance, the pre-
RNA passes its rhythm down to the spliced RNA. In the same manner every life stage of an
mRNA is described by the same model, where the previous species is approximated by a rhythmic
production rate.
Solving the model Equation 2.1 gives a cosine function describing the abundance of x with
magnitude, relative amplitude and phase:
x(t) = Mx (1 +Ax cos (ωt− φx)) , (2.3)
Mx =
k
γ
, (2.4)
Ax =
γAprod√
γ2 + ω2
, (2.5)
φx = φprod + arctan
(
ω
γ
)
. (2.6)
According to this solution, the relative amplitude of x is determined by the relative amplitude
of the production, reduced by the factor γ√
γ2+ω2
. Consequently, the processing time or species’
half-life in the described system dictates the strength of amplitude reduction. Accordingly,
every processing step of the mRNA will result in an amplitude reduction in its abundance or
diminishes oscillation strength. Figure 2.1 shows the amplitude reduction in relation to the
rhythm’s period. For example, the species’ oscillation is reduced by one half if the processing
time takes about 20% of the period.
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Which steps in mRNA processing will therefore contribute most to an amplitude reduction
in a circadian time frame where the period equals 24 hours? In Figure 2.1 the time scales of
some mRNA processing steps are plotted against the amplitude reduction. The life of an mRNA
begins with its transcription initiation. Assuming transcription speed is ∼35 base per second as
measured by Bahar et al. [208], the completion of a transcript with a length of 100kb takes 45
min. Further processing of the freshly transcribed mRNA includes splicing, adding its stabilizing
elements, poly(A) tail and the 5’cap, and finally transport out of the nucleus. Splicing of one in-
tron takes about 10 minutes [209]. However, since most splicing occurs co-transcriptionally [198]
this step will not prolong the processing time of mRNA during transcription. The same is true
for the co-transcriptional mRNA capping. Adding the poly(A) tail, in mammals consisting of
250 adenosides, takes no longer than 5 minutes [210]. Nuclear export can take up to 30 minutes
depending on where in the nucleus the transcript is produced [211]. In total, the time from
transcription start to the nuclear export can take up to 1.5 hours. Hence, an oscillation in
transcription initiation, e.g. by an oscillating transcription factor, is already reduced by 40%
due only to the long mRNA processing time.
However, 1.5 hours is quite an extreme example for mRNA processing. In most cases the
processing, from the start of transcription until nuclear export, will probably not exceed 0.5
hours due to shorter transcripts and faster nuclear export and hence this step will not play
the dominant role in rhythm loss. By far the most amplitude reduction can be expected due
to the mRNA’s half-life. Friedel et al [212] and Schwanhäusser et al. [213] measured half-lives
of mRNAs in mammalian cell lines. Both studies used labeled nucleotides to distinguish newly
transcribed from pre-existing RNA. Half-lives were then estimated by the ratio of both fractions.
According to these studies, mRNA half-lives span a range from a few minutes to up to 25 hours,
with a median of 5 hours. Hence, for long-lived mRNA the oscillation of its production will be
lost even if production strongly oscillates.
Long mRNA half-lives weaken rhythms. Furthermore, the half-life also influences the phase
of the mRNA. It is intuitively clear, that a product abundance peaks after its production, the
abundance of a mature mRNA will peak after its rhythmic transcription initiation. The solution
of the ODE Equation 2.6 gives a more precise time frame. The product abundance peaks after
its production at most at 1/4 of the period, 6 hours for the circadian period. The longer the
half-life the longer is the phase shift.
In summary, it depends mainly on the mRNA half-life if an mRNA has a rhythmic abundance
due to a rhythmic transcription initiation. Long half-lives result in a loss of rhythms accompanied
with a phase shift of up to 6 hours between transcription initiation and mRNA abundance. This
result also gives a good starting point to characterize 2 RNA sequencing data sets with additional
information about transcriptional activity. In the next section, I will introduce both data sets
in more detail.
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Figure 2.1: Time matters for oscillations. Above: Amplitude reduction in percentage plotted
against the processing time in number of periods. Below: Range of different mRNA
processing steps.
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2.2 RNA Abundance and Transcriptional Activity:
2 Data Sets on Mouse Liver and Kidney
All further analyses in the following sections will examine two data sets. In this section I will
first characterize the properties regarding circadian gene expression. The first data set is derived
from mouse liver and is published by Menet et al. [5], the second data set was generated from
mouse kidney by our group in collaboration with the group of Achim Kramer (Charité) and
Roman-Ulrich Müller from University of Cologne. Both data sets are based on RNA sequenc-
ing. To access transcriptional activity, the second feature of the data sets, different methods
are utilized. Menet et al. [5] make use of the so-termed “nascent-seq” method, explained in
Section 1.2.3. Here, they separate experimentally pre-mature mRNA from mature mRNA fol-
lowed by sequencing. In contrast, transcriptional activity in kidney is obtained from the same
RNA sequencing data set which provides mRNA abundance. Separation between transcriptional
activity and mRNA abundance is performed computationally by individually quantifying tran-
scripts with (pre-RNA) or without (mature mRNA) introns, a method which possibly provides
not as “clean” results as the method applied by Menet et al. [5] as described earlier. Further-
more, the sampling frequency is different between the two data sets. Mouse liver was sampled
every 4th hour, 6 time points per period and 12 time points in total, mouse kidney was sampled
with a slightly higher frequency, every 3rd hour, 8 time points per period and 16 in total.
In the following 3 sections, there will be a lot of numbers arising regarding these two sets. For
the convenience of the reader these numbers are summarized in a table in Appendix F.2.
In mouse liver 13698 genes are expressed with information on both, mRNA and transcriptional
activity, in kidney 14324 genes are expressed. I consider circadian genes as genes with mRNA
or transcriptional activity with a 24 hour-periodic pattern (detected with RAIN [200] and a
false discovery rate ≤ 0.25) and a relative amplitude larger than 0.1, see also Section 1.3.3.
With these cut-offs I find 3813 (30%) of expressed mRNA to be rhythmic in liver and 4137
(29%) in kidney. If I include transcriptional activity into this analysis I find that 5581 (43%)
of expressed genes have a circadian rhythm in either their RNA abundance or transcriptional
activity, for kidney this is true for 6489 (47%) of expressed genes. Compared to other studies
these percentages of circadianly expressed genes are more than twice as high [94, 5]. This can be
in part explained by a higher sampling frequency and the different experimental methods. RNA
sequencing employed in the present studies produce data less prone to technical noise compared
to microarrays [214]. Both, sampling with higher frequency and less noise, increases the detection
of rhythms. Furthermore, RAIN, not employed by the other studies, is able to detect rhythms
which other known detection algorithms miss [200]. However, this is not enough to explain the
large discrepancy, also the parameter thresholds which separate circadian from non-circadian
gene expression play an important role. Here, rather the choice of relative amplitude than a
different false discovery rate affects the proportion, see Appendix C.1.2. Hence, many genes I
classify as circadian have a low relative amplitude, see also Figure 2.2A. One may argue, that a
large proportion of these genes are not able to fulfill a circadian function in the cell. However,
the main purpose of this study is to investigate rhythmic PTR. Not asking for specific gene
functions but rather for fundamental regulation principles justifies rather loose parameters for
gene classification in order to keep the test set as large as possible.
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A different phase distributions of mRNA abundance and transcriptional activity for liver and
kidney suggest that circadian gene expression is organ specific, see Figure 2.2B. A clear difference
between both organs is also found for the phase difference of transcriptional activity and mRNA
abundance, see Figure 2.2C. In kidney most of the mRNA abundance peaks within 6 hours after
its transcriptional activity, while in liver a broader distribution of phase differences is observed.
The theoretical boundary for a phase difference is 6 hours when rhythms in mRNA abundance
stem only from rhythmic transcriptional activity, see previous section. Hence, one would expect
the proportion of genes where rhythms in mRNA are only generated by a transcriptional activity
to be much higher in liver than in kidney. However, this needs further validation.
Consistent with the organ specific circadian transcriptome, I find that most of the genes
(12148) are expressed in both organs, but only a small proportion (1361 genes, 11% of genes
expressed in both organs) is found to be circadian in both organs.
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High relative amplitudes suggest that rhythmicity is important for gene function. With that in
mind it is not surprising that genes with a high relative amplitudes in their mRNA abdunance
in both kidney and liver are almost exclusively core clock genes, see Figure 2.3A. For some
other genes no connection to the circadian clock has yet been investigated, despite their strong
rhythmicity, see Figure 2.3A. It seems that, to date, we have only scratched the tip of the iceberg
when it comes to knowledge of output and consequences of the circadian clock. Furthermore,
there are mRNA which show a relative amplitude larger than 1, which would include theoretically
(see Section 1.3.1) negative RNA abundances. However, the time series of these mRNAs have a
distinct, rather pointy shape and a sine fit results in larger relative amplitudes, see Figure 2.3C.
It might be desirable to introduce a different fit to these time series. This is beyond the scope
of this thesis.
The phases of genes expressed in both organs often differ among organs, see Figure 2.3B. In
contrast, phases of genes with a high relative amplitude correlate quite well, see Figure 2.3B.
Interestingly however, we observe a systematic phase shift between those genes whose phases
correlate. Transcript abundances peak later, while transcriptional activities peak earlier in
kidney than in liver. For the latter, the experimental setup may be blamed. Nascent-seq
applied for transcriptional activity in liver captures a broad range of newly synthesized RNA
including already spliced RNA. The computational separation of exons, proxy for the mature
mRNA, from introns accounting for transcriptional activity captures only unspliced RNA. Since
RNA is often spliced very early in its life time, the phase of transcriptional activity in kidney
appears earlier than in liver.
However, the systematic phase difference in mRNA abundance - especially in core clock genes
- is rather odd. It could mean that the core clock oscillates with a phase difference of about
5 hours in both organs. But we must take into consideration that the two data sets were
generated in different laboratories, each with its own routines, mouse strains etc.. Although
both experiments used mice housed in LD 12:12, probably the most significant influence on
possible phase differences, it would still require an investigation of both organs in one laboratory
in order to exclude any other experimental influences.
Two organs, two distinct circadian transcriptomes with some similarities, especially in core
clock gene expression, leads to the question: How much of the circadian transcriptome can be
explained by the transcriptional activity? There seems to be a difference between the two organs
because many more mRNA in liver in comparison to kidney have phase differences between
transcriptional activity and mRNA abundance larger than 6 hours, the theoretical boundary
for constant PTR, see also Figure 2.2C. In the following section I examine both data sets by
comparing transcriptional activity and transcript abundance with respect to the model from
Section 2.1.
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2.3 Rhythmic Transcriptional Activity Cannot Fully Explain Rhythms
in mRNA Abundances
How many of all rhythmically expressed genes can be explained by rhythmic transcriptional
activity alone? I will develop in the following chapter a 2-stage-test which tests first mRNAs
without half-lives. In the second, refined test stage half-lives are included. In this way, more
genes can be tested.
The overarching strategy in both test-stages is to compare the model prediction from the
previous Section 2.1, where only rhythmic transcriptional activity was considered, with the
actual findings. If prediction and findings agree the mRNA abundance can be explained by only
transcriptional activity.
2.3.1 A Test in Two Stages - Without and With Half-Life
To make full use of the model Equation 2.1 one needs three ingredients: time series of mRNA
abundances, transcriptional activities as proxy for the production rate and the mRNA half-
lives. However, information on only mRNA abundance and transcriptional activity allows a first
estimate on the extent of rhythmic PTR as I will outline in the following. This estimate is not as
precise as if mRNA half-lives were included, but it takes more transcripts into account since the
majority of transcript half-lives were not measured and a more precise analysis is not possible
for these transcripts.
The graphical representation of the model solution gives an intuitive understanding of the
comparison between model prediction and measurement. As outlined in Section 1.3.1, every os-
cillation can be represented by a vector, where the vector direction indicates the oscillation phase
and the vector length the oscillation strength or relative amplitude. The model solution predicts
that the mRNA abundance peaks at most 6 hours after the transcriptional activity and is ac-
companied by an amplitude reduction. Exact phase shift and amplitude reduction depends on
the transcript’s half-life. This result translates into a semicircle in the vector-representation, see
Figure 2.4A. The upper edge of the semicircle marks the phase shifts and amplitude reductions
for a transcriptional activity with relative amplitude of 1, the highest possible relative ampli-
tude. Consequently, this semicircle marks the maximal range for rhythmic transcripts which are
only influenced by a rhythmic transcriptional activity. Transcripts influenced by transcriptional
activity with a smaller amplitude lie within the semicircle. Transcript abundances outside of
this semicircle cannot be explained by the model, indicating that there is an additional rhythmic
process which influences the transcript abundance. These two fractions of mRNA rhythms, lying
either inside and outside the semi-circle, allow for a first distinction between transcripts with or
without additional rhythmic PTR regardless of their half-life.
Including the half-life allows for a further refinement of this distinction. For all transcripts
within the semi-circle and for which the half-life is known, we can check if phase and amplitude
match the model prediction.
This two-stage-test, first to test all transcripts regardless of their half-life and second further
validation of phase and amplitude, will give an estimate for the extent of rhythmic PTR taking
as much information as possible into account.
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2.3.2 Two-stage-test on Mouse Liver and Kidney
To apply the first stage of the test, namely to test if transcripts are inside or outside the
semicircle, I align all mRNA phases to one production phase and allow the semicircle to be
larger than dictated by the model, which takes uncertainties in amplitude and phase estimation
into account, see Figure 2.4B for kidney.
With this set-up I find that of all rhythmic transcripts 939 (∼14%) are outside the semicircle
in kidney and 2191 transcripts (∼36%) in liver, see Figure 2.4B.
The second stage of the test is applied to the remaining fraction, namely transcripts inside
the semi-circle, for which a half-life was measured by Friedel et al. [212] and/or Schwanhäusser
et al. [213]. That is the case for 1163 transcripts in kidney and 850 transcripts in liver. With
the model solution Equation 2.6, 2.5 I calculate the expected phase and amplitude of transcript
abundance based on the transcriptional activity and half-life. Next, these results are compared
to the transcript phases and amplitudes that were actually measured and I allow again for a
certain deviation to account for uncertainties in phase and amplitude estimation, see Figure 2.5
for kidney.
Here, a large part of the examined transcripts fail to pass the second test and hence their
rhythmic abundance profiles cannot be explained by rhythmic transcriptional activity alone. In
kidney this comprises of 483 transcripts (∼42%) and in liver 419 transcripts (∼49%). It seems
that in many cases relative amplitudes are larger than the model prediction, see Figure 2.5. This
may indicate that PTR generally leads to an increase in relative amplitude of mRNA abundance.
Additionally, PTR might fine-tune phases, i.e. the timing of abundance peaks, as the differences
between the phase distributions of model prediction and measurement suggest.
In summary, I could quantify in a two-stage-test that the majority of rhythmic transcripts
cannot be explained by rhythmic transcriptional activity alone. The nature of the test, that is,
to first test data on transcriptional activity and transcript abundance regardless of their half-life
and second, to test the remaining fraction with known half-lives again, gives only a relative
number of total transcripts under rhythmic post-transcriptional control. This is obtained by
summing results from both stages. Accordingly, in the transcriptome of kidney more than half,
56% of all rhythmic transcripts, are under rhythmic-post-transcriptional control, in liver this
fraction is with 85% extraordinary high.
These percentages are surprisingly high. Consequently, one may question the reliability of
this result. Each test result depends on a binary decision, namely, does the oscillation belong
to an allowed range or does it not. Uncertainties in phase and amplitude determination are
generally handled as if uncertainties would be the same for all measured transcripts. Choosing
a different threshold which allows a greater divergence from the model prediction would greatly
influence the fraction of genes which cannot be explained by their transcriptional activity alone.
For example, if I allow for a divergence from the model prediction by 30% instead of 20%,
see Figure 2.5, the gene fraction which cannot be explained by their transcriptional activity
decrease to 31% in kidney and 53% in liver. Such a strong dependence of the result on an
arbitrary threshold is not desirable. Furthermore, there is transcript specific information on the
reliability of phase and amplitude estimation for each transcript available, hence there is no need
to choose one threshold valid for all genes.
However, no matter how trustworthy the fraction of transcripts with rhythmic PTR is, the
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result demonstrates one fact: the observed rhythms in mRNA abundance cannot be generated
by rhythmic production alone. To alter propterties of rhythm such as phase and amplitude it
needs the influence of other rhythms. When a rhythmic transcriptional activity does not explain
the rhythm in transcript abundance then there must be a rhythmic post-transcriptional process
involved.
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2.4 Quantifying the Extent of Rhythmic PTR
In the following section I will set out to reliably quantify the proportion of transcripts with a
rhythmic PTR. Again, I will compare model prediction and measurement for transcript abun-
dance, however this time I shall include all available information. This has the disadvantage
that not every transcript can be tested or the test becomes very stringent and will only detect
extreme cases.
2.4.1 PA-test – A Statistical Test with Half-Life
A good approach is to construct a statistical test which not only gives a yes-or-no-answer but
also provides a p-value, a measure for the unlikeliness of the null-hypothesis, that is in this case
“Oscillation in a transcript stems only from its rhythmic production”.
To construct a statistical test based on the model results we require information about the
uncertainties for all measured quantities. The uncertainties of phase and amplitude of transcript
abundance and transcriptional activity are obtained by the residuals of the fit, see derivation in
Appendix C.1.3. To estimate the errors of transcript half-life measurements, we would require
more than one measurement per transcript, assume a Gaussian distribution and obtain its
standard derivation. But only a small fraction of half-lives is measured in both Friedel et
al. [212] and Schwanhäusser et al. [213]. This restricts the transcripts to which the test can be
applied to only 23% of all circadian transcripts in kidney and 24% in liver. In Appendix C.2 I
outline how I retrieve means and standard deviation for half-lives from Friedel et al. [212] and
Schwanhäusser et al. [213].
The null hypothesis of the test is that an observed oscillation of a transcript stems only from
the oscillation in its transcriptional activity. The model from Section 2.1 predicts a transcript
abundance with only rhythmic transcriptional activity. If model and data do not agree within
the assumed measurement errors, we can reject the null hypotheses.
In mathematical terms an oscillation is represented by a vector consisting of its cosine and
sine fractions. Their uncertainties, depicted as ellipses, are defined by their two-dimensional co-
variance matrices, see Appendix C.1.3. To derive the covariance matrix in the model prediction,
a quantity derived from transcriptional activity and half-life, we need to apply error propagation
as outlined in Appendix A.2.1.
The test compares the two dimensional vectors describing transcript abundance derived from
model prediction ~amodel and the fit of the time series ~ameasure. I assume that both quantities are
characterized by a two-dimensional Gaussian-distribution with means µmeasure, µmodel and co-
variance matrices Σmeasure, Σmodel, derived with error propagation (Appendix A.2.1). Then the
mean difference between model prediction and measurement ∆ = µmodel−µmeasure describes the
deviation of the measurement from the model prediction. Its distribution can be approximated as
a two-dimensional Gaussian distribution N(∆,Σ) with covariance matrix Σ = Σmodel+Σmeasure.
To test if model prediction and measurement have the same mean leads us to a multivariate
equivalent of a Student’s t-test. This multivariate test statistic is characterized by Hotelling’s
T-squared distribution T 2:
T 2 = n∆TΣ∆, (2.7)
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where n is the number of observations. It can be shown, that for a large number of observations
T 2 follows a Chi-square distribution with, in this case, 2 degrees of freedom [215]:
T 2 ∼ χ22. (2.8)
The estimation of covariance matrices from the fit of time series and estimation of p-values
according to the chi-squared statistic were implemented by Paul Thaben as the function pa.test
in the R package “patest”.
Figure 2.6A shows an illustration of the test. Note that we predict from transcript abundance
together with the half-life the transcriptional activity. This prediction is then compared to the
actually measured transcriptional activity. For each gene a different test will be performed,
each with its own oscillation properties, half-lives and measurement errors to provide the best
possible accuracy.
Another major advantage of this test is to avoid detecting a disagreement between model
prediction and measurement solely based on the binary decision, either rhythmic or arrhythmic
as has been done in the previous section. In this mind set, an arrhythmic transcriptional activity
alone is not able to produce rhythmic transcript abundances. Camk2b, an example from liver,
Figure 2.6B, proves the opposite. It has an arrhythmic transcriptional activity, but a rhythmic
mRNA abundance. However, the χ2 test detects no significant difference between measured and
predicted transcriptional activity due to the large noise in transcriptional activity. This proves
arrhythmic transcriptional activity is able to produce rhythmic mRNA abundances.
In the following I will use the χ2 test to quantify the proportion of transcripts under rhythmic
post-transcriptional control.
To apply the test, we need an estimate of the transcript’s half-life and its variance as mentioned
earlier. Furthermore, I only investigated genes which are rhythmic in their abundance and/or
their transcriptional activity (false discovery rate below 0.25 and relative amplitude larger than
0.1). These restrictions result in 899 genes in kidney and 1023 genes in liver from the previously
introduced data sets.
I estimated phase and amplitude of each time series by fitting a sine-function using the R-
package Harmonic.Regression implemented by Pål Westermark. The package further provides
the sum-squared-residuals (ssr) of the fit. With information on phase, amplitude and their
uncertainties for transcript abundance and transcriptional activity, together with the mean and
standard deviation of half-life measurements of Friedel et al. [212] and Schwanhäusser et al. [213]
I can now apply the statistical test. It reveals that 158 out of 899 (18%) genes in kidney and
349 out of 1023 (34%) in liver have a rhythmic PTR (FDR ≤ 0.25), Figure 2.6D.
Comparing transcripts in both organs reveals a very small overlap. 393 genes were tested
in both organs, but only 44 of these show a positive test result for rhythmic PTR (FDR ≤
0.25). This suggests, that not only the circadian abundance of many transcripts is organ spe-
cific but also their rhythmic PTR. I will discuss the test result in more detail in Section 2.7.
Figure 2.6C shows the Cold-inducible RNA binding protein (Cirbp) which ranked low according
their q-values in both organs. This figure also illustrates what a significant test-result means
in the vector representation. Cirbp is also already experimentally shown to be under rhythmic
post-transcriptional control [170]. Interestingly, Cirbp itself is known to control circadian gene
expression by affecting PTR in a rhythmic manner [169].
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2.4.2 Test without Half-Life
The previous test results made use of measured half-lives. However, half-life measurements are
only available for a small fraction of transcripts. Is there a way to test every transcript for
rhythmic PTR regardless of its half-life? Ignorance of the half-life needs to be compensated
by taking into account every possible half-life. This will weaken the power of a possible test
significantly, but may still yield more insight on the data structure and provide potential for
detection of PTR.
The overall idea for this test follows the geometrical consideration from the previous Section 2.3
but additionally includes the uncertainties of each oscillation derived from the sum-squared
residuals of the sine-fit.
Any oscillation in the transcriptional activity is represented by a two-dimensional vector with
an error ellipse. The model from Section 2.1 dictates that a rhythm in the transcript abundance
appears on a point on the edge of a semi-circle if the rhythm is only influenced by a rhythmic
transcriptional activity. The exact point is defined by the half-life. The semicircle spans between
transcriptional activity and the origin, see Figure 2.6A. These two points correspond to very short
transcript half-life, no phase shift and no amplitude reduction on one hand and very long half-life,
maximal possible phase shift of 6 hours and complete loss of oscillation on the other hand, see
also Figure 2.4A. The line of the semicircle describes only one possible oscillation derived from
the mean of the distribution of the transcriptional activity. Taking into account the uncertainty
or measurement error of transcriptional activity means that an error ellipse of transcriptional
activity is spanned from each point on the semicircle. This yields an area which contains all
possible transcript abundances which could be produced by the specific transcriptional activity
distribution, see Figure 2.6A. If an oscillation of a transcript abundance cannot be explained by
the transcriptional activity then the transcript abundance and its error ellipse will lie outside of
this semicircle.
Note that, in this case, the transcriptional activity is used to predict possible transcript
abundance. This approach is the other way around than the previous test, where transcript
abundance was used to predict the transcriptional activity, see Figure 2.6A.
To apply the test I follow a similar procedure as previously. Only genes which have a circadian
oscillation (FDR ≤ 0.25 and relative amplitude larger than 0.1) in either their transcriptional
activity and/or their transcript abundance are tested. For each of these genes I fit a sine curve to
transcriptional activity and transcript abundance using the package Harmonic.Regression, which
also provides the sum-squared residuals to construct the error ellipses. For each transcriptional
activity I construct a semicircle-area as described above and check if there is an overlap with
the error ellipse of its associated transcript abundance. In this way, only 52 genes in liver and
11 genes in kidney were tested to have a rhythmic PTR.
The size of error ellipses influences the outcome of this test significantly, smaller error ellipses
would decrease a possible overlap. Smaller error ellipses can be achieved if the oscillation, a
dot in the vector plane, is measured more often and hence the confidence of the measurement is
increased. In Atger et al. [216] transcriptome of mouse liver was measured by RNA sequencing
with a high sampling frequency, every 2 hours over the course of 4 days, in total 48 samples.
An estimation of the transcriptional activity can be achieved from the intronic reads of RNA
sequencing as has been done for the kidney data set.
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Equipped with this data I receive 8109 out of 12351 (66%) circadianly expressed genes, either
in transcriptional activity or transcript abundance. Here, already the higher confidence of
oscillation is visible in the higher percentage of circadian genes. This can be seen even better
when we apply the test. Here, 69 genes instead of 52 genes in mouse liver were tested to have
a rhythmic PTR. However, this result is still far lower than the results of the test which uses
half-lives.
In conclusion, I described two tests which compare model prediction with measurement. The
first test, a statistical test taking into account the transcript half-lives was used on a representa-
tive subset of the circadian transcriptome liver and kidney and found that 18% of the circadian
transcriptome in kidney and 34% in liver are under rhythmic PTR. The second test does not
require the transcript half-life. However, with this test only very few genes can be detected. The
test could be used to find genes for which a rhythmic PTR has a strong influence. Compared
to the χ2-test the second test (without half-life) revealed a few genes which were not detected
by the first test due to a missing measured half-life: 10 genes in kidney and 48 genes in liver.
Accordingly, 1 and 4 genes for kidney and liver, respectively, were detected by both tests.
For convenience of the reader, the whole set of genes positively tested for rhythmic PTR is
published in Appendix F.3. Can you find your favorite gene?
Additionally, the numbers of how many circadian genes and which genes were tested from
Sections 2.2, 2.3 and this section are summarized in a table in Appendix F.2.
Having quantified the amount of genes under rhythmic PTR the following questions emerge:
Which post-transcriptional processes can explain the discrepancies between model prediction
and measurement? Is rhythmicity in any step of PTR sufficient to explain the findings? To
answer these questions I will introduce in the following a second model which describes not
only rhythmic production, but also rhythmic degradation. This will be the starting point to
investigate other post-transcriptional processes.
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2.5 Rhythmic Post-Transcriptional Degradation
More than 15% and up to one third of the circadian transcriptome cannot stem from rhythmic
transcription alone, see previous section. The search for additional rhythmic processes influ-
encing mRNA abundance leads the focus to PTR. To investigate rhythmic PTR I will again
use an ODE model similar to the one presented in Section 2.1. Instead of rhythmic production
and constant degradation, I will now describe an mRNA which is rhythmically produced and
rhythmically degraded. I will use this model further not only to examine rhythmic degradation
but also to answer the question if other rhythmic post-transcriptional processes such as rhythmic
splicing or rhythmic nuclear export can explain the findings.
2.5.1 An ODE Model: Production and Degradation with Oscillating Rates
An mRNA x is rhythmically produced and rhythmically degraded with circadian rates (see
Figure 2.7A):
dx
dt = prod(t)− deg(t)x,
prod(t) = k (1 +Aprod cos (ωt− φprod)) ,
deg(t) = k (1 +Adeg cos (ωt− φdeg)) .
(2.9)
The time dependent rates are described by cosine functions with angular frequency ω, means k
and γ, relative amplitudes Aprod and Adeg, phases φprod and φdeg for production and degradation
rate, respectively. The angular frequency is set to ω = 2pi24 h−1 to reflect circadian dynamics.
The mean degradation rate is connected to the half-life as described before in Equation 2.2.
The solution x(t) of Equation 2.9 cannot be calculated analytically. I therefore use a Fourier
expansion to find an approximation for the solution. The derivation is described in
Appendix A.1.2. Furthermore, I verified, that this approach is suitable for this problem. Specif-
ically, I verified that Fourier terms in the approximation vanish for higher order and I quantified
the error made by the approximation by comparing it to the numerical solution of the model
Equation 2.9. This inspection of the approximated solution is published in Appendix A.1.3 and
A.1.4.
The solution can be understood intuitively as vector calculation. Rhythms in production and
degradation rate characterized by phase and amplitude are represented by vectors in the 24-hour
plane as described in Section 1.3.1. The vector of mRNA abundance, the solution of the model
Equation 2.9, is then determined by first taking the vector difference of production and degra-
dation rate. We termed this vector difference “production-degradation-vector”, see Figure 2.7B.
The production-degradation-vector is further shifted and decreased in length by very similar
half-life-dependent factors to the ones already received from the model of constant degradation
(Equation 2.6, 2.5). Hence, it follows that this solution in the limes of constant degradation falls
together with the solution of the previous model describing constant degradation.
In mathematical terms the vector describing the mRNA abundance is characterized by its
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2.5.2 Rhythmic Degradation Explains All Observed Phases and Amplitudes.
Phase and amplitude of a transcript is determined by the production-degradation-vector and
therefore by the production and degradation rates’ properties.
The rates’ amplitudes can add up and form an amplitude boost if the phase relation between
both rates is appropriate. The maximal amplitude is reached when production and degradation
are in antiphase. A reduction of oscillation occurs if both rates oscillate in phase. The reduc-
tion is strongest for similar oscillation strengths. When production and degradation rate have
the same oscillation strength and have exactly the same phase the length of the production-
degradation vector is zero and there is no oscillation in the mRNA abundance, see Fig 2.8A.
The phase of production-degradation-vector, and hence the transcript phase, is dictated by the
phase of the dominant rate, i.e. the rate with the strongest oscillation. A transcript peaking 6 to
12 hours before the production peak can only be realized when the degradation rate dominates,
Figure 2.8B. Such phase relationships have been observed in both kidney and liver, see also
Figure 2.4B. Furthermore, if a production and degradation rate oscillate with similar strength,
i.e. the ratio of relative amplitudes is close to 1, the transcript’s amplitude is low, but - at
the same time - the biomolecule’s phase is highly sensitive to changes in the relative amplitude
in production or degradation. This is reflected by the sensitivity coefficient, Figure 2.8C and
Appendix A.2.2.
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Figure 2.8: Conclusions drawn from model solution: rhythmicity properties of the
rates. A Production and degradation can cancel or boost each other depending
on phase and amplitude relationship. Shown is the model solution for different pa-
rameter sets of degradation and production rate. Half-life t1/2 = 2 h. B Possible
phase ranges of mRNA abundance phase for different relations of production and
degradation amplitudes. An mRNA which peaks 12 to 6 hours before its transcrip-
tional activity must be influenced by a dominating oscillation in the degradation. C
The sensitivity coefficient characterizes the change of mRNA phase under slightly
different rate parameters. There is a high sensitivity, i.e. the mRNA phase is highly
susceptible for changes in rate parameters, if production and degradation oscillate
with a similar strength and phases are similar (see blue curve). A complete derivation
of the coefficient is shown in Appendix A.2.2.
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The production-degradation vector is further shifted and decreased in length. This shifting
and shorterning is dictated by factors depending mainly on the transcript’s half-life. These are
very similar to the factors, which already describe the phase shift and amplitude decrease in the
model of constant degradation, Equation 2.6, 2.5. Consequently, the same conclusions are also
true for rhythmic degradation. For long mRNA half-life the oscillation of mRNA abundance
vanishes accompanied by a phase shift of up to 6 hours. This was also verified through numerical
simulations of the model, Figure 2.9A.
However, an additional rhythm in degradation can lead to an amplitude boost. Because of
this additional amplitude gain, transcripts with longer half-lives can oscillate with functional
rhythms. Let us assume only rhythmic mRNA abundances with amplitudes larger than 0.1 are
biologically functional. Then, the half-life of transcript influenced only by rhythmic production
can take values of up to 26.5 hours and still be biologically functional. However, transcripts
under the influence of rhythmic production and rhythmic degradation can have a half-life twice
as large, up to 53 hours, due to the amplitude boost. These values depend strongly on the rates’
amplitudes and phase differences, Figure 2.9B.
In conclusion, the model solution tells us that the phase range and amplitude range of tran-
scripts under the control of rhythmic production and rhythmic degradation spans between the
extreme values, all possible values between these can be reached. Consequently, rhythmic degra-
dation is able to explain the discrepancy between transcriptional activity and transcript abun-
dance found in mouse liver and kidney. What about other PTR steps? Can a rhythm in any
PTR explain the discrepancies? Or is there something special in rhythmic degradation? This
will be looked at in the next main section. However, before we proceed I briefly present how
possible degradation rates can be predicted using the ODE model. This is useful since in the
data we tackle degradation is the unknown variable.
44
2.5 Rhythmic Post-Transcriptional Degradation
φ    - φ     = 12 h deg prod φ    - φ     = 6 h deg prod φ    - φ     = 0 h deg prod
half-life (h)
xφ  
 - 
φ  
   
 (h
)
half-life (h)
pr
od
x
re
la
tiv
e 
am
pl
itu
de
 A
0
2
4
6
0.1 1 10 100
4
6
5 20
0
0.2
0.4
0.6
0.1 1 10 100
0
0.1
0.2
5 20
A
A = 1prod
A = 0.8prod
A = 0.6prod
A = 0.4prod
A = 0.2prod
A = 0prod
Δφ = 12 h
Δφ = -12 hdegdeg
degradation amplitude Adeg
m
ea
n 
ha
lf-
lif
e 
t1
/2
 (h
)
m
ea
n 
ha
lf-
lif
e 
t 1
/2
 (h
)
0 0.5 1 0 0.5 10
20
40
60
0
10
20
30
Δφ = 0 hdeg
degradation amplitude Adeg
B
Figure 2.9: Conclusions drawn from model solution: influence of half-lives. A Phase
shift and amplitude reduction for long half-lives if mRNA also is influenced by rhyth-
mic production and rhythmic degradation. Shown are numerical simulations. Depen-
dence of relative amplitudes and phases on the half-life. Parameter: Aprod = 0.25,
Adeg = 0.15, k = 1 h−1, t1/2 = 2 h. B The relative amplitude Ax vanishes for
long half-lives. Shown are maximal mRNA half-lives required to generate a relative
amplitude Ax > 0.1 for different rate parameters.
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2.5.3 Predicting Possible Degradation Rates
The model Equation 2.9 uses given production and degradation rates to predict the transcript
abundance. The data I investigate contains information of production rate and the transcript
abundance. The degradation rate is not measured.
However, I can use the approximated solution of the model to predict an unmeasured degra-
dation rate by transforming Equations 2.10, 2.11.
The vector annotation provides an intuitive understanding of this transformation. Phase and
amplitude of an unknown degradation can be estimated by the reverse calculation of the model
solution. The vector of the now known molecule abundance x is rotated backwards and increased
in length by a half-life dependent factor. From the resulting production-degradation vector the
production-rate-vector is subtracted. The resulting vector is the degradation rate-vector in
opposite direction, see Figure 2.10.
In mathematical terms this reads:
φdeg ≈ arg
(
Aprode
iφprod −Apdeiφpd
)
, (2.12)
Adeg ≈
∣∣∣Aprodeiφprod −Apdeiφpd ∣∣∣ (2.13)
where the relative amplitude Apd and phase ϕpd of the production-degradation vector are
calculated using the half-life and the phase and relative amplitude of the molecule, yielding
Apd = Ax
√
γ2 + ω2/γ and φpd = ϕx − arctan(ω/γ).
In order to verify this approach, I estimated the degradation rates from numerical simulations
with different parameter sets for rhythmic production and degradation rates. I found there is
a reasonably good agreement between degradation rate used for the numerical simulation and
estimated degradation rate. Especially for low relative amplitudes in the rates, the estimation of
the degradation phase deviates by up to 2 hours (12% of 24 hours) from the numerical simulation
and the degradation amplitude deviates by up to 0.2 (20% of the maximal relative amplitude),
see Appendix A.1.4. This is useful for an application since most transcript abundances have
small relative amplitudes, which would translate into even smaller relative enzyme abundances
and possibly activity rates and hence production and degradation rates might often oscillate
with a small amplitude.
2.6 Rhythms in Other Stages of PTR
The previous model describes one post-transcriptional process, degradation, to be rhythmic. Is
it possible to use the same model to investigate any other post-transcriptional process? Can
other processes besides degradation explain discrepancies between transcriptional regulation
and transcript abundance? Or, in other words, which post-transcriptional process can result
in a phase shift of more than 12 hours between transcriptional activity and mRNA abundance
and which processes are able to increase amplitudes? These are findings which are seen in
the data and cannot be explained simply by transcriptional activity. In the following I will
examine other post-transcriptional processes to investigate if any of these can explain observed
phase and amplitude relationships. Since PTR is complex involving different steps acting on
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of m6 mRNA methylation would be filtered out already by the first question.
After ensuring that the post-transcriptional process of interest is captured by the data and
that this process corresponds to the overall dynamics of the analyzed model the last question
reveals if the model must be extended in order to fully describe the rhythmic post-transcriptional
process.
There is no need for an extension if the post-transcriptional process of interest removes mature
mRNA with no return. Besides mRNA degradation, this could be realized, for example, by
rhythmic mRNA export out of the cell [217]. Every conclusion drawn from the previous analysis
is also true for these processes and they serve for an explanation of the observed phase and
amplitude discrepancies between transcriptional activity and mRNA abundance.
However, if the rhythmic post-transcriptional process of interest acts on pre-mRNA, it is
necessary to expand the model by one additional species. In this expanded model, the pre-RNA
is rhythmically produced by transcriptional activity and rhythmically transformed to RNA or
in other words rhythmically “destroyed” as pre-RNA. The rhythmic transformation serves as
rhythmic production of the biomolecule mature RNA. In mathematical terms this reads
dx
dt = prodx(t)− degx(t)x,
dy
dt = degx(t)x− degyy,
prodx(t) = k (1 +Aprod cos (ωt− φprod)) ,
degx(t) = L (1 +Adeg cos (ωt− φdeg)) ,
degy = γ.
(2.14)
Here, prodx(t) and degx(t) are the time dependent production and degradation rate of pre-
RNA x with relative amplitudes Aprod, Adeg and phases φprod, φdeg, respectively. L is the
mean rate of the rhythmic post-transcriptional process. The mature mRNA y is constantly
degraded with rate γ. Although constituting a new system the dynamics of this ODE system
can be broken down to the already known solutions stated in the previous section. The first
equation describes a biomolecule being rhythmically produced and degraded, the second can be
interpreted as RNA with rhythmic production and constant degradation. The phase difference
and amplitude relation between measured transcriptional activity and mRNA abundance is then
stated by the phase and amplitude relation between rhythmic production of x and the abundance
of y. It is given by combining solutions from the two models. The rhythmic post-transcriptional
process in this formulation acts as rhythmic degradation of the pre-RNA. The model of rhythmic
production and rhythmic degradation dictates that production and degradation rate or rhythmic
post-transcriptional process form the production-degradation vector which is shifted and reduced
by a factor depending on the mean rate of the rhythmic post-transcriptional process. The
resulting vector is then further shifted and reduced in length by a factor depending on the mRNA
half-life, as described by the model of constant degradation, see Sec. 2.1. Consequently, an
unknown rhythmic post-transcriptional processing of pre-RNA can also result in any phase and
amplitude relation between transcriptional activity and mRNA abundance. However, a possible
amplitude boost, arising from an advantageous relation between rhythmic rates of transcriptional
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activity and post-transcriptional process, is subject to a stronger decrease in amplitude due to
more processing steps, i.e. rhythmic post-transcriptional processing and mRNA degradation,
between generation of the oscillation and measurement of mRNA abundance.
In summary, with a systematic analysis guided by three questions, I systematically examine
the influence of a rhythmic post-transcriptional process on available data. I first ensure that any
particular rhythmic post-transcriptional process is captured by the data and can be described by
the model of rhythmic production and rhythmic degradation. I then use the previously achieved
results to deduce if this rhythmic process can explain every observed phase and amplitude in
mRNA abundance.
I will discuss this approach using the process of splicing. Rhythmic splicing of certain tran-
scripts occurs due to the rhythmic abundance of splicing-(co-)factors, availability of splicing
sites due to changed conditions [218] or possibly due to variation of transcriptional speed which
changes the availability and consequently the cooperativity between splice sites. A single gene
can code for many proteins. This is realized by so-called alternative splicing, i.e. including or
excluding certain exons due to different splicing conditions. In mouse liver it is estimated that
20% of expressed genes contain a circadian exon [186].
2.6.2 Systematic Analysis of Rhythmic Splicing
Can rhythmic splicing result in any phase and amplitude relation between transcriptional activity
and mRNA abundance? Let us follow the proposed system to answer this question. The data
on pre-RNA or transcriptional activity represents unspliced RNA, RNA sequencing accounts
for spliced RNA. Splicing is hence represented by the data. Furthermore, splicing transforms
pre-RNA into mature RNA with no return, the overall dynamics of the model of rhythmic
production and rhythmic degradation is valid. Splicing changes the level of pre-RNA. The
process is therefore described by an 2-ODE-system, where a pre-RNA (x in model model 2.14)
is rhythmically transcribed and rhythmically spliced, the rhythmic splicing serves as a rhythmic
production of mature RNA (y in model 2.14). The phase and amplitude of an mRNA is then
determined by the phase and amplitude relation of transcriptional activity and splicing. Since
the mean splicing rate is fast (see Section 2.1), the mRNA abundance is mainly influenced
by the transcript’s half-life. To have any resulting phase relationship between pre-RNA and
mature RNA, observations that we seek to explain, splicing should oscillate independently from
transcriptional activity. However, in many cases splicing occurs co-transcriptionally [198] and
is thus timely coupled to transcriptional activity. Rhythmic splicing that is not coupled to a
rhythmic transcription would furthermore lead to accumulation of unspliced transcripts in the
nucleus. However, RNA accumulation in the nucleus has, to date, been rarely observed and
is rather a reaction to stress signals [219, 220, 221] than a common cellular program. Hence,
rhythmic splicing resulting in only one transcript is not supported by existing knowledge on
splicing and furthermore, would fail to explain a wide range of phase relationships owing to the
coupling of transcription and splicing and hence similar phases in the rates.
Alternative splicing, however, produces 2 or more transcripts. The switching between one
transcript variant to another due to alternative splicing is not coupled to the transcription
itself. Transcription rate and splicing rate of a certain transcript variant can take any phase
relationship and, hence, circadian alternative splicing together with circadian transcription can
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produce any phase and amplitude in mRNA abundance.
In summary, many phase and amplitude relationships between transcriptional activity and
mRNA abundance cannot be explained by rhythmic transcription alone. Consequently, mRNA
abundance is further influenced by other rhythmic post-transcriptional processes. Only rhythmic
processes which are reflected by the data and are not timely coupled to the transcription can
explain the wide range of phases in mRNA abundance. Processing of pre-RNA, however, is
often coupled to transcription, for example adding the 5’cap is completed before the end of
transcription, most splicing occurs co-transcriptional [198] and the poly(A) tail is added once the
transcription is terminated. Regulating nuclear export seems to be transcription independent
and if being rhythmic, nuclear export could possibly explain observed phase relation ships.
However, rhythmic nuclear export together with uncoupled rhythmic transcription would lead
to RNA accumulation in the nucleus. As explained earlier, this does not seem to be a regular
cellular program such as circadian gene expression. With that I conclude, up to the current
state of knowledge, only three biological processes are able produce every relationship between
transcription and mRNA abundance, that is rhythmic alternative splicing, rhythmic degradation
and rhythmic mRNA export out of the cell.
2.7 Characterizing and Analyzing Rhythmic PTR in Liver and Kidney
About 18% transcripts of all circadian transcripts in kidney and 34% in liver are positively tested
for rhythmic post-transcriptional control, see Section 2.4. With that the fraction of genes with
rhythmic PTR is twice as large in liver compared to kidney. Only processes with an independent
phase from transcription can explain these findings, see previous section. Furthermore, it is
possible to predict the phase and amplitude of the rhythmic post-transcriptional process, see
Section 2.5.3. All of these findings are based on mathematical modeling. This is of course only
a hint towards actual evidence.
Is it possible to support these findings with additional evidence derived from a different source?
Already, in our paper Lück et al. [179] we showed that genes positively tested for rhythmic PTR
are also overrepresented in targets for CIRBP (Cold induced RNA binding protein), a protein
which has a circadian abundance and destabilizes transcripts [169]. Furthermore, we showed
that predicted degradation rates correlate with measured rhythmic poly(A) tail lengths [189].
Poly(A) tail length of a transcript is connected to its half-life. These two findings verify that
RNAs we classify using our test as under rhythmic post-transcriptional control are also found
experimentally to be under rhythmic post-transcriptional control.
Is there further evidence? Why are the fractions of circadian transcripts with rhythmic PTR
so different between both organs? To answer these question I will try to find the “footprints”
of rhythmic PTR, either in biologically motivated evidence or based on the shape of mRNA
abundance time series.
2.7.1 Circadian Genes Have Longer UTRs in Liver than in Kidney
Any PTR is mediated by so-called trans-factors, which bind to their recognition sites in the
un-translated regions (UTRs) of mRNA. It is interesting to see that genes circadianly expressed
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in liver have slightly longer UTRs in liver than kidney, see Figure 2.11. This difference is not
observed for all expressed genes in liver and kidney, see Figure 2.11. With longer UTRs and
presumably more recognition sites transcripts are prone to a more complex PTR. This might
explain the larger proportion of genes positively tested for rhythmic PTR in liver.
UTRs contain recognition sites for trans-factors, known examples are miRNA and RNA bind-
ing proteins. The first, miRNA, are, most likely, not able to influence circadian rhythms because
timescales in miRNA-dependent regulation are too long [178], see also Section 1.2.1. Therefore,
I will concentrate in my investigations on RNA-binding proteins (RBPs). RBPs bind to the
mRNA and determine the mRNA’s fate by controlling post-transcriptional processing on every
step of an mRNA’s life time. More than 1500 RBPs have been identified in humans [151], each
usually targeting groups of mRNAs rather than single mRNAs. These groups of genes are then
each co-regulated by one RBP. It has been argued that each group encodes functionally related
proteins [222]. I will therefore investigate, which RBP are rhythmic in mouse liver and kid-
ney. Furthermore, I will investigate if binding sites of these RBPs are enriched in those genes
which are positively tested for rhythmic PTR. And finally, I will investigate if those genes group
together regarding their gene function which would support that there is a co-regulation.
2.7.2 Rhythmic RBPs and Predicted Degradation Rates are Different in Both
Organs
A rhythmic RBP activity is induced by three situations: First, a rhythmic RBP abundance;
second, a constant abundance but rhythmic protein activity caused by post-translational modi-
fications or third, the rhythmic appearance of RBP recognition motives on the transcript itself
mediated by alternative splicing. It is estimated that 20 % of circadian genes contain a circadian
exon [186]. Likewise, one can assume the regulatory region and with that availability of RBP
binding sites to be affected by alternative splicing. However, to characterize alternative splicing
of UTRs in circadian genes is far beyond the scope of this thesis. To my knowledge, there
is no comprehensive investigation of RBP activity available. Rhythmic abundance of RBPs in
mouse liver and kidney, however, can be estimated from their transcript abundance. I used three
curated databases to find a comprehensive list of RBPs. I excluded those with non-circadian
transcripts and transcripts which have only a small relative amplitude. Additionally, I excluded
those, for which a long protein half-life was reported [213]. In this way I found 25 RBPs in liver
and 15 RBPs in kidney whose transcript have a circadian abundance, which is an indicator for
rhythmic protein abundance. Only 4 RBPs have rhythmic RNAs in both organs. A complete
list, together with known gene functions, can be found in Appendix F.4. Phase distributions of
the RBP transcript phases reveal that in both organs certain phases are more prominent, see
Figure 2.12A, in kidney more RNA binding proteins are expressed during the first half of the
day, in liver more transcripts are expressed in the second half of day. Although the phase of
a transcript is not a reliable estimator for the protein phase, the accumulation of RBP tran-
script phases indicate that rhythmic PTR might be more pronounced at some specific times
throughout the day.
This is supported by distributions of predicted degradation phases for genes with rhythmic
PTR, see Figure 2.12A. Here, I also found an accumulation of degradation phases at some
times of the day. Interestingly, these peaks in the distribution are almost antiphasic between
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both organs. Different phases in RBP transcripts and predicted degradation rates indicate that
rhythmic post-transcriptional is highly organ specific, not only that there are different RBPs but
also they act at different times during the day. Furthermore, PTR seems to cluster at specific
times in both organs.
2.7.3 RBP Binding Sites and Gene Functions
Are genes with rhythmic PTR enriched in targets of specific RBPs? To investigate this I searched
for RNA binding sites in the regulatory regions, 5’untranscribed region (UTR) and 3’UTR, of
transcripts with rhythmic PTR. To test for enrichment I used a Fisher’s exact test and tested
an enrichment of bindings sites against binding sites in all circadian transcripts. With this
I found that 4 RBPs in kidney and 70 RBPs in liver have significantly more targets in the
group of transcripts with PTR than in all circadian transcripts. If these RBP truly mediate
rhythmic PTR they would act at specific times of the day, that is to say, their action itself
is circadian. Hence the predicted degradation phases of the RBPs’ targets would accumulate
at those times. However, the degradation phase distribution of the target genes for each RBP
shows no pronounced accumulation of phases for any of the RBP (not shown). Instead, each
distribution is similar to the distribution of all degradation phases.
It seems that looking at RBP binding sites is not an appropriate way to search for hints on
rhythmic PTR. Most of the binding sites found are, most likely, not functional which results in
many false-positives. This is supported by the fact that a larger number of significant RBPs
have been found in liver. In liver rhythmic transcripts have much longer UTRs, which contain
more RBP binding sites.
The search for RBP binding sites ended in a dead end due to unspecific binding sites. Although
I could not pinpoint single RBPs which regulate groups of transcripts these groups might exist,
since one RBP targets several RNA. These genes are possibly connected through their gene
function [222].
Are genes with similar degradation phases and hence a possible co-regulation enriched for
certain gene functions? To test for enrichment in gene functions I used the DAVID Function
Annotation Tool [223, 224]. This tool uses a diverse range of annotation databases to identify
gene functions. It then tests for enrichments of gene functions which are related in their biological
function. These genes form gene function clusters. To test for enrichment the tool uses a
Fisher’s exact test where the background can be provided by the user. The tool then provides
an enrichment score for each gene function cluster.
To use the DAVID Function Annotation Tool I carefully chose my background against which
genes I wanted to test for enrichment. The genes I tested for rhythmic PTR had to fulfill certain
requirements, namely rhythmicity in either transcript abundance or transcriptional activity and
sufficient certainty about the half-life. These requirements limited the set of genes substantially.
Hence, I first searched for enrichment in all genes tested for rhythmic PTR against all circadian
genes. It turns out that this gene-set is highly enriched, i.e. high enrichment scores, for protein
maintenance in a broad sense, see Figure 2.12B. I now tested the genes with rhythmic post-
transcriptional for a gene function enrichment against all tested genes, see Figure 2.12B. I also
found gene function clusters which relate to protein maintenance and could even relate them
to degradation phases. However, the small enrichment scores for each cluster and high false
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discovery rate for each single gene function indicate that the gene functions I found do not
relate directly to rhythmic PTR.
In summary, it is possible to draw some general conclusions regarding the nature of rhythmic
PTR. The investigation of predicted degradation phases and phases of rhythmic RBP transcripts
indicate that rhythmic PTR is more pronounced at specific times of the day. These times
do not relate to the overall RNA phases, see Figure 2.2B. Furthermore, comparison between
both organs reveals that rhythmic PTR is highly organ-specific. However, revealing further
biologically motivated evidence for rhythmic PTR was not feasible. Functional RBP binding
site were drowned in noise and gene function enrichment failed due to the small and specific
gene set and possibly also to an incomplete gene function annotation. It seems only direct
experimental evidence can support the modeling findings, as for example the investigation of
single RBPs with rhythmic abundance or activity together with the RBPs’ targets.
54

2 Post-Transcriptional Regulation of Clock Controlled Genes
2.7.4 Shape of Time Series
Another approach implemented to investigate hints for rhythmic PTR is to look at the shape of
the time series. A numeric simulation of the model from Section 2.5 reveals that rhythmic degra-
dation changes the form of the RNA time series in a specific way. While rhythmic production
described by cosine-function results again in a cosine-function in the RNA abundance, rhythmic
degradation rate introduces narrow peaks and broad valleys to the time series, see Figure 2.13A.
If interpreted as time-dependent functions these abundances can be approximated by Fourier
series with a limited number of terms. A Fourier series of a pure cosine function consists only
of the first term. More complicated functions as, for example, generated by a rhythmic degra-
dation require more Fourier terms to be approximated, see Figure 2.13 A&B. In this way, RNA
abundance mainly influenced by rhythmic production would be approximated by a Fourier series
with the same number of Fourier terms as its rhythmic production, while rhythmic degradation
would increase the number of Fourier terms.
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Figure 2.13: Rhythmic degradation alters the shape of mRNA time series. Shown are
simulations of the model 2.9 in blue, in yellow for comparison the production rate,
squares illustrate how many Fourier terms are needed to describe each function.
A Production described by cosine function, B production described by a cosine
production + 0.3 times its second harmonic.
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Hence, I argue that if fitting of an RNA time series would need more Fourier terms than a fit
of its transcriptional abundance this gene is likely to be tested positively to be under rhythmic
PTR (methods see Appendix C.6). Accordingly, I first tested how many Fourier terms would
be needed to describe transcriptional activity and secondly, if transcript abundance would be
better fitted with a Fourier Series with one more term than its transcriptional activity. To
compare different model fits I used the ANOVA-package implemented in R. The p-values of
both tests, test of the time series shape and for rhythmic PTR, do not correlate. Also large
relative amplitudes of the predicted degradation rate, an indicator for a strong influence of
rhythmic PTR, only correlate with the test result testing for rhythmic PTR but not with the
test for a different shape of the time series, see Figure 2.14A. However, both tests test different
things. The p-value distribution of any test under the null-hypothesis is uniformly distributed.
Hence, large p-values of independent tests are always uncorrelated. I therefore tested if hits of
one test are enriched in the hits of the other test, see Appendix C.6. It turned out that this is
true, with high significance, see Figure 2.14B.
Consequently, investigation of the shape of time series of transcripts returns the genes found
to be under rhythmic degradation. However, not every gene with rhythmic PTR shows this
characteristics in the time series. A possible reason for this may be the limited number of
measured time points, which does not allow to fit Fourier series with many terms. Additionally,
other kinetic influences, not captured by the simple model, might shape time series.
It is worth mentioning that the shape of time series altered by rhythmic degradation also influ-
ences the RNA’s magnitude. This leads to higher magnitudes for RNA influenced by rhythmic
degradation compared to magnitudes of RNA influenced by rhythmic production. We termed
this phenomenon “magnitude effect” in the paper [179].
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Figure 2.14: Hits in genes with a different Fourier series fit for transcriptional activ-
ity and RNA abundance are enriched in genes with rhythmic PTR. A
Scatter plots of p-values of both tests. Orange indicate genes where relative am-
plitude of transcriptional activity ATRXact is much smaller than relative amplitude
of predicted degradation rate Adeg, i.e. AdegATRXact ≥ 1.5 B p-value of enrichment test
from genes with a different Fourier series fit for transcriptional activity and RNA
abundance in genes with rhythmic PTR dependent on threshold to define hits in
each test set.
58
2.8 Discussion of the First Part
2.8 Discussion of the First Part
In the preceding chapter, I answered the main question of what effect post-transcriptional reg-
ulation, constant or rhythmic, have on rhythms in mRNA abundance. First, in Section 2.1, I
investigated how rhythms from transcription are transmitted to mRNA abundance. The anal-
ysis showed that every mRNA processing step dampens the rhythm. The longer it takes for
processing, the greater the loss. Since mRNA half-lives introduce the longest time scales in
mRNA processing, half-lives contribute most to rhythm loss. The presented mathematical rela-
tion between processing time and loss of rhythm allows the quantification of such effects. If a
transcript is influenced by only one rhythm in its production, it can peak at most 6 hours (one
quarter of a period) after the peak in production. The exact phase difference depends again on
its processing time.
If mRNA abundance and transcriptional activity are compared on a genome-wide scale, one
can observe several transcripts where mRNA peaks much later than 6 hours after its tran-
scriptional peak activity. Furthermore, rhythm gain from transcriptional activity to mRNA
abundance can be observed, that is, mRNA abundance shows a higher relative amplitude then
mRNA transcriptional activity. These observations imply additional rhythms influencing the
mRNA abundance. My model was kept general, allowing to systematically test diverse couples
of potentially rhythmic processing steps. An obvious example for this is rhythmic degradation. I
introduced a model describing rhythmic production and rhythmic degradation in Section 2.5 and
presented an analytical solution together with an intuitive interpretation of the model solution.
In Section 2.6 the model is re-interpreted and extended to test other candidates of rhythmic
processing steps. The discussion of the model solution revealed that any phase relationship
between mRNA abundance and transcriptional activity is now possible. For extreme cases,
e.g., a phase shift of 12 hours between production and abundance, the second rhythmic process
must, firstly, be the dominating oscillation, that is, it has to oscillate with a higher relative
amplitude and, secondly, it must be uncoupled from transcription. After a careful discussion
of the known post-transcriptional processes, I conclude that, with the information we have to
date, only rhythmic degradation, cellular export or alternative splicing can explain the wide
range of phase relationships between transcriptional activity and transcript abundance. In our
publication we analyzed two specific data sets[179]. Transcripts that showed evidence of a sec-
ond rhythmic processing step were enriched in targets of the RBP CIRBP and in mRNA with
rhythmic poly(A) tail lengths. Poly(A) tail length is connected to its transcript’s half-life and
CIRBP is known to destabilize its target mRNA. Hence, both experimental findings point to
rhythmic mRNA degradation.
If a transcript is influenced by rhythmic production and constant degradation there are strict
limits for phase and amplitude relationships between mRNA abundance and transcriptional
activity. This understanding allowed the development of a variety of tests whether a rhythm in
mRNA abundance can be explained by the rhythm of its transcriptional activity alone. These
tests are presented in Section 2.3 and 2.4. The most powerful of these is the so-called PA-
test (production-abundance-test). It takes time series specific noise into account and provides
a probability (p-value) to reject the null hypothesis of no additional rhythmic process. The
test has, however, quite stringent data requirements: For each tested gene the half-life must
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be independently measured at least twice. This is not provided for many genes. Therefore, I
presented and discussed alternative ideas to test for rhythmic post-transcriptional regulation.
I used the modeling ideas together with the PA-test to investigate two data sets on mouse liver
and kidney. This led to an estimate that 34% of circadian genes in liver are under rhythmic post-
transcriptional control, while in kidney this portion is found to be much smaller, with only 18%.
One reason for this discrepancy might stem from the longer regulatory sequences in liver RNA
of circadian genes compared to circadian genes in kidney, a difference which was not observed
between all expressed genes in liver and kidney, see Section 2.7.1. Longer regulatory sequences
give rise to the possibility of harboring more RBP-binding sites and, hence, might provide
more regulation possibilities. Furthermore, the predicted phases of the post-transcriptional
processes and measured phases of rhythmic transcripts of RNA-binding proteins, showed no
systematic correlation between the two organs. These observations may indicate that rhythmic
post-transcriptional regulation is highly organ-specific. Notably, unusually long 3’UTR have
been observed in the mammalian brain [225]. An investigation of circadian transcriptomes of
the brain would be an intriguing application of the tool set presented herein.
I took another approach to verify genes with post-transcriptional control and investigated the
shape of time-series, an idea based on numerical simulations of the model. Here, I could show
an enrichment of genes where the shape of the time series indicate a rhythmic PTR in hits of
genes positively tested for rhythmic PTR with the PA-test.
Unfortunately, the search for further independent evidence for rhythmic post-transcriptional
regulation of the identified candidates in liver and kidney was not very fruitful. Neither RNA-
binding site nor gene function enrichment analyses revealed further confirmation. Further exper-
imental evidence might be necessary to verify the post-transcriptional control for the identified
candidates. However, motif enrichment analysis is an art in itself, and further improvements may
change the picture. One possibility for example would be to account for RNA accessibility of
RBP-binding sites, that is, to exclude motifs that are masked by RNA secondary structure [226]
into the previous analysis to reduce false-positives. Probably, other refinements of the proposed
investigation methods are also possible.
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3.1 Can Harmonics be Generated by Post-Transcriptional
Regulation?
In all of the previous results I left the period untouched and implicitly assumed that every
transcript under rhythmic post-transcriptional regulation has a circadian period of about 24
hours. However, besides the circadian period, 12 hour rhythms were also observed in transcript
abundances in mouse liver [106, 129, 227], although in only 1% of all circadian transcripts [106].
Cretenet et al. [228] investigated a pathway which activates with a 12-hour rhythm, the IRE1α
pathway, in more depth. They not only showed 12-hour rhythms in mRNA abundances, but
also that proteins oscillate in this shorter rhythm. Furthermore, they demonstrated that a
disruption of the clock also diminishes the 12 hour-rhythms. They hypothesize the rhythmic
pathway activation relates to a stress response of the endoplasmatic reticulum which is also
reported to have a 12 hour rhythm. The findings of Cretenet et al.[228] not only demonstrate
that 12 hour rhythms fulfill a biological function, but also that the circadian clock is needed for
their generation.
A 12 hour rhythm is the second harmonic of a 24 hour rhythm, that means the frequency is
twice as high as the original frequency. Which biological processes can generate this higher har-
monic? At present an experimental proof is missing. Westermark et al.[229] showed that 12-hour
rhythms can be generated by certain transcriptional activation patterns. If two transcription
factors with a circadian abundance activate independently from each other the transcription of
one gene, they can generate a second harmonic in the gene’s transcript. The second harmonic is
most pronounced if the abundance of the two transcription factors oscillate in anti-phase. Here,
the coordination of the two rhythms with the same frequency gave rise to higher harmonics. Can
rhythmic post-transcriptional regulation combined with rhythmic transcriptional activity, i.e.
two rhythms influencing the transcript abundance, generate a 12 hour rhythm? In the following
I want to use the previous model results to investigate this question.
Any rhythmic time series can be approximated with a Fourier Series, a linear combination of
sines and cosines with whole-number multiples of the frequency:
x(t) = A02 +A1 cos(ωt) +B1 sin(ωt) +A2 cos(2ωt) +B2 sin(2ωt) + ... (3.1)
Here, ω = 2pi24h−1 describes the angular frequency related to the circadian period, and A0,
A1, B1 ... are the Fourier coefficients, which determine the contribution of each sine or cosine
function. We observe a second harmonic in the time series if the contribution of the first
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frequency is smaller or equal compared to the contribution of the second, i.e. A1 ≤ A2 and
B1 ≤ B2.
For a transcript which is rhythmically produced and rhythmically degraded I show in Ap-
pendix A.1.3 that the Fourier coefficients are proportional to 1 over the Fourier terms order,
that is An 1/n and Bn 1/n. Hence, the first Fourier term is larger than the second. Conse-
quently, rhythmic production together with rhythmic degradation cannot generate a 12 hour
rhythm. This is supported by extensive numerical investigation.
Rhythmic splicing, however, is able to generate a 12 hour rhythm as I will show in the following.
An mRNA which is rhythmically produced and rhythmically spliced reads:
dx
dt = prodx(t)− splic(t)x,
dy
dt = splic(t)x− degy,
prodx(t) = k (1 +Aprod cos (ωt− φprod)) ,
splicx(t) = L (1 +Asplic cos (ωt− φdeg)) ,
degy = γ.
(3.2)
Here, x describes the unspliced pre-RNA, y the mature mRNA. The time-dependent produc-
tion and splicing rate is again described with a specific relative amplitude and a phase. The
production term of y, the mature mRNA, consists of a product of two periodic functions: the
rhythmic splicing rate and the rhythmic level of the unspliced pre-RNA x. This product gives
rise to the 12 hour rhythm. In principle, a product of two pure cosine functions always oscillates
with the doubled frequency, independent of their phase relation ship. This can be shown with
the calculation of the product of two cosines with a phase difference φ
cos(ωt) cos(ωt− φ) = 12 (cos(2ωt− φ) + cos(φ)) . (3.3)
While the input oscillations oscillate with ω their product oscillates with 2ω, independent of their
phase relationship. However, the reduction of the pre-RNA to a cosine function is misleading.
Numerical investigation reveal that the generation of 12 hour rhythms is not as immanent as
the calculation suggests, but, in contrast, strongly depends on the properties of production and
splicing rates. Here, not only the relative amplitude of each rate and the phase difference between
both rates play an important role, but also the shape of the rates influences the generation
of 12 hour rhythms. If we assume that production and splicing rate follow cosine functions,
then in order to observe 12 hour rhythms either the oscillation in splicing rate must be very
strong or splicing peaks more than 12 hours later than the production, see Figure 3.1A. This
result changes if we assume that the production is described by a rather pointy function, see
Figure 3.1B and Appendix D.1. Such a pointy function has been observed both for kidney and
for liver as exemplified in Section 2.2. In Figure 3.1B the parameter range which generates 12
hour rhythms for a pointy production rate is shown. Comparison with the previous result reveals
that the graph is rotated. This means, in order to produce a 12 hour rhythm and assuming a
pointy production rate, the phase difference between both rates must be smaller compared to a
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system with a cosine-shaped production rate. However, a large relative amplitude in the splicing
rate is still required.
Are these results biologically relevant? Are large phase differences between production and
splicing plausible? What about a strong oscillation in the splicing rate? A large phase difference
means that unspliced transcripts remain in the nucleus for a quarter day or longer. Most of the
splicing, however, is coupled to the transcription [198]. Furthermore, it seems that the splicing
machinery protects the pre-RNA from early nuclear degradation [230]. A long residence of
unprocessed pre-RNA in the nucleus seems therefore to be unlikely. Hence, I expect the phase
difference between production and splicing to be small, rather in the range of minutes than
hours. Therefore, a large proportion of phase differences which would, in principle, generate 12
hour rhythms are not realistic. High relative amplitudes in the rates, on the other hand, are
in principal possible. However, most circadian transcripts, an indicator for enzyme abundance
and therefore also for rate amplitudes, have low relative amplitudes. Additionally, oscillations
observed in mRNA can be easily lost in protein abundances due to the kinetics explained in
Section 2.1. An increase of amplitude is possible due to several mechanisms, e.g. rhythmic
protein degradation as discussed in this work to great extent. But this requires a finely tuned
regulation of protein abundance.
Hence, the model results suggest that splicing can theoretically produce 12 hour rhythms. If
we observe 12 hour rhythms due to splicing this process seems to be highly regulated as it poses
high demands on the shape of the production rate and the splicing rate’s relative amplitude.
I argue that this would need a high evolutionary pressure to evolve, there would have to be a
strong advantage of 12 hour rhythms over 24 hour rhythms.
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Figure 3.1: Rhythmic splicing can produce 12 hour rhythms. Shown are two systems
for which the generation of 12 hour rhythms by rhythmic splicing were investigated.
The large circles show the result, on the left is the legend. If a 12 hour rhythm was
observed for certain parameters, a colored dot is plotted. All results are aligned to
one production phase φprod. The position of the dot is determined by the relative
amplitude of production Aprod and the splicing phase φsplic. The splicing amplitude
is encoded by color and size of the dot. They can stack onto each other and still be
visible, see legend in gray box. A The model was simulated with a cosine shaped
production. B The model was simulated with a pointy production, see Appendix D.1.
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3.2 Post-Transcriptional Regulation of Clock Genes
The circadian core clock is a network of transcription-translational feedback loops. With its
tuned inhibition and activation of gene expression the clock components oscillate with a period
of about 24 hours. They are the molecular basis for any circadian regulation, including rhythmic
PTR. However, core clock genes themselves are targets for rhythmic degradation, both at the
transcript [159, 160, 161] and the protein level [231, 232]. How does a rhythmic degradation of
a core clock component effect its oscillation properties, amplitude and phase? Is rhythmic PTR
of core clock components able to change the period, a key feature of the circadian clock?
Rhythmic degradation within the core clock is not captured by the model presented in Sec-
tion 2.5. Up to now I investigated only genes which do not feed back into a gene network system,
see Figure 3.2A. A basic description of a network system which can produce oscillations is pro-
vided by the Goodwin model [57]. It provides a phenomenological description of a protein which
suppresses the transcription of its own gene. It features the three important components that
generate oscillations: negative feedback, delay and nonlinearity [56, 233]. The circadian clock is
modeled by the Goodwin oscillator itself [234, 235] or by closely related models [236, 237, 238].
Consequently, the Goodwin model provides a good starting point to characterize the influence
of rhythmic PTR on core clock components.
The Goodwin model is a 3-variable model with two activations and one inhibition. The
synthesis and degradation rates are linear except of the inhibition rate, which takes the form of
a sigmoidal curve, a Hill-curve. To simulate rhythmic PTR in the core clock I let the degradation
rate of either one of the variables be rhythmic. This is achieved by introducing a cosine function
with phase and amplitude which does not affect the average degradation rate, see Figure 3.2B,
Appendix E.1. For each degradation phase and degradation amplitude I simulate the system
and determine the oscillation properties, period, magnitude, relative amplitude and phase, of
each system variable, see Appendix E.1 for details. In Figure 3.2C an example for a Goodwin
oscillator with rhythmic degradation rate is plotted together with the original Goodwin oscillator
with constant degradation rates.
Since it is well established that longer half-lives prolong the period of the Goodwin oscilla-
tor [234], I expected the period to be affected also by periodic half-lives. This could not be
confirmed, instead the period remained stable for almost all parameters, see Figure 3.3. One
exception was observed: If the degradation rate of the repressing species oscillated with an am-
plitude larger than 0.7 I observed a period doubling. All species then oscillated with twice the
period, however this oscillation still contained the original period, see Figure 3.2D.
Apart from this exception, introducing a rhythmic degradation to the Goodwin model had
a very stable effect, irrespective which variable was affected by rhythmic degradation. An
increasing relative amplitude in the degradation rate resulted in an stronger overall oscillation
of the whole system regardless of the degradation phase. This amplitude increase was very large,
with up to a 2 fold increase for strongly oscillating degradation rates. This degradation phase
independent amplitude increase contrasts with the results of clock-controlled genes, where only
a specific phase range produced an amplitude boost, see Section 2.5. Increasing the degradation
amplitude also increased the magnitude of all variables, see Figure 3.3. The degradation phase
affected only the phase of the oscillating system. The relationship between degradation phase
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and phase of the system is linear and the phase range of the system spans over all possible
phases.
These results suggest that rhythmic degradation of core clock genes is beneficial to the core
clock as it increases the overall amplitude and, hence, the biological impact of oscillations. Fur-
thermore, rhythmic degradation could serve to easliy shift the phase of all core clock genes since
there is a linear relationship between degradation phase and system phase. It seems, that oscil-
lating degradation rates in this model system contribute to the overall energy of the oscillating
system. However, the Goodwin oscillator is a toy-model which only consists of one negative
feedback loop. The circadian clock network, on the other hand, contains several intertwined
negative and positive feedback loops. Conclusions drawn from the Goodwin oscillator’s prop-
erties are not necessary true for the circadian clock itself. For example, the fact that longer
half-lives cause generally longer periods is true for the Goodwin model [234] but could not be
confirmed for a more complex model of the circadian network [239]. Experimental evidence
underlines this. A longer period of the core clock was observed either with a longer Cry1-mRNA
half-life [161] or with a shortened Cry1-protein half-life [232].
Interestingly, downregulation or upregulation of degradation rate influencing factors - common
experimental tools to investigate biological systems - primarily changes the average degradation
rate, but not necessarily its rhythmic properties, relative amplitude and phase. To investigate
only the rhythmicity of degradation one would need a tightly controlled down or upregulation
at specific times of the day in a system which forgets quickly relative to circadian time scales.
To my knowledge, such an experimental system has not been established. At present, it is not
possible to disturb and, with that, investigate experimentally the rhythmicity of degradation
rates and their contribution to the clock properties. Consequently, this problem can only be
tackled by mathematical modeling.
In summary, for a rather simple model I find that when introducing oscillating degradation the
system’s period remains stable for most of the cases. Any rhythmicity in the degradation rate
contributed to a stronger overall oscillation in all system’s variables, which might be desirable
for biological function. For more complex systems, these very general findings must be reviewed.
In order to do that, one could introduce rhythmic degradation to an already established math-
ematical model of the circadian clock, for example in the model of Relogio et al. [239] or Woller
et al. [240].
However, the proposed model, a Goodwin oscillator with modulated rates, should be discussed
a little further. In this model I actually modulated the degradation rate externally. With this,
the model describes an oscillating system driven by an oscillating degradation rate with the
system’s period. This means we are looking at an oscillator driven by an external force in
resonance and this easily explains the contribution of oscillating degradation rates to the overall
system’s oscillation strength. Another implementation of this system is realized when the core-
clock itself modulates the degradation rate. Hence, the degradation rates are modulated by one
of the variables, for example dx = dx(y).
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3.3 Aging of Molecules - Poly(A) Tail and Oxidized Proteins
I started this journey through rhythms and post-transcriptional regulation with the fundamental
statement that time matters for rhythms and long-lived molecules will loose their rhythms. In
this last section I want to partially withdraw this statement and show that molecules do not
completely loose their rhythms, but rather remember their history. If the age of a molecule is
measurable it is possible to see traces of rhythmic production also in long-lived molecules.
I describe the aging of a molecule by a Partial Differential Equation (PDE), a direct extension
of the ODE model describing rhythmic production and rhythmic degradation from Section 2.5.
In this chapter, I will introduce this model and characterize its dynamics. I will present two
examples where the cryptic concept of a molecule’s age can be related to actual data. And lastly,
I will demonstrate how a molecule remembers its history and how the PDE model can be used
to predict other, yet unmeasurable, dynamic quantities.
3.3.1 The Aging of Molecules - a PDE with a Physical Background
When we look at a person we can easily make a good guess how old he or she is by taking
into account several signs of aging such as gray hair or wrinkles. This concept of age does not
translate directly to biological molecules since neither proteins nor mRNAs get wrinkles, but
in both cases we can find different aspects which can be an indicator for a molecule’s age. In
the case of proteins it is known that long-lived proteins accumulate damage, mainly caused by
reactive oxygen species (ROS). mRNAs however, receive after their transcription a stabilizing
element, the poly(A) tail, a chain of about 250 adenosides. This chain is eroded during an mRNA
life time. Roughly speaking an “aged” protein is then a protein which accumulated damage and
an aged mRNA is an mRNA where the poly(A) tail is shortened. However, both processes,
accumulation of damage in proteins and erodation of the poly(A) tail in mRNA, do not always
proceed linearly in time as the term “aging” might suggest. For example there might be times
during the day with an increased ROS production and consequently a higher protein damage.
Similarly, it has been suggested that erodation or deadenylation of a poly(A) tail happens quite
quickly for the first adenosides but slows down for the last ones it. In both cases the “aging” of
either proteins or mRNA occurs faster or slower depending on the condition and background.
The McKendrick [241, 242] or von-Foerster [243] equation describes the aging of a population.
I use this model to describe “aging” molecules and modify it in such a way that the molecule’s
aging do not occur linearly in time. For simplicity, and to avoid the poor analogy of “aged”
molecules, I will refer from now on to “damaged” molecules. This can be directly translated into
damaged proteins. To translate this concept to mRNA with shortened poly(A) tail we calculate
the mRNA with a “damaged” tail, a newly synthesized mRNA with a full poly(A) tail has no
damage.
In the modified McKendrick model a molecule is characterized by two variables, time t and
damage d. It can be represented in a three-dimensional graph, see Figure 3.4A. Let then x(t, d)
be the number of molecules of damage (d, d+ dd) at time t. Hence, x(t, d) is a density function
in the damage d. An integration by the whole damage range gives the total concentration of
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molecules X with all possible damages at a specific time t
X(t) =
∫ ∞
d=0
x(t, d) dd. (3.4)
The concentration of molecules within a certain damage rangeD+∆d is given by an integration
over a certain range of damage
X(t,D) =
∫ D+∆d
D
x(t, d) dd. (3.5)
The fact that the modeling variable actually refers only through integration to a physical
property, molecule concentration, requires a careful derivation of the rates. This and a mathe-
matical justification of the model is presented in Appendix B.1 and B.2. However, to translate
from x(t, d) to X(t,D) in an intuitive way is rather straightforward, despite the not informative
integration. Figure 3.4B illustrates the integration and hence the intuitive understanding for
two cases. In short, x(t, d) is linear to X(t,D) for sufficiently small ∆d. Using this linear rela-
tionship it is possible to find a translation from x(t, d) to X(t,D). To avoid cluttered text I will
use in the following the term molecule concentration for x(t, d), although technically speaking
it is a molecule concentration density.
A molecule which is produced, damaged during its life time and degraded is described with
the PDE
∂x(t, d)
∂t
= −q(t, d)∂x(t, d)
∂d
− x(t, d)∂q(t, d)
∂d
− v(t, d)x(t, d).
x(t, 0) = k(t)
q(t, 0)
(3.6)
Here, k(t) is the production rate of newly synthesized proteins without damage, it characterizes
the initial condition x(t, d = 0). The rates v(t, d) and q(t, d) refer to molecule degradation
and damage accumulation, respectively. Since I want to describe a system under the influence
of the circadian clock all rates contain a time dependent, periodic function which describes
the oscillating variation of the rates. Degradation and damage accumulation can additionally
depend on damage. This can reflect different scenarios: For example, in the case of protein
oxidation, highly damaged proteins are more likely to be recognized for degradation than proteins
with lower damage. In this case the degradation rate increases with damage. In the same
manner the damage accumulation rate could depend on damage as I will show later. The actual
mathematical formulation of this damage dependent term depends on the biological situation.
In Appendix B.2 I discuss different scenarios for damage dependent degradation and damage
accumulation rates and suggest some mathematical description.
The Equation 3.6, known from population dynamics, is also well known in physics in a very
different context. In physics, this equation is used to describe the gas flux through a tube, its
name is then “transport equation”. In the following I want to use this physical interpretation to
discuss the different influences of the rates. This will, hopefully, provide us with a very intuitive
understanding.
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In this picture, the concentration of molecules x(t, d) at time t and damage d is the gas density
at time t and position d in the tube, see Figure 3.4C. This gas is poured into the tube only at
one end of the tube. During this pouring the gas density is varied with a time-dependent rate.
In this way, there are packages of highly dense gas and packages of low density gas produced at
the opening and then further transported. In our damaged molecule system, the pouring of gas
represents the production rate k(t) of molecules with zero damage. The gas is further transported
through the tube with small pumps, with a pump placed on each point along the tube. In this
way different speeds of transport can be enforced. Furthermore, all pumps are controlled by one
clock which dictates the same periodic rhythm to all pumps. If the small pumps have different
power outputs they locally change the gas density. The time dependency of gas transport,
however, can not generate a change in gas density since all pumps are controlled together. The
time dependency of transport rate only changes the overall transport. Transport changes the
position of gas, in the molecule image this is the damage of a molecule, hence the transport
reflects the rate of damage accumulation. The last rate to be explained is the degradation rate.
This rate can be imagined as little holes in the tube where gas escapes. Again, the hole size and
therefore the escape rate can depend on the position on the tube. But all holes together are
controlled by one clock which can close and open the holes. Also this rate is able to change the
gas concentration, in this case both time and position dependent. However, degradation rate
can only decrease gas density because it removes gas. In contrast to that the transport rate is
able to both increase and decrease locally gas density when gas is pooled or thinned out.
It is worth mentioning that the model is only analytically solvable if damage accumulation and
degradation rate do not depend on damage, see Appendix B.3. Hence, I will rely on numerical
solutions. In Figure 3.5 some numerical simulations for different rates are shown.
This model describing a molecule concentration with two features, time and a property ac-
quired over time is very general. Also the two very different examples which I will introduce in
the following in more detail underline the model’s generality. In the first example the model is
used to describe long-lived proteins and their oxidation, the second describes the poly(A) tail of
mRNA.
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3.3.2 Oxidized Proteins – Rhythms are Conserved
Proteins, in contrast to mRNAs, have much longer half-life, for proteins a median of 46 hours
compared to 9 hours for mRNA was detected [213]. Long half-lives destroy rhythms. Hence,
despite their rhythmic production many proteins possibly do not oscillate in their abundance.
Proteins however are exposed to reactive oxygen species (ROS), highly reactive molecules which
are a by-product from mitochondrial respiration. These free radicals attack proteins in different
ways. The most frequent alteration of attacked proteins is introducing a carbonyl group [244].
These alterations can be detected using an immunoblot technique (OxyBlot by Millipore). This
makes it possible to measure the concentration of damaged proteins.
With that we now have all ingredients to implement the model: the two variables time t
and damage d given by the concentration of proteins with carbonyl groups characterize the
protein concentration x(t, d). A simulation of long-lived proteins with a rhythmic production
demonstrates that the protein concentration is almost constant if we look at the total proteins
content whilst neglecting the damage variable. However, proteins with a certain damage, the
measured carbonyl groups, still show the conserved rhythm in production rate, see Figure 3.3.2.
Rhythmic production can cause a rhythm in damaged proteins. Desvergne et al. [245] observed
rhythms in proteins with carbonyl groups in two cell lines. They monitored all carbonylated
proteins using OxyBlot. However, production of all proteins does not oscillate, especially not
with one phase. This deems it very unlikely that rhythmic production caused the observed
rhythms in damaged proteins. In addtion, an oscillating degradation rate, oscillating damage
accumulation or a combination of both can generate oscillating levels of damaged proteins.
Biological evidence is found for all these cases. Desvergne et al. [245] demonstrated that key
components of the 20s proteasome, the proteasome which removes damaged proteins [246],
oscillate with a circadian rhythm and hence the degradation rate oscillates. Mitochondrial
activity and, with that, the ROS production and damage accumulation rate is controlled by the
circadian clock [113, 114]. This could be caused by oscillating mitochondrial key enzymes [115,
114] as well as an oscillating mitochondrial dynamic [113] which is correlated with mitochondrial
activity [116]. With further information on rate constants the proposed model Equation 3.6 can
be used to discriminate these different influences.
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3.3.3 Deadenylation of Poly(A) Tail
Another example to which we can apply the model characterizes a post-transcriptional process,
deadenylation of poly(A) tails. After transcription the poly(A) tail, in mammals a chain of
usually 250 adenosides [247], is added to the pre-mRNA. This stabilizing element at the 3’-end
of the mRNA is successively shortened in the cytosol by several deadenylases. The orchestration
of the diverse deadenylases is not yet fully understood but it seems that different deadenylases
successively attack the poly(A) tail [248, 187] and hence the poly(A) deadenylation rate depends
on the poly(A) tail length. Once the poly(A) tail is removed from the mRNA the whole mRNA
is attacked usually by exonucleases and quickly degraded. The half-life of an mRNA is therefore
mainly determined by the deadenylation of the poly(A) tail. Furthermore, only mRNA with
sufficient long poly(A) tails can be efficiently translated [249]. With that the length of the
poly(A) tail dictates two key features of the mRNA, namely for how long and how efficiently can
the mRNA fulfill its function i.e. being translated. However, the whole process of deadenylation
is incompletely understood.
How can we elucidate the deadenylation process and its involved deadenylases in more detail?
A big step in this direction is to look at deadenylation rates. Qualitatively changes in this
rate over the length of the poly(A) tail or over the course of a day provides hints that the tail
is attacked by different deadenylases or that deadenylases are controlled in a time-dependent
manner. To my knowledge, an experimental approach to measure genome-wide deadenylation
rates in vivo is not feasible at the moment. It is only possible to measure deadenylation rates
of radio-labeled bulks of different RNA or deadenylation rates of single RNA using qPCR-based
methods [250, 251]. However, we can describe the deadenylation of mRNA with the PDE model
and use this with new sequencing-data to predict deadenylation rates in a genome-wide manner
as I will outline in the following.
PDE-model Describing Poly(A) Tail Deadenylation
I will first translate this process of deadenylation into the PDE-model. In this framework, x(t, d)
describes the mRNA concentration with d already deadenylated adenosides, a newly synthesized
mRNA has zero deadenylated adenosides. This means d counts as removed adenosides. Newly
synthesized mRNA have a very narrow poly(A) tail length distribution of about 250 adenosides.
This allows us to introduce a new variable d′ in the model solution in order to translate to the
actual length of the poly(A) tail, a more accessible variable. The new variable d′ is determined
by the variable transformation
d′ = 250− d. (3.7)
In the model, the production rate k(t) refers to the transcript synthesis or transcriptional activity.
The damage accumulation rate q(t) describes the deadenylation rate and the degradation rate
the mRNA removal by exonucleases. Transcription of specific mRNA can exhibit a circadian
rhythm, accordingly the production rate is time dependent. Degradation rate, the removal of
the mRNA by exonucleases, depends strongly on the tail length. Only when the poly(A) tail
length is removed, the mRNA is degraded. If there are exonucleases with a circadian rhythm is
not known yet, however I deem it unlikely since this would mean accumulation of mRNA with
no tail and hence nonfunctional mRNA with a circadian manner. To my knowledge, this has
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not been observed. Consequently, the degradation rate is described well by a step function with
a steep increase for d ≈ 250 or d′ ≈ 0 and has no time-dependence.
Since deadenylation is performed by different proteins which successively attack the poly(A)
tail, possibly each at a different rate, the deadenylation rate depends on the poly(A) tail length
d′. The deadenylation rate can also exhibit a circadian rhythm due to circadian activity of
Nocturnin, a deadenylase with cycling gene expression in various tissues [166]. Hence, the
deadenylation rate depends on the poly(A) tail length d′ and on time. It is not yet known if
Nocturnin’s activity requires a specific poly(A) tail length. If this was the case, the mathematical
descriptions requires a function dependent on poly(A) tail length coupled to the time, best
described by an amplitude which depends on the tail length d′. Kojima et al. [189] identified
mRNA with long (60-250 adenosides) and short (<60 adenosides) poly(A) tails over the course
of a day. Even with this coarse distinction they identified 237 mRNA with a rhythm in their
short/long ratio of poly(A) tail length. Obviously, there is some influence of the circadian
clock on poly(A) tail length control. As we learned from the previous example, an oscillating
production rate results in an oscillation of mRNA with a specific poly(A) tail length. An
oscillating deadenylation rate that additionally depend on length causes rhythmic profiles in
poly(A) tail length. Although I discussed in detail time-dependent rates, for many mRNA
no time-dependence in any of the rates is required. The model can serve to describe a time-
independent, non-circadian deadenlytation aswell.
I will now use this PDE model to predict deadenylation rates.
Prediction of Deadenlytation Rates from Poly(A) Tail Sequencing
The basis of predicting genome-wide deadenylation rates is provided by an advancement in
RNA sequencing. In 2014, two methods were published which sequenced the poly(A) tail.
Up to this date, sequencing of long homopolymeric sequences (longer than 30 nucleotides)
was not possible. The sequencing of long stretches of one nucleotide, adenosides for example,
contain reading errors. The possibility for errors increases with the length. This makes it
impossible to define the correct end of a long homopolymeric sequence. However, Chang et
al. [252] and Subtelny et al. [253] independently found two methods called TAIL-seq and PAL-
seq to overcome this problem. TAIL-seq uses a machine-learning based method to interpret
the inaccurate signal [252], in PAL-seq the beginning and end of a poly(A) tail is chemically
tagged [253]. With these methods both groups were able to measure distributions of poly(A)
tail lengths in a genome-wide fashion.
In the model description the poly(A) tail length distribution is described by the solution x(t, d)
of the model. Inferring the deadenylation rate from the sequencing data, TAIL-seq or PAL-seq,
poses a so-called inverse problem. What does this mean?
Usually, a model solution x(t, d) is defined by its input parameters, here the production k(t),
deadenylation q(t, d) and degradation rate v(t, d). One can say, the model input parameters cause
the model solution. To identify the deadenylation rate we have to inverse this problem. With
the now known model solution, the information on poly(A) tail lengths, we want to recalculate
one of the input parameters, the deadenylation rate. In order to obtain a unique solution we
have to neglect the influence of other parameters. This can be done with two, biologically
reasonable, assumptions. First, only mRNA with a short poly(A) tail, e.g. <20 nucleotides,
77
3 Other Aspects of Rhythmic Post-Transcriptional Regulation
gets degraded, consequently, the degradation rate does not affect the mRNA for most of the
poly(A) tail length. The second assumption demands that the poly(A) tail length distribution
changes only slowly over time. Deadenylation is fast compared to circadian time scales. This
neglects the time dependence of all rates. An investigation of oscillating deadenylation rates,
hence time-dependent rates, would require a time series of snapshots of poly(A) tail length
distributions. Each snapshot is analyzed independently and a comparison between deadenylation
rates of different time points would reveal oscillations. Up to now, TAIL-seq of a time series
is not available, but I know from personal communication that two groups are working on this
problem.
If all these assumptions are fulfilled we can recalculate the deadenylation rate up to one linear
factor, which accounts for the production rate. Mathematically this is done by a discretization
of the solution and the model. Comparison of both results in a linear system of equations
from which the deadenylation rate in dependence of the poly(A) tail length is calculated. In
Appendix B.4 the method is outlined in more detail. Figure 3.7B shows a very simple simulation
of some data. Interestingly, already the simple assumption on the deadenylation rate, namely
q(d) e−0.1d, (3.8)
can reproduce the appearance of already published data, see Fig 3.7A1. In Figure 3.7C the
deadenylation rate is shown twice, once the one used for the simulation in Figure 3.7B and
secondly, the one I calculated from the simulated data using the method described above. Both
deadenylation rates agree very well proving the reliability of the proposed method.
1Reprinted from Molecular Cell, 53/6, Hyeshik Chang, Jaechul Lim, Minju Ha, V. Narry Kim, TAIL-seq:
Genome-wide Determination of Poly(A) Tail Length and 3’ End Modifications, 6, 2014, with permission from
Elsevier.
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Figure 3.7: Prediction of deadenylation rates. A Measured poly(A) tail length distribu-
tion for Cdh11, reproduced from [252]. B Simulated data with time-independent
production, damage accumulation and degradation rate. Damage accumulation
q(t) = 5e−0.1d, degradation is modeled as step function similar to the one in Fig-
ure 3.5C&D, see also Appendix B.2 for details. C Deadenylation rate q(d). Gray:
q(d) used for simulation shown in panel B. Blue: q(d) recalculated from simulation
by using the inverse method, see Appendix B.4 for details.
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3.4 Discussion of the Second Part
In the second part of this thesis I analyzed more specific aspects of post-transcriptional regula-
tion in a hypothesis-driven approach. Can rhythmic splicing generate 12-hour periods? What
happens if the core clock experiences rhythmic degradation? And finally, I extend my model to
a partial differential equation model that accounts for an “aging” process of molecules.
It had been suggested that 12-hour rhythms can serve a biological function within a circadian
context [228]. Using a two component model I found that rhythmic splicing is able to generate
12-hour rhythms in abundance of mature mRNA from circadian pre-mRNA production profiles.
However, this poses stringent requirements on the ryhthms in transcription, i.e. transcription
must oscillate with a very high relative amplitude. Such amplitudes are only observed in a
hand-full of genes in liver and kidney; many of them are core clock members, see also Figure 2.3
for which, to my knowledge, no such harmonic expression patterns have been reported.
To investigate rhythmic degradation of core clock genes I introduced rhythmic degradation
rates to a Goodwin oscillator. A systematic analysis showed that increasing rhythms in one of
the degradation rates can strongly increase the amplitudes of all variables, driving the system
in resonance. Thus, rhythmic degradation could well be involved in the observed exceptionally
strong amplitudes of the core clock.
Interestingly, a rhythmic degradation of an inhibiting component of the Goodwin oscillator
can yield periods twice as large as the original period, pointing towards a “period doubling bi-
furcation”. Notably, such period doubling bifurcations had been suggested to have accompanied
the evolution from primordial clocks to the extant circadian clocks during lengthening of earth’s
rotation period in early evolution [44]. The observed effect of rhythmic degradation may thus
serve as an interesting starting point for further theoretical investigations. An interesting next
extension of the model could be to let one of Goodwin variables directly modulate a degradation
rate.
In the last section, I revisited the model of rhythmic production and rhythmic degradation and
expanded it by another variable, the age or rather the damage of a molecule. This PDE describes
the development of a molecule during its life. The PDE is described by three rates, molecule
production, damage accumulation and finally molecule degradation. I discuss the influences of
the rates with the help of an intuitive interpretation as a transport equation. With different
mathematical formulation of the rates, also outlined in Appendix B.2, the PDE can be applied
to describe different biological processes. In this thesis, I presented two distinct applications.
First, I described proteins which accumulate damage through accumulation of oxidation. Here,
I showed that rhythms of a rhythmic production are lost if one observes the whole population,
but are still pronounced when specifically looking at damaged, e.g. oxidized, proteins. This
result implies that experimental observations of non-oscillatory protein levels should be taken
with a grain of salt, since an oscillation in damaged fractions of the protein may still serve
biological functions.
The second application of the PDE model is a description of poly(A) tail length development.
This description provided the basis to calculate yet unmeasured genome-wide deadenylation rates
using TAIL-seq data. In this thesis I provided a proof of concept and presented an example based
on a numerical solution of the PDE model. This will be used to interprete upcoming TAIL-seq
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data from the laboratory of Carla Green.
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This thesis is based on one very simple modeling motif, rhythmic production and rhythmic
degradation. One can think of it as a building block. This building block can be tuned to also
describe constant production or degradation by switching rhythms on and off, simply by setting
relative amplitudes to zero.
An analytical solution, an equation, together with its intuitive vector representation was
presented. This is useful for a systematic analysis of parameters or fitting the model to data.
The intuitive interpretation allows also scientists which are not trained in mathematics to work
with this model. Furthermore, it facilitates a quick inspection of scientific ideas.
This building block was further varied to examine different aspects of rhythmic post-transcrip-
tional processes. First, I varied the interpretation of the model. The same model described a
diverse range of biological processes, such as rhythmic transcription, rhythmic splicing or rhyth-
mic mRNA degradation. This could be achieved because the main motivation of the modeling
approach was to investigate a very general idea, that is how rhythms in these very different
processes affect mRNA abundance. This generality is in contrast to the idea of asking very
specific questions regarding biological processes, such as how protein x influences the splicing
efficiency.
I further varied the main building block and joined several of these blocks together. With
this I obtained a modeling system describing more than one species, allowing the investigation
of arbitrary phase relationships between transcriptional activity and mRNA abundance, and
how rhythmic splicing can in theory, account for higher harmonics of mRNA abundance in the
context of circadian transcription.
The PDE describing aging of molecules is also a variation of the main building block. Here,
a second dimension besides time is introduced, the age of a molecule. This second dimension
provieds the life of a molecule assigning different life stages to the molecule. Folding together
this dimension and the life stages to the binary molecule’s existence or non-existence reduces
the PDE to our main building block. Mathematically, this is achieved by integration over all
ages as described in Section 3.3.
Interestingly, also the modification of the Goodwin oscillator is inspired by the core modeling
motif. As in the core motif I let the degradation rate be rhythmic by modeling them with cosine
functions.
I applied this set of modeling tools to explain and analyze different aspects of rhythmic
PTR, such as the extend of rhythmic PTR, which rhythmic post-transcriptional processes can
contribute to the observed data and many more as explained in the discussion sections at the end
of each chapter. I concentrated on post-transcriptional processes because the life of an mRNA
is extensively covered by the diverse sequencing techniques. The birth of an mRNA can be
monitored using ChIP-seq of polymerase II, GRO-seq and Nascent-seq. Transcript abundance
is readily accessible by common RNA sequencing. Today, aspects of the mRNA decay is now
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available by monitoring the poly(A)tail length through TAIL-seq or PAL-seq. All of these
techniques work genome-wide and, with that, give a comprehensive insight into the lives of all
expressed mRNAs. This data situation provides a rewarding ground to ask and answer specific
questions using modeling.
However, it is equally possible to find other interpretations for the presented models. One
obvious interpretation is to describe not rhythmic production and degradation of mRNA but of
proteins or any other molecules. Also different binary states of molecules could be described by
this model, for example an mRNA inside or outside of the nucleus. The rates can be reinter-
preted. Instead of degradation, one can think of a permanent modification, for example RNA
editing. It should also be tested how well the model can serve as a description of rhythmic
reversible modifications, for example protein phosphorylation. In addition, the PDE model can
probably be used to explain and analyze many more processes than the two presented in this
thesis. The fact that the two presented processes describe very different biological processes
underlines this.
Taken together: the model’s modularity on one hand and the very general description of
rhythmic processes on the other hand, makes the model a powerful tool to describe a diverse
range of rhythmic biological processes, some of them outlined in this thesis, many more yet
to be found. Hence, this thesis does not only provide a comprehensive analysis of rhythms in
post-transcriptional processes, summarized in Section 2.8 and 3.4, but also provides some tools
to handle models build out of the main building block and its variations in future. I expect
that the analytical solution of a model with rhythmic production and rhythmic degradation
degradation and the PDE, together with its intuitive understanding as a transport equation and
the implementation of different rates will be useful. One indicator for this is that the analytical
solution of the ODE has been already used elsewhere [254].
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All following derivations from this chapter plus the accompanying text were taken from the
supplement of our published paper “Rhythmic Degradation Explains and Unifies Circadian
Transcriptome and Proteome Data”, S. Lück, K. Thurley, P.F. Thaben, P.O. Westermark in
Cell Reports, 2014 [179]. The solution of the model derivation, its analytical and numerical
justification and the error propagation used in the statistical test to test for rhythmic post-
transcriptional regulation were my main contribution to this publication. The text has been
slightly modified to fit to the text of this thesis.
Elsevier asks to make the following statement: Some rights reserved. This work permits non-
commercial use, distribution, and reproduction in any medium, provided the original author and
source are credited.
A.1 ODE Model
A biomolecule x is rhythmically produced and rhythmically degraded:
dx
dt
= u(t)− v(t)x(t), (A.1)
where u(t) and v(t) are a zero-order-production coefficient (unit = abundance× time−1) and a
first-order-degradation coefficient (unit = time−1), respectively. The degradation rate coefficient
u(t) and the half-life t1/2(t) are connected by the relationship
v(t) = log 2
t1/2(t)
. (A.2)
We use both terms interchangeably here, as well as in the main text. Equation A.1 is a linear
differential equation with periodic coefficients. It has the ω-periodic solution [255]:
x(t) = x0e
∫ t
0 v(s)ds +
∫ t
0
u(t′) et
′−
∫ t
0 v(s)ds dt′. (A.3)
However, even for simple cases, the integrations in Equation A.3 cannot be performed analyti-
cally.
In circadian biology, data (e.g. gene expression profiles) are often well described by cosine-
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shaped functions, and we assume:
u(t) = k(1 +Aprod cos(ωt− φprod))
v(t) = γ(1 +Adeg cos(ωt− φdeg)).
(A.4)
Thus, we assume the time-dependent production degradation rate coefficients u(t) and v(t) are
cosine-shaped functions determined by their mean values k and γ, the relative amplitudes Aprod
and Adeg, the angular frequency ω and the phases φprod and φdeg. The relative amplitudes
take values between 0 and 1 and are indicators for the strength of the oscillation. The relative
amplitude is normally the amplitude parameter that can be best inferred from experimental
data, as absolute concentrations are rarely determined. The angular frequency is set to
Without loss of generality, the phase φdeg can be described with reference to the phase of
production φprod, so that only the phase difference ∆φdeg = φdeg − φprod between production
and degradation needs to be considered. The model then takes the form
dx
dt
= u(t)− v(t)x(t)
u(t) = k(1 +Aprod cos(ωt))
v(t) = γ(1 +Adeg cos(ωt−∆φdeg)).
(A.5)
The phase difference ∆φdeg takes values between −pi and pi, i.e. between −12 h and +12 h
in the circadian time frame. A negative value indicates that the degradation peaks before the
production.
A.1.1 Constant Degradation: Exact Solution
In the following, the exact solution (Equation 2.4, 2.5 and 2.6 in Section 2.1 in the
main text) for the special case of constant degradation (Adeg = 0) is derived. The
solution of model Equation A.5 is found by standard techniques for solving ordinary differential
equations [256]. After an initial transient (i.e., for t → ∞), the abundance is described by a
cosine-shaped function:
x(t) = Mx (1 +Ax cos(ωt− φx)) , (A.6)
with magnitude Mx, relative amplitude Ax, and phase φx. The abundance x is described with
its phase shift with respect to the production rate ∆φx = φx − φprod:
x(t) = Mx (1 +Ax cos(ωt−∆φx)) . (A.7)
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The solution for mean, amplitude and phase read then:
Mx =
k
γ
Ax =
γAprod√
γ2 + ω2
φx = φprod + arctan
(
ω
γ
)
or
∆φx = arctan
(
ω
γ
)
.
(A.8)
The last expressions show that in the case of constant degradation, the mean concentration
equals the non-oscillatory steady-state (i.e., Aprod = Adeg = 0 and dx/dt = 0 in Equation A.5).
In Equations A.8, the range of ∆φx is limited to the range of the arctan function for positive
argument, which is between 0 and pi/2, so that ∆φx can only vary between 0 and 6 hours on
the circadian time scale. Another direct conclusion from Equations A.8 is that M → ∞ and
Ax → 0 for γ → 0. This means that for long half-lives, magnitudes increase but amplitudes
vanish, so that circadian rhythms are lost.
A.1.2 Rhythmic Degradation:
Approximation with Fourier Expansion and Harmonic Balancing
Floquet theory guarantees that the solution to Equation A.1 is an ω-periodic function [255].
Thus, after an initial transient, the abundance x can be approximated by Fourier expansion to
the order of n:
x(t) ≈ A0 +A1 cos(ωt) +B1 sin(ωt) + ...+An cos(nωt) +Bn sin(nωt). (A.9)
The exact Fourier coefficients in such a truncated Fourier expansion cannot be calculated in
closed form. Therefore, we use the following idea: We plug the truncated Fourier expansion
Equation A.9 into the model, Equation A.1, and compare the coefficients. This leads to a
system of linear equations which can be solved to obtain the approximate coefficients A0, A1,
B1, ..., An, Bn. These coefficients are not the exact Fourier coefficients, since we use a truncated
Fourier series to obtain the describing linear equations. Below, we show that the error of this
approximation vanishes as the expansion becomes longer, and that the coefficients then converge
to the exact Fourier coefficients.
Numerical solutions generally exhibit shapes close to cosine-functions, this means that al-
ready a Fourier expansion to the first order is generally sufficient, see also numerical validation,
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Section A.1.4, to describe the solution of the full model Equation A.5. Hence we obtain
A0 =
k
γ
2(γ2 + ω2) +AprodAdegγ(ω sin(∆φdeg)− γ cos(∆φdeg))
2(γ2 + ω2)−A2degγ2
A1 =
2kγ(Aprod −Adeg cos(∆φdeg))− 2kAdegω sin(∆φdeg)
2(γ2 + ω2)−A2degγ2
−
AprodA
2
degkγ sin2(∆φdeg)
2(γ2 + ω2)−A2degγ2
B1 =
2kω(Aprod −Adeg cos(∆φdeg)) + 2kAdegγ sin(∆φdeg)
2(γ2 + ω2)−A2degγ2
−
AprodA
2
degkγ sin(∆φdeg) cos(∆φdeg)
2(γ2 + ω2)−A2degγ2
.
(A.10)
The relative amplitudes Aprod and Adeg take values smaller than or equal to 1, and the
same is true for the absolute values sin(∆φdeg) and cos(∆φdeg). Mixed products of these terms
as AprodA2deg sin(∆φdeg) cos(∆φdeg) and AprodA2deg sin2(∆φdeg) are small, and are therefore ne-
glected in the following, to obtain a more convenient approximation:
A0 =
k
γ
2(γ2 + ω2) +AprodAdegγ(ω sin(∆φdeg)− γ cos(∆φdeg))
2(γ2 + ω2)−A2degγ2
A1 ≈ 2kγ(Aprod −Adeg cos(∆φdeg))− 2kAdegω sin(∆φdeg)2(γ2 + ω2)−A2degγ2
B1 ≈ 2kω(Aprod −Adeg cos(∆φdeg)) + 2kAdegγ sin(∆φdeg)2(γ2 + ω2)−A2degγ2
.
(A.11)
A Fourier Series to the first order describes a harmonic function as linear combination of a
cosine function and a sine function. We reformulate this linear combination to gain a cosine
function with a relative amplitude Ax and a phase ∆φx [256] (cp. also Equation A.7):
x(t) = A0 +A1 cos(ωt) +B1 sin(ωt) = Mx(1 +Ax cos(ωt−∆φx)), (A.12)
where
Mx =A0
Ax =
1
A0
√
A21 +B21
∆φx = arctan 2 (B1, A1) .
(A.13)
The function arctan 2(y, x) is the arctangent function with two arguments, which computes the
principal value of the argument function applied to the complex number x+ iy. The definition
of arctan 2(y, x) is given in Figure A.1. With this ansatz we neglect higher order terms in the
Fourier expansion, which is justified below.
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Figure A.1: Definition of the function arctan 2(y, x). The function arctan(y/x) covers a range from −pi/2
to +pi/2, which would not be suitable to describe an arbitrary phase shift. To consider all
possible phases, we use the function arctan 2(y, x), which covers the full range from −pi to +pi
and is defined as follows: ∆φx = arctan 2(y, x) is the angle between (x, y) and (y = 0, x > 0)
in the x-y plane. If y > 0, the angle is taken counterclockwise from 0 to pi, and if y < 0,
then the angle is taken clockwise from 0 to −pi.
With Equations A.11 we obtain the following expressions:
Mx =
k
γ
2(γ2 + ω2 − AprodAdeg2 γ (ω sin(∆φdeg) + γ cos(∆φdeg)))
2(γ2 + ω2)− γ2A2deg
Ax =
γ
√
A2prod +A2deg − 2AprodAdeg cos(∆φdeg)√
γ2 + ω2 − AprodAdeg2 γ (ω sin(∆φdeg) + γ cos(∆φdeg))
∆φx = arctan 2
(
ω (Aprod −Adeg cos(∆φdeg))−Adegγ sin(∆φdeg),
γ (Aprod −Adeg cos(∆φdeg)) +Adegω sin(∆φdeg)
)
.
(A.14)
For the special case of constant degradation (Adeg = 0), these equations reduce to the exact
expressions, Equations A.8. As defined previously, we used the relative phase ∆φdeg =
φdeg − φprod.
Vector Representation of Phase and Amplitude
The Fourier expansion resulted in a good approximation for biologically relevant parameter val-
ues, see also numerical validation, Section A.1.4, and if needed it is possible to use the same ap-
proach and expand to a higher order to achieve higher accuracy. However, Equations A.14 do not
provide intuitive insight into the properties of phase and amplitude of a rhythmically degraded
biomolecule. In the main text (see also Section 2.5), we introduce phase and relative
amplitude as a result of a vector addition in the complex plane (Equations 2.10,
2.11. In the following we derive this description from the Fourier expansion derived
above.
The phase ∆φx is formulated in Equations A.14 with an arctan 2(y, x) function. This equation
can be reinterpreted as a calculation in a two-dimensional vector space. Then, the phase is the
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angle of a vector with the entries x and y:
∆φx = arctan 2(y, x)
def= angle
(
x
y
)
.
Now the phase is described as the result of a vector calculation. The expression in Equation A.14
can be rewritten as an angle:
∆φx = angle
{
[Aprod −AdegR(∆φx)]
(
γ
ω
)}
. (A.15)
Here, R(∆φx) is a rotation matrix that describes a counterclockwise rotation by the angle ∆φx:
R =
(
cos (∆φx) − sin (∆φx)
sin (∆φx) cos (∆φx)
)
.
From the two-dimensional vector space to the complex plane, a rotation matrix by the angle
φ translates to eiφ and a vector with positive entries x and y to
√
x2 + y2ei arctan(y/x). Thus,
Equation A.15 translates to:
∆φx = arg
{[
Aprod −Adegei∆φdeg
]√
γ2 + ω2ei arctan(ω/γ)
}
∆φx = arg
(
Aprod −Adegei∆φdeg
)
+ arg
(
ei arctan(ω/γ)
)
. (A.16)
To derive the Fourier approximation we reduced the number of parameters by describing all
phases in relation to the phase of the production. We now return to a description in the
absolute time frame and rewrite ∆φdeg = φdeg−φprod and ∆φx = φx−φprod. This gives for the
calculation A.16 in the complex space:
φx = arg
(
Aprode
iφprod −Adegeiφdeg
)
+ arctan
(
ω
γ
)
. (A.17)
This is the vector representation of the phase in the main text (Equation 2.11).
We introduced the term Aprodeiφprod −Adegeiφdeg in the main text as the so-called “production-
degradation vector”. It describes the influence of only the oscillatory part of the production
and degradation rate independent from their mean rates. The absolute value of the effective
production is:∣∣∣Aprodeiφprod −Adegeiφdeg∣∣∣ = √A2prod +A2deg − 2AprodAdeg cos(φdeg − φprod) . (A.18)
Replacing ∆φdeg = φdeg − φprod, the square root in Equation A.18 can be identified in the
previously derived amplitude of x (see Equation A.14), which yields:
Ax =
γ
∣∣∣Aprodeiφprod −Adegeiφdeg∣∣∣√
γ2 + ω2 − AprodAdeg2 γ (ω sin(φdeg − φprod) + γ cos(φdeg − φprod))
. (A.19)
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We refer to the factor AprodAdeg2 γ (ω sin(φdeg − φprod) + γ cos(φdeg − φprod)) as a correction fac-
tor and replace it by C in the main text. With this step we have derived the vector
description of the amplitude (Equation 2.10 in the main text).
A.1.3 Analytical Validation of the Approximation
The approximation Equation A.14 is derived by a truncated Fourier expansion. In
the following we justify this truncation and the convergence of the approximation.
Assume that u(t) and v(t) in Equation A.1 are smooth and bounded ω-periodic functions. This
ensures that x(t) and x′(t) are smooth and bounded ω-periodic functions [255], and therefore
the Fourier series of x(t) converges [257]. Moreover, the sequence of the Fourier coefficients
A0, A1, · · · and B1, B2, · · · decays in a way that |An| < K/n2, |Bn| < K/n2, with a constant K
independent of n. If in addition u′(t) and v′(t) are smooth functions, we can take the derivative
on the right-hand side of Equation A.1, and therefore also on the left-hand side, and so on. If
the differential coefficients of a function x(t) are bounded and continuous up to the order p− 1,
the sequence decays even faster [257]:
|An| < K/np, |Bn| < K/np. (A.20)
Therefore, the smoothness of the input functions u(t) and v(t) determines the error made by
truncating the Fourier series of the (unknown) function x(t). Since cosine functions, which we
use here (Equations A.5), are indefinitely often differentiable, a reasonably good approximation
can be expected, even if only the first Fourier coefficients are taken into account. We were able to
justify this expectation by numeric simulations (see Figure A.4). In principle, the approximation
procedure outlined in the last section can also be used for other types of input functions u(t) and
v(t) such as square-waves or spikes. However, the reasoning above suggests that the convergence
of the Fourier series will be weaker for input functions that are not as smooth as cosine functions.
Thus, it might be necessary to include higher order Fourier coefficients in that case.
There is no exact formula for the Fourier coefficients of x(t), which is why we derived an
approximation procedure for the first Fourier coefficients (Equation A.10). Here, we show that
such approximations improves with the number of terms of the series that are included. A
Fourier expansion to the nth term results in the following set of linear equations:
γ A1×2 · · ·
A2×1 RS1 RS− · · · 0RS+ RS2 RS− · · ·
RS+ RS3 · · ·
...
...
...
... . . .
...
...
...
0 · · · RS+ RSn−1 RS−· · · RS+ RSn

·

A0
C1
C2
C3
...
Cn−1
Cn

=

a
vec
0...
0

, (A.21)
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with these abbreviations:
A1×2 =
(
γ
2Adeg cos(∆φdeg)
γ
2Adeg sin(∆φdeg)
)
, A2×1 =
(
γAdeg cos(∆φdeg)
γAdeg sin(∆φdeg)
)
,
RS− = γ2Adeg
(
cos(∆φdeg) sin(∆φdeg)
− sin(∆φdeg) cos(∆φdeg)
)
, RS+ = γ2Adeg
(
cos(∆φdeg) − sin(∆φdeg)
sin(∆φdeg) cos(∆φdeg)
)
,
RSn =
(
γ nω
−nω γ
)
, Cn =
(
An
Bn
)
and vec =
(
Aprodk
0
)
.
The matrix that defines the approximated Fourier coefficients has a block-structure and by
following this pattern, the matrix can readily be extended to higher orders. It consists of mainly
three submatrices RS+, RS− and RSn. The first two submatrices can be identified as matrices
that rotate either clockwise (RS+) or counterclockwise (RS−) by the angle ∆φdeg, and scale
by the constant factor γ2Adeg. The third submatrix RSn can also be interpreted as a rotation-
scaling-matrix:
RSn =
√
γ2 + n2ω2
 γ√γ2+n2ω2 nω√γ2+n2ω2−nω√
γ2+n2ω2
γ√
γ2+n2ω2
 = √γ2 + n2ω2( cos(θ) sin(θ)− sin(θ) cos(θ)
)
,
RSn =
√
γ2 + n2ω2 R(θ) . (A.22)
It describes a rotationR(θ) by the angle θ = arctan(nω/γ) and scaling by the factor
√
γ2 + n2ω2.
With increasing order n this scaling factor becomes larger. In the following, we justify that in a
truncated Fourier expansion to the order of n, the coefficients have a small approximation error
compared to the exact Fourier coefficients and that with increasing n, the approximated Fourier
coefficients converge to the exact Fourier coefficients.
The block-structure of the matrix shows that the nth coefficients are only determined by the
neighboring coefficients Cn+1 and Cn−1:
RSn ·
(
An
Bn
)
= RS− ·
(
An+1
Bn+1
)
+RS+ ·
(
An−1
Bn−1
)
. (A.23)
We reformulate Equation A.23 by multiplying with the inverse of RSn. Using Equation A.22
yields:(
An
Bn
)
= 1√
γ2 + n2ω2
R(−θ)RS− ·
(
An+1
Bn+1
)
+ 1√
γ2 + n2ω2
R(−θ)RS+ ·
(
An−1
Bn−1
)
. (A.24)
If the coefficients An+1 and Bn+1 were known and identical to the exact Fourier coefficients,
then with Equation A.24 and with the equations for the following coefficients defined by the
block-structure of the matrix, every exact Fourier coefficient of order n and lower could be solved
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Figure A.2: Numerical simulation and analytical approximation of the model. Marked is the
error made by the approximation. Parameter values: Aprod = 0.2 and Adeg = 0.8
(black/gray) or Aprod = 0.8 and Adeg = 0.2 (blue), ω = 2pi/24 h, γ = 0.35 h−1,
k = 1 h−1, ∆φdeg = pi/2.
for. However, the coefficients An+1 and Bn+1 are always unknown, and in our approximation
the Fourier series are truncated by setting the term
(
An+1
Bn+1
)
to zero:
(
An
Bn
)
≈ 1√
γ2 + n2ω2
R(−θ)RS+ ·
(
An−1
Bn−1
)
. (A.25)
The coefficients
(
Ai
Bi
)
, i < n, are also defined only by their neighboring coefficients, higher
coefficients do not contribute. This means setting the (n + 1)th coefficients to zero is the only
approximation we apply to derive the coefficients. We define a relative error as the ratio of the
approximation error to the nth coefficients:
error def=
∣∣∣∣∣(γ2 + n2ω2)− 12 R(−θ)RS− ·
(
An+1
Bn+1
)∣∣∣∣∣∣∣∣∣∣
(
An
Bn
)∣∣∣∣∣
= γAdeg
2
√
γ2 + n2ω2
∣∣∣∣∣
(
An+1
Bn+1
)∣∣∣∣∣∣∣∣∣∣
(
An
Bn
)∣∣∣∣∣
. (A.26)
Here, | · | denotes the Euclidean vector norm. With increasing n the ratio in front of the vector
norm ratio becomes small. In addition to that, the vector norm ratio becomes small since Fourier
coefficients decay fast with increasing order, as outlined above. Thus, with increasing order n,
the relative approximation error becomes small and the coefficients of the truncated Fourier
series converge to the exact Fourier coefficients.
A.1.4 Numerical Validation of the Approximation
To validate the Fourier approximation, we compared the approximation to numer-
ically computed abundances for different parameter sets by variation of the mean
degradation rate γ, the phase difference between production and degradation ∆φdeg,
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and the relative amplitudes Aprod and Adeg, as outlined in the following. We denote
the difference between numerical solution and approximation by the model as “Error”, see also
Fig. A.2. For example, the Error(φprod − φx) stands for:
Error(φprod − φx) = (φprod − φx)numerical − (φprod − φx)approximation (A.27)
The production term and degradation rate were either cosine-functions simulated with
u(t) = k (1 +Aprod cos(ωt)) and (A.28)
v(t) = γ (1 +Adeg cos(ωt−∆φdeg)) , (A.29)
or a Fourier series to the seventh order of periodic parabolas:
u(t) = γ
(
1− Aprod6 +
4Aprod
pi2
(
cos(ωt) + 122 cos(2ωt) +
1
32 cos(3ωt) +
1
42 cos(4ωt)+
1
52 cos(5ωt) +
1
62 cos(6ωt)
))
and (A.30)
v(t) = γ
(
1− Adeg6 +
4Adeg
pi2
(
cos(ωt−∆φdeg) + 122 cos(2(ωt−∆φdeg))+
1
32 cos(3(ωt−∆φdeg)) +
1
42 cos(4(ωt−∆φdeg))+
1
52 cos(5(ωt−∆φdeg)) +
1
62 cos(6(ωt−∆φdeg))
))
. (A.31)
As an example we plot a degradation rate defined by this Fourier series in Figure A.3. It reflects
non-cosine-shaped time series similar to typical transcript abundances [5].
The difference between the numerical solution and approximation depends on the set of pa-
rameters and of the form of production and degradation rate. From the theoretical point of view
we expect for both rate forms that the approximation by the model is close to the numerical
solution, since the proposed rates are both smooth functions and therefore higher Fourier coef-
ficients, which we do not include in the model, vanish fast, as we discussed earlier. However, for
rates described by a Fourier series with higher terms, we expect less conformity.
For numerical simulation a C-script was used. To detect phase, amplitude and magnitude
in the time series I used a similar algorithm as I later did to detect oscillation properties in
the Goodwin model described in Appendix E.1. The same C-script was also used to produce
Figure 2.9A.
In Figure A.4, we show the absolute error between model prediction and numerical solution
of cosine-shaped rates, in Figure A.5 the absolute error for rates defined by the Fourier series
of periodic parabolas. As expected for the rates modeled by periodic parabolas, the absolute
error is higher than for cosine-shaped rates although there is no qualitative change. For most
parameter combinations, the error is below 10% for both phase difference and
amplitude. The approximation is particularly accurate if the degradation rate oscillates weaker
than the production term (Aprod > Adeg), and for small phase differences ∆φdeg ≈ 0.
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Figure A.3: Function with non-sinusoidal shape as in Equation A.31. Parameters: γ = 0.35 h−1, Adeg =
0.2, ∆φdeg = 0.5pi.
Unknown Degradation Phase
In the main text we used our model to predict the unknown degradation rates for given produc-
tion rates and RNA abundances (see Section 2.5.3). In the Section 2.5.3, we present equations for
phase φdeg and amplitude Adeg of the degradation (Equations 2.12, 2.13). Figures A.6 and A.7
show that these approximations of the phase and amplitude are particularly good at moderate
to long half-lives. We compared the approximations to numerical simulations as follows: We first
chose a certain parameter set [k, γ, Aprod, Adeg, φprod, φdeg] and ran the numerical integration of
our model Equation A.5. Then, we estimated the relative amplitude Ax and phase φx from the
obtained time series and used these parameters together with our approximation, Equation 7, to
recalculate the values of Adeg and φdeg. The differences between the values of Adeg and φdeg in
the parameter set and those obtained from the approximation show the accuracy of the latter.
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Figure A.4: Validation of the Fourier approximation. The production term and the degradation rate
were modeled as cosine functions. The expressions for amplitude, phase and magnitude
(Equations A.14) were compared with the numerical solution of Equations A.5 (see Exper-
imental Procedures), shown are absolute errors. Parameters: Aprod = 0.5, k = 1 h−1.
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Figure A.5: Validation of the Fourier approximation. The production term and the degradation rate are
modeled as non-sinoidal functions (see text). Same procedure and parameter choice as in
Figure A.4.
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Figure A.6: Validation of the Fourier approximation for an unknown degradation rhythm at varying
half-lives. The approximation (Equations 2.12, 2.13) is compared to the numerical solution
of the inverse problem (see text). We show absolute errors at indicated parameter values.
Parameters: k = 1, Adeg = 0.5
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Figure A.7: Validation of the Fourier approximation for an unknown degradation rhythm at varying
phases and relative amplitudes. γ = 0.35h−1.
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A.2 Additional Results from the ODE model
A.2.1 Error Propagation of Half-Lives for the Production-Degradation Vector
Here we derive the point estimate and the covariance matrix for the production-
degradation vector. These estimates are needed for the chi-squared test described
in Section 2.4.1 and implemented in the R package “patest”.
We estimate amplitudes and phases using harmonic regression: Ordinary least squares fitting
to a linear combination of cosine- and sine-functions:
x(t) = m+ a cos(ωt) + b sin(ωt) + , (A.32)
where x(t) stands for the abundance of a molecule at time t, and  is an error term. The
parameters a and b define (span) the circadian phase plane and constitute the vector x
x =
(
a
b
)
,
and the fitting procedure results in estimates of a and b denoted µx with symmetric covariance
matrix covx:
µx =
(
µa
µb
)
, (A.33)
covx =
(
σ2a σa,b
σa,b σ
2
b
)
. (A.34)
If the measured time series is evenly sampled and consists only of fully measured periods the
covariance matrix reduces to a diagonal matrix:
covx =
(
σ2ab 0
0 σ2ab
)
. (A.35)
Estimates µx and covx are obtained from the residuals of the fit [215, 258]. In the same way,
a vector p representing production phase and amplitude is obtained from measurements of
transcriptional activity for the case of mRNAs (in practice, these are often also abundances, for
example of nascent mRNA), together with an estimated covariance matrix covp.
In our model for rhythmic degradation we define the so called production-degradation vector
pd, which is determined by a shift in the x- and y-coordinate of x depending on the half-life
τ . Our chi-squared test is based on the difference between the production-degradation vector
and the measured production vector. The null distribution for this difference can be estimated
if an estimation for the covariance matrix of the production-degradation vector is available.
Such an estimate can be obtained from the abundance vector (harmonic regression estimates
from mature mRNA-seq data in the present study), the production vector (harmonic regression
estimates from nascent mRNA-seq data), and the estimated covariance matrices for these. Also
needed is the estimated half-life of the mRNA molecule, and the variance of this estimate. The
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half-life τ of the molecule is measured with mean µτ and standard deviation στ .
The x-component of the production-degradation vector pd follows:
xpd =
√
γ2 + ω2
γ
√
a2 + b2 cos (arctan2(b, a)− arctan(ω/γ))
=
√
γ2 + ω2
γ
(a cos (arctan(ω/γ)) + b sin (arctan(ω/γ)))
=
(aγ + bω)
√
1 + ω2
γ2√
γ2 + ω2
= a+ bω
γ
. (A.36)
Here, γ is the mean degradation rate which is inversely related to the half-life: γ = log(2)/τ .
The y-component of the vector pd follows:
ypd = b− aω
γ
. (A.37)
We search the estimate µpd and covariance matrix covpd for the vector pd:
µpd =
(
µxpd
µypd
)
, (A.38)
covpd =
(
σ2xpd σxpd,ypd
σxpd,ypd σ
2
ypd
)
. (A.39)
The components of the vector pd are functions of three variables, a, b, and τ . The mean µpd
is then obtained from the definitions of pd, Eqns. (A.36 and A.37)
µpd =
(
µa + µbµτlog(2)
µb − µaωµτlog(2)
)
. (A.40)
To derive the covariance matrix we apply multivariate error propagation. In the general case of
m functions yk in n variables x1, ..., xn = x, each function yk is linearized around the mean µx
yk ∼ yk(µx) +
n∑
i=1
(xi − µi) ∂yk
∂xi
∣∣∣∣
µx
. (A.41)
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To derive the covariance matrix cov of the functions yk, the definition of variance is used:
covkl(y) = 〈[yk(x)− 〈yk(x)〉][yl(x)− 〈yl(x)〉]〉
= 〈[yk(x)− yk(µx)][yl(x)− yl(µx)]〉 EquationA.41 applied
=
m∑
k=1
m∑
l=1
∂yk
∂xi
∣∣∣∣
µx
∂yl
∂xj
∣∣∣∣∣
µx
〈(xi − µi)(xj − µj)〉
=
m∑
k=1
m∑
l=1
∂yk
∂xi
∣∣∣∣
µx
∂yl
∂xj
∣∣∣∣∣
µx
covij(x).
In a compact notation:
cov(y) = J|µx cov(x) JT
∣∣∣
µx
, (A.42)
where cov(y) is the covariance matrix of y, cov(x) is the covariance matrix of the variables x,
and J|µx is the m × n Jacobian Jij = ∂yi∂xi evaluated at the mean of x. Using this method, the
covariance matrix of pd can be derived:
covpd =
(
∂xpd
∂a
∂xpd
∂b
∂x∆pd
∂τ
∂ypd
∂a
∂ypd
∂b
∂ypd
∂τ
)∣∣∣∣∣
µa,µb,µτ
 σ2a σa,b 0σa,b σ2b 0
0 0 σ2τ


∂xpd
∂a
∂ypd
∂a
∂xpd
∂b
∂ypd
∂b
∂xpd
∂τ
∂ypd
∂τ

∣∣∣∣∣∣∣
µa,µb,µτ
=
(
σ2xpd σxpd,ypd
σxpd,ypd σ
2
ypd
)
(A.43)
with
σ2xpd =
log(2)2σ2a + ω
(
ωµ2τσ
2
b + ωµ2bσ2τ + σa,b log(4)µτ
)
log(2)2 , (A.44)
σ2ypd =
log(2)2σ2b + ω
(
ωµ2τσ
2
a + ωµ2aσ2τ − σa,b log(4)µτ
)
log(2)2 and (A.45)
σxpd,ypd =
σa,b log(2)2 − ω
(
σa,bωµ
2
τ + log(2)
(
σ2a − σ2b
)
µτ + ωµaµbσ2τ
)
log(2)2 . (A.46)
If the time series is evenly sampled and over an integer number of periods, the covariance matrix
has a simpler form:
covpd =
(
∂xpd
∂a
∂xpd
∂b
∂xpd
∂τ
∂ypd
∂a
∂ypd
∂b
∂ypd
∂τ
)∣∣∣∣∣
µa,µb,µτ
σ2ab 0 00 σ2ab 0
0 0 σ2τ


∂x∆pd
∂a
∂y∆pd
∂a
∂x∆pd
∂b
∂y∆pd
∂b
∂x∆pd
∂τ
∂y∆pd
∂τ

∣∣∣∣∣∣∣∣
µa,µb,µτ
=
σ2ab + ω2(µ2bσ2τ+µ2τσ2ab)log(2)2 −µaµbσ2τω2log(2)2
−µaµbσ2τω2log(2)2 σ2ab +
ω2(µ2aσ2τ+µ2τσ2ab)
log(2)2
 . (A.47)
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A.2.2 Sensitivity
In Section 2.5 we describe how a small change of the relative amplitudes Aprod and Adeg can
have a large effect on the phase φx. This can be quantified as the sensitivity of the phase φx
with respect to changes in the input parameters Aprod, Adeg, φprod and φdeg. In the following
we derive the sensitivity coefficient for the phase φx as a measure of the sensitivity.
First, we introduce the ratio between the amplitudes of the production term and the degradation
rate: c = Aprod/Adeg. Then, the phase φx is calculated from Equation A.17:
φx = arctan 2
c cos (φprod + arctan (ωγ ))− cos (φdeg + arctan (ωγ )) ,
c sin
(
φprod + arctan
(
ω
γ
))
− sin
(
φdeg + arctan
(
ω
γ
))  . (A.48)
We now define the sensitivity coefficient Sφxc as the derivative of the phase φx with respect to
the relation c:
Sφxc
def= ∂φx
∂c
= sin(φdeg − φprod)1 + c2 − 2c cos(φdeg − φprod)) . (A.49)
In Figure 2.2C we plotted the sensitivity coefficient for different values of c. Here, a large value
means that a small change in the input parameters results in a large change in the phase φx.
The sensitivity is large when production and degradation peak roughly at the same time, i.e.
φprod−φdeg ≈ 0. This effect becomes very pronounced when the amplitudes Aprod and Adeg are
similar, i.e. c ≈ 1. The large sensitivity coefficient implies a phase inversion in this range of c.
This means that a small change in the relation of Aprod and Adeg can cause a phase shift of up
to 12 h.
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In this section I derive the PDE model used in Section 3.3, discuss different rate functions which
describe different scenarios and present an analytical solution of the PDE for a specific case.
Furthermore, I formulate the inverse problem which can be used to recalculate unmeasured
deadenylation rates TAIL-seq data.
B.1 Derivation of the PDE Model
Let x(t, d′) be the number of molecules of damage (d, d + dd) at time t. Therefore x(t, d) is
a density function in the damage d. If we integrate x(t, d) over all possible damage values we
receive the total molecules concentration at time t:
X(t) =
∫ ∞
d=0
x(t, d) dd. (B.1)
The rate of change in molecules of a given damage interval ∆d is defined by
∂x(t, d)
∂t
∆d =
+ rate of entry at d− rate of departure at d+ ∆d
− degradation
 (B.2)
or
∂x(t, d)
∂t
∆d = J(t, d)− J(t, d+ ∆d)− v(t, d)x(t, d)∆d, (B.3)
where v(t, d) is the degradation rate of molecules with damage d at time t. J(t, d) is a flux of
molecules with damage d at time t in more detail examined below. Division by ∆d yields
∂x(t, d)
∂t
= −J(t, d)− J(t, d+ ∆d)∆d − v(t, d)x(t, d). (B.4)
Taking the limit ∆d→ 0 we receive a ’transport equation with advective flux’ for the molecules
∂x(t, d)
∂t
= −∂J(t, d)
∂d
− v(t, d)x(t, d). (B.5)
The flux J is not a flux in space as in the original transport equation but a flux in the damage
domain and describes the movement of molecules towards higher damage. As a flux in space
the damage-dependent flux depends on the molecule density x(t, d) and the speed of damage
accumulation q(t). The speed q(t) is defined by the change of damage per time unit q(t, d) = dddt
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and the flux J therefore is given by:
J(t, d) = x(t, d)q(t, d). (B.6)
The model equation Equation B.5 calculates thus to
∂x(t, d)
∂t
= −q(t, d)∂x(t, d)
∂d
− x(t, d)∂q(t, d)
∂d
− v(t, d)x(t, d). (B.7)
This equation is defined for positive d, we assume there is no negative damage, and the damage is
steadily increasing, hence we need a boundary condition x(t, 0) where molecules with no damage
enter the system.
x(t, d) describes the molecule density in damage. For any acceptable solution x(t, d) the
integral Equation B.1 is well defined and hence converges which requires that
lim
d→∞
x(t, d) = 0. (B.8)
The integral of the model equation EquationB.7 over damage d calculates then∫ ∞
0
∂x(t, d)
∂t
dd =
∫ ∞
0
(
−q(t, d)∂x(t, d)
∂d
− x(t, d)∂q(t, d)
∂d
)
dd ,
dX(t)
dt =
∫ ∞
0
(
−q(t, d)∂x(t, d)
∂d
− x(t, d)∂q(t, d)
∂d
)
dd−
∫ ∞
0
v(t, d)x(t, d)dd . (B.9)
The first integral on the right hand-side can be reduced by using partial integration∫ (
− q(t, d) ∂x(t, d)
∂d
− x(t, d)∂q(t, d)
∂d
)
dd (B.10)
= −
(
x(t, d)q(t, d)−
∫
x(t, d)∂q(t, d)
∂d
dd
)
−
∫
x(t, d)∂q(t, d)
∂d
dd (B.11)
= −x(t, d)q(t, d) . (B.12)
Taking into account borders and Equation B.8 we receive∫ ∞
0
(
− q(t, d) ∂x(t, d)
∂d
− x(t, d)∂q(t, d)
∂d
)
dd
= −
[
x(t, d)q(t, d)
]∞
0
= x(t, 0)q(t, 0).
(B.13)
The time development of molecule concentration reads therefore (EquationsB.9,B.13)
dX
dt = x(t, 0)q(t, 0)−
∫ ∞
0
v(t, d)x(t, d)dd . (B.14)
The equation for a general time development of a molecule concentration X where molecules
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ΔdU(t)
Jin Jout
q(t,0)
Figure B.1: Illustration of the model Equation B.17. Illustration of the model as transport.
The molecule density x(t, d) of a given damage interval ∆d is determined by the entry
Jin, the departure Jout and degradation v(t, d). Newly synthesized molecules enter
the system with the rate x(t, 0) = U(t)q(t,0) .
are produced with a production rate k and is degraded with a degradation rate V is given by:
dX
dt = U − V X. (B.15)
We assume that the production rate is time dependent U = U(t). Comparison of EquationB.14
and B.15 gives us then an expression for the boundary condition:
x(t, 0) = U(t)
q(t, 0) . (B.16)
With that we received the model Equation 3.6 which describes a molecule density in damage
where molecules are born with zero damage, accumulate damage over time described by a flux
in d-direction and get eventually degraded (see Fig.B.1):
∂x(t, d)
∂t
= −q(t, d)∂x(t, d)
∂d
− x(t, d)∂q(t, d)
∂d
− v(t, d)x(t, d)
x(t, 0) = k(t)
q(t, 0)
(B.17)
To calculate from the molecule density x(t, d) the actual molecule concentration of molecules
within a certain damage range [d, d+ ∆d] one has to take the integral
Xd,d+∆d(t) =
∫ d+∆d
d
x(t, d)dd . (B.18)
B.2 Rates - Personalize your Model
In the following we take a closer look at the three rates we use in our model: k(t) is the
production rate, v(t, d) is connected to the degradation of molecules, and q(t, d) describes the
speed of damage accumulation.
With a specific mathematical formulation of the rates the very general model Equation B.17
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can describe specific biological situations. Additionally, besides the mathematical description of
biological processes, we need to make a connection to measurable quantities. In this section I will
draw a connection from the damage-dependent degradation rate v(t, d) to the general molecule
degradation rate V (t) which is damage independent and usually measured in experiments when
investigating molecule half lives. Furthermore, I will present some general ideas how all rates,
k(t), q(t, d) and v(t, d) can be formulated in the context of circadian biology and in the examples
presented in this thesis where I used the model to describe such diverse phenomena as protein
damage and poly(A) tail deadenylation.
The production rate describes only a production of undamaged proteins (d = 0). Hence, in
contrast to the degradation rate the production rate k(t) of the molecule concentration X(t)
therefore already only depends on time
U(t) = k(t) (B.19)
and is the production rate which would be measured. For example if describing deadenylation
of poly(A) tails the production rate is constituted by transcriptional activity.
To get a meaningful degradation rate, i.e. an experimentally measurable rate, we compare
Equation B.14 and Equation B.15 and extract the term which describes the degradation of
molecules:
V (t)X(t) =
∫ ∞
0
v(t, d)x(t, d)dd. (B.20)
V (t) is the damage-independent degradation rate of molecules and connected to the half-life τ
via τ(t, d) = ln(2)/V (t).
How should all these rates k(t), q(t, d) and v(t, d) be formulated? Describing phenomena with
a circadian rhythm demands a time dependence in each rate. I will model this time dependence
as periodic cosine-function with mean M , relative amplitude Arel and a phase shift φ
f(t) = M (1 +Arel cos(ωt− φ)) . (B.21)
Since production depends only on time it is described only by this cosine function with specific
mean k, relative amplitude Aprod and phase φprod:
k(t) = k (1 +Aprod cos(ωt− φprod)) (B.22)
The rate of damage accumulation is also circadian but additionally it can depend on the
damage d:
q(t, d) = c (1 +Adam cos(ωt− φdam)) · f(d). (B.23)
The function f(d) modulates the mean damage accumulation c and should hence do not exceed
a certain value range, e.g. f(d) ∈ [0, 1] to be reasonable (within the measured range) damage d.
To reproduce the data from Chang et al. [252] I used a simple exponential function for the
damage dependency:
q(d) = e−0.1d. (B.24)
This describes that deadenylation slows down exponentially with shortened poly(A) tail. How-
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ever, any other description could be plausible, for example a step-like function describing two
different (constant) deadenylation speeds of two different deadenylases acting only at specific
poly(A) tail lengths.
Also the degradation rate can be damage dependent. To describe RNA molecules which are
degraded only with a short poly(A) tail I used a tunable step-like function v(t, d):
v(t, d) = γ · (1 +Adeg cos(ωt− φdeg))︸ ︷︷ ︸
time-dependence
·
(
d−β
s
)h
1 + d−βs
·H(d− β)︸ ︷︷ ︸
damage-dependence
. (B.25)
Here, the function is defined by the mean degradation rate γ and two terms, the first only
dependent on time, the second only dependent on damage. While the time-dependence has the
same structure as time-dependence defined in Equation B.21, the part with damage-dependence
deserves more explanation. We assume that degradation eventually get switched on at a certain
threshold of accumulated damage or shortened poly(A) tail. The damage-dependence part has
to reflect this behavior. It consists of a sigmoid Hill-function to reflect a switching behavior. This
function is defined by the parameter h and s, the first is the so-called Hill factor h and defines the
steepness of the slope, the second scales the slope to a given range. The Hill-function is further
shifted in d-direction by the parameter β and the Heaviside-function H(d− β) assures that the
shifted Hill-function takes only values higher than zero. In Fig. B.2 the damage-dependence of
the rate v(t, d) is plotted for different parameter values.
How can we translate the proposed rate v(t, d) to the measurable degradation rate V (t) defined
by Equation B.15. Inserting v(t, d) into Equation B.20 gives:
V (t, d)X(t) =
∫ ∞
0
γ (1 +Adeg cos(ωt− φdeg))
(
d−β
s
)h
1 + d−βs
H(d− β)x(t, d)dd (B.26)
V (t, d)X(t) = γ (1 +Adeg cos(ωt− φdeg))
∫ ∞
0
(
d−β
s
)h
1 + d−βs
H(d− β)x(t, d)dd. (B.27)
The integral in Equation B.27 is now defined by the damage-dependence of v(t, d) and the
molecule density x(t, d). As the integral is not solvable in the present form we examine the limit
case for a small scaling factor s and a high Hill factor h. This limit case will result in a step-like
function and the damage dependence of v(t, d) reduces to
v(d) =
(
d−β
s
)h
1 + d−βs
H(d− β) −−−−−−−→s 1, h 1
{
0 for d < β
1 for d ≤ β (B.28)
Inserting this extreme case EquationB.28 in EquationB.27 gives an estimate for the degradation
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Figure B.2: The damage dependence of v(t, d) (Equation B.25) for different parameter
values. The Hill factor h defines the steepness of the step, parameter s scales the
slope to a range. Parameter, if not indicated: s = 1, h = 2, β = 6, γ = 0.05.
term which the molecule concentration X(t) experiences:
V (t)X(t) = γ (1 +Adeg cos(ωt− φdeg))
∫ ∞
β
x(t, d)dd (B.29)
B.3 Analytical Solution of the PDE
Here, I will demonstrate the derivation of an analytical solution for the PDE. However, a closed
solution is only possible for damage-independent rates. In this section I denote
∂x(t, d)
∂t
= xt and (B.30)
∂x(t, d)
∂d
= xd. (B.31)
The PDE with time-dependent production and degradation rates and constant damage accu-
mulation rate reads then:
0 = xt + cxd + v(t)x with
x(t, 0) = k
c
(1 +Aprod cos(ωt− φprod)) quadand
v(t) = γ (1 +Adeg cos(ωt− φdeg))
(
eβd − 1
)
.
(B.32)
To solve this equation I use the method of characteristics, where one variable is limited by
basically changing the coordinate system such that the eliminated variable constitutes the new
coordinate system. It is only applicable for first order linear PDEs with constant coefficients.
In this case it means, in order to use the method the damage accumulation rate is required to
be constant. I learned this standard technique for solving PDEs from the well written script on
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PDEs by Victor Grigoryan (http://web.math.ucsb.edu/~grigoryan/124A/lectures.html).
The new variables ξ and η then read
ξ = t+ cd (B.33)
η = ct+ d. (B.34)
The old variables expressed by the new ones:
t = ξ + cη1 + c2 (B.35)
d = cξ − η1 + c2 . (B.36)
With this new variables the PDE turns into an ODE:
0 = (1 + c2)xξ + v(ξ, η)x (B.37)
v(ξ, η) = γ
(
1 +Adeg cos
(
ωξ + cη1 + c2 − φdeg
))(
e
β cξ−η1+c2 − 1
)
(B.38)
This homogeneous ODE can be solved by separating the variables. After some integration and
retransformation to the old variables one obtains for the general solution of the homogeneous
ODE
x(t, d) = f(ct− d) exp
{
γ
[
− 11 + c2 (t+ cd)−Adeg
[
sin (ωt− φdeg)
(
− 1
ω
+ ω(βc)2 + ω2 e
βd
)
+
+ + cos (ωt− φdeg)
(
βc
(βc)2 + ω2 e
βd
)]]}
(B.39)
The unknown function f(ct− d) is determined by the initial condition:
x(t, 0) =k
c
(1 +Aprod cos(ωt− φprod)) = k(ct) = (B.40)
=f(ct) exp
{
γ
[
− 11 + c2 t−Adeg
[
sin (ωt− φdeg)
(
− 1
ω
+ ω(βc)2 + ω2
)
+
+ cos (ωt− φdeg)
(
βc
(βc)2 + ω2
)]]}
(B.41)
=f(ct)g(ct). (B.42)
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It follows
f(ct) = k(ct)
g(ct) and (B.43)
f(ct− d) = k(ct− d)
g(ct− d) . (B.44)
With this one receives the final solution for the PDE Equation B.32:
x(t, d) =k
c
(
1 +A− prod cos
(
ωt− ωd
c
− φprod
))
·
· exp
{
− γ
[
1
βc
(
e−βd − 1
)
− d
c
+
+Adeg
[
sin (ωt− φdeg)
(
− 1
ω
+ ω(βc)2 + ω2 e
βd + (βc)
2
ω ((βc)2 + ω2) cos(ωd/c)−
βc
(βc)2 + ω2 sin(ωd/c)
)
+ cos (ωt− φdeg)
(
ω
(βc)2 + ω2 e
βd − (βc)
2
ω ((βc)2 + ω2) cos(ωd/c) +
βc
(βc)2 + ω2 sin(ωd/c)
)]]}
(B.45)
B.4 Recalculation of Deadenylation Rates: Inverse Problem
I use the model Equation B.17 in Section 3.3.3 to describe the deadenylation of poly(A) tails,
stabilizing elements at the 3’end of an mRNA. A new sequencing techniques allows genome-wide
measurement of poly(A) tails. With this data, in the model description constituting x(t, d), it
is possible to recalculate unmeasured mRNA specific deadenylation rates q(t, d) by formulating
an inverse problem as I will outline in the following.
The model describes development of the concentration of mRNA x(t, d) with certain poly(A)
tail lengths d in time t. In this description d = 0 means an intact, unshortened poly(A) tail of
250 adenosides, x(t, d = 250) describes the concentration of mRNA with completely removed
poly(A) tail. These mRNA with their poly(A) tails are transcribed with rate k(t) and degraded
with v(t, d). The poly(A) tail is shortened with rate q(t, d). These processes are captured by
the PDE model from the previous section:
∂x(t, d)
∂t
= −q(t, d)∂x(t, d)
∂d
− x(t, d)∂q(t, d)
∂d
− v(t, d)x(t, d)
x(t, 0) = k(t)
q(t, 0)
(B.46)
The TAIL-seq data gives poly(A) tail length distributions for each gene, in the model description
a time-independent solution of the model x(d). To use these data to recalculate poly(A) tail
length-dependent deadenylation rates, in the model description q(d), we need to discuss the
influence and make assumptions with regards to all other parameters. It is well established
that a poly(A) tail of about 250 nucleotides is added to each mRNA right after completion
of its transcription [247] and mRNA are mostly only degraded after complete removal of their
poly(A) tails [187]. For the model this means mRNAs are born only with a complete poly(A) tail,
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consequently the transcription rate enters the model only as boundary condition. Furthermore,
mRNAs are not degraded if the poly(A) tail is longer than 20 nucleotides and hence for d < 230
the degradation rate equals zero, v(t, d < 230) = 0. Furthermore, to formulate an inverse
problem with an unique solution I need to assume that poly(A) tails are not relengthened. This
is true for most RNA, however it is known that cytosolic relengthening is possible. For example,
some mRNA of housekeeping genes are stored in stress granules, where mRNA are translationally
silenced via a shortened poly(A) tail and upon stress the translation is reactivated through
poly(A) tail relengthening [259]. Since one TAIL-seq measurement captures one snapshot in
time the model description does not include time dependence. To capture a poly(A) tail length
distribution which changes in time, e.g. a poly(A) tail length distribution which is influenced by
the circadian deadenylase Nocturnin [166], one would need a time series of these measurements
and apply the following procedure to each TAIL-seq data separately.
Applying all the above mentioned reduces the Equation B.46 for d < 230 to
0 = −q(d)dx(d)dd − x(d)
dq(d)
dd
x(0) = k
q(0) .
(B.47)
This model describes the development of a poly(A) tail length of one mRNA species for d < 230.
The unknown function x(d) solves this equation. However, with the TAIL-seq data x(d) is
known and the deadenylation rate is the unknown function. To recalculate the length-dependent
deadenylation rate from the TAIL-seq data I discretize the derivatives, for example:
dq(d)
dd =
qk − qk−1
∆d , (B.48)
where the step size ∆d equals one adenoside, the smallest reasonable solution in this description.
With this I gain from Equation B.47 a system of linear equations
x0 =
k
q0
(B.49)
0 = −qk xk − xk−1∆d + xk
qk − qk−1
∆d , k = 0...220. (B.50)
This system of linear equation with given xk from the TAIL-seq data is solvable for qk except
for a proportionality factor k, discrete values of the deadenylation rate q(d). To relate qk to
absolute values one would need additionally information on the transcriptional activity k.
In the main text, Section 3.3.3, the discretization and recalculation of q(d) has been done on
a simulated model which resembled measured data. To apply it on real data would follow the
same procedure. However, I expect that the data has to be smoothed beforehand.
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C.1 Sequencing Data
C.1.1 Read Quantification
For the liver data set, already published in Menet et al. [5], raw data was downloaded from the
public domain at GEO with the accession number GSE36916
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE36916). The raw data for mouse
kidney was provided by Roman-Ulrich Müller from University of Cologne.
All raw data was annotated using Bowtie2 [260].
Read quantification was done using an R-script which is geared to the vignette “Overlap
encodings” of the package “GenomicAlignments” [261]. Read counts were normalized to Reads
Per Kilobase per Million mapped reads (RPKM).
In short, for each gene a list of the genomic ranges of exons and introns were extracted
from the reference genome TxDb.Mmusculus.UCSC.mm9.refGene. For liver, two sequencing data
sets were available, nascent-sequencing and common RNA sequencing. Reads from nascent-seq
which overlapped with exons of a gene were counted as its transcriptional activity, reads from
RNA sequencing which overlapped with exons of a gene were counted as RNA abundance. For
kidney, information on both transcriptional activity and mRNA abundance came from one RNA
-sequencing data set. Aligned reads from introns of a gene were counted as its transcriptional
activity. Aligned reads from exons were counted as RNA abundance.
The threshold for expressed genes were set after inspection of histograms of read counts
according to the following table.
data set Expressed genes are genes with
mean read count larger than
kidney, transcriptional activity 2−7.
kidney, RNA abundance 2−5.
liver, transcriptional activity 2−5.
liver, RNA abundance 2−3.
From now on I only consider expressed genes without an explicit statement.
C.1.2 Circadian Genes
To test if time series of either transcriptional activity or RNA abundance are rhythmic I tested
each time series with RAIN [200] by using R-package “rain” (Version 1.4.0) and used Benjamini-
Hochberg correction to calculate for each time series a False Discovery Rate (FDR). Additionally,
I fitted a cosine curve to each time series using the R-package “HarmonicRegression” [179].
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Figure C.1: Proportion of genes which are classified as circadian. RNA abundances were
classified as circadian or not circadian with different threshold values. Color-coded
are percentages of circadian RNA from all expressed RNA. FDR comes from RAIN,
relative amplitude from cosine fit.
From this fit I obtained the relative amplitudes. In Fig. C.1 the proportion of genes which are
classified as circadian of all expressed RNA abundances for different thresholds are shown. It is
interesting to see that mainly the relative amplitude is the determining factor if gene is classified
as circadian. If not stated elsewhere I classified time series with a FDR≤ 0.25 and a relative
amplitude > 0.1 as circadian.
C.1.3 Estimate Uncertainty of Cosine Fit
A rhythmic abundance of a species x is measured by a time series consisting of n points. The
time series is fitted with a linear model
xt = A cos (ωt) +B sin (ωt) + at (C.1)
where {at} are random and uncorrelated errors with a standard deviation σ:
E(at) = 0
E(ata′t) =
{
σ2, t = t′
0, otherwise.
(C.2)
C.1.4 Covariance Matrix of Fitting Parameters
In matrix form the fitting problem Equation (C.1) can be stated as
y = βX (C.3)
116
C.1 Sequencing Data
with
y =

x1
x2
...
xn
 , X =

cos(ωt1) sin(ωt1)
cos(ωt2) sin(ωt2)
...
cos(ωtn) sin(ωtn)
 and β =
(
A
B
)
(C.4)
In the method of linear least squares we are now seeking for parameters A and B which minimize
the sum of squared vertical distances S(A,B) between the observed responses in the dataset
and the responses predicted by the linear approximation:
S(A,B) =
n∑
i=1
(xi −A cos (ωt)−B sin (ωt))2 = (y− βX)T (y− βX) (C.5)
This function has a global minimum at βˆ =
(
µA
µB
)
. The covariance matrix of the fitting
parameters covβ is given by
covβ = σ2
(
XTX
)−1
(C.6)
where σ2 is the standard deviation given in Equation (C.2). The time series are measured
at equally distributed along the period time points and can consists either of fully measured
periods or fully measured periods plus additional time points. Assuming, we have m fully
measured periods with N time points each and k additional time points. An example would be
a circadian time series (period = 24) measured at time points 0, 5, 11, 17, 23, 29. This would
mean 6 time points in total, m = 1 fully measured period of N = 4 time points per period and
k = 1 additional time point.
We can now rewrite the matrix X:
X =

cos
( 2pi
N
0
)
sin
( 2pi
N
0
)
cos
( 2pi
N
1
)
sin
( 2pi
N
1
)
...
cos
( 2pi
N
m ·N + k
)
sin
( 2pi
N
m ·N + k
)
 (C.7)
To calculate the covariance matrix of the fitting parameters Equation (C.6) we first look at the
matrix XTX
XTX =
(
cos
( 2pi
N
0
)
cos
( 2pi
N
1
)
. . . cos
( 2pi
N
m ·N + k
)
sin
( 2pi
N
0
)
sin
( 2pi
N
1
)
sin
( 2pi
N
m ·N + k
)) ·

cos
( 2pi
N
0
)
sin
( 2pi
N
0
)
cos
( 2pi
N
1
)
sin
( 2pi
N
1
)
...
cos
( 2pi
N
m ·N + k
)
sin
( 2pi
N
m ·N + k
)

=
(
CC CS
CS SS
)
(C.8)
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with following symbols:
CC =
mN+k−1∑
i=0
cos2
(2pi
N
i
)
(C.9)
SS =
mN+k−1∑
i=0
sin2
(2pi
N
i
)
(C.10)
CS =
mN+k−1∑
i=0
cos
(2pi
N
i
)
sin
(2pi
N
i
)
(C.11)
All these sums can be divided into two parts of fully measured periods and the rest. As an
example I show this for the entry CC Equation C.9:
CC =
mN+k−1∑
i=0
cos2
(2pi
N
i
)
=
mN−1∑
i=0
cos
(2pi
N
i
)
+
mN+k−1∑
i=mN
cos2
(2pi
N
i
)
= CCfull periods + CCrest (C.12)
The sums of fully measured periods can be strongly simplified. The sum of squared cosines
reduces to
mN−1∑
i=0
cos2
(2pi
N
i
)
=
mN−1∑
i=0
1 + cos
(
4pi
N i
)
2 used trigonometric identity
= mN2 +
1
2
mN−1∑
i=0
cos
(4pi
N
i
)
︸ ︷︷ ︸
= 0, sum of mN
cosines
which are evenly dis-
tributed on a 4pi-period
= mN2 = CCfull periods. (C.13)
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We use this result and the Pythagorean identity to calculate the sum of squared sines:
mN =
mN−1∑
i=0
1
=
mN−1∑
i=0
(
cos2
(2pi
N
i
)
+ sin2
(2pi
N
i
))
used Pythagorean identity
=
mN−1∑
i=0
cos2
(2pi
N
i
)
+
mN−1∑
i=0
sin2
(2pi
N
i
)
= mN2 +
mN−1∑
i=0
sin2
(2pi
N
i
)
used result in Equation C.13
⇔
mN−1∑
i=0
sin2
(2pi
N
i
)
= mN2 = SSfull periods. (C.14)
The sum of the mixed product reduces to
mN−1∑
i=0
cos
(2pi
N
i
)
sin
(2pi
N
i
)
=
sin
(
4pi
N i
)
+ sin(0)
2 used trigonometric identity
=
mN−1∑
i=0
sin
(
4pi
N i
)
2︸ ︷︷ ︸
= 0, sum of mN sines
which are evenly dis-
tributed on a 4pi-period
= 0 = CSfull periods (C.15)
Taken together the results from Equations (C.8-C.15) the matrix XTX transforms to:
XTX =
(
CC CS
CS SS
)
=
(
CCfull periods + CCrest CSfull periods + CSrest
CSfull periods + CSrest SSfull periods + SSrest
)
=
(
mN
2 + CCrest CSrest
CSrest
mN
2 + SSrest
)
(C.16)
The covariance matrix of the parameters covβ of only full measured periods (CCrest = SSrest =
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CSrest = 0) is then given by Equation (C.6):
covβ, full = σ2
(
XTX
)−1
= σ2
(
mN
2 0
0 mN2
)−1
= σ2
(
2
mN 0
0 2mN
)
(C.17)
and for time series with fully measured periods and some additional time points the covariance
matrix covβ reads
covβ = σ2
(
XTX
)−1
= σ2
(
mN
2 + CCrest CSrest
CSrest
mN
2 + SSrest
)−1
= σ
2(
mN
2 + CCrest
) (
mN
2 + SSrest
)
− CS2rest
(mN2 + SSrest) −CSrest
−CSrest
(
mN
2 + CCrest
) (C.18)
with following abbreviations:
CCrest =
mN+k−1∑
i=mN
cos2
(2pi
N
i
)
,
SSrest =
mN+k−1∑
i=mN
sin2
(2pi
N
i
)
and
CSrest =
mN+k−1∑
i=mN
cos
(2pi
N
i
)
sin
(2pi
N
i
)
.
(C.19)
C.2 Half-Lives
Half-lives were collected from two studies: Friedel et al. [212] and Schwanhäusser et al. [213],
where mRNA half-lives in NIH3T3 mouse fibroblasts were assayed. In these two studies, a
technique based on labeling of newly synthesized mRNA was used, resulting in significantly
more accurate half-life estimates than obtained by older technique based on transcriptional
arrest induced by actinomycin [262]. These data were merged on MGI gene symbol, a geometric
mean (equivalent to mean of the inverse half-lives or, in other words, degradation rates) was
used for the cases several transcripts mapped to the same gene. In total, 9595 mRNA half-lives
mappable to MGI symbols were assayed by at least one of these two studies, 3308 were assayed
in both. A simple linear least squares fit log(t1/2, Friedel) = a + b log(t1/2, Schwanhäusser) yielded
estimates a = −0.22 and b = 0.98. Since b is within the error margin of 1 the fit is excellent, and
we chose to correct the Schwanhäusser et al. [213] data for the offset by multiplication with the
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factor 10a. For the 3308 cases where half-lives were obtained in both studies, unbiased estimates
of their variances were made, using the corrected values of Schwanhäusser et al. [213].
C.3 UTRs
In Section 2.7.1 I investigated the 5’ and 3’ UTRs of genes positively tested for rhythmic post-
TRXreg in mouse liver and kidney. For this I reprocessed the annotated reads and quantified
all reads not on gene annotation but on transcript annotation, see Section C.1.1, followed by
finding circadian transcripts using a q-value cut-off obtained by RAIN and an amplitude cut-off
(FDR<0.25, Arel ≤ 0.1), see Section C.1.2. Then I applied to these transcripts the PA-test to
find transcripts under rhythmic post-transcriptional control as I also already did for sequencing
data quantified using the gene annotation.
From these transcripts in liver and kidney, which are positively tested for rhythmic post-
transcriptional regulation I retrieved the UTRs. A complete list of all 5’UTRs and 3’UTRs
of mouse transcripts was obtained using the R-package GenomicRanges [261] together with
the reference genome TxDb.Mmusculus.UCSC.mm9.refGene. To use these lists it was neces-
sary to map the RefSeq identifier gained during transcript quantification to UCSC transcript
identifier. For that I used a list downloaded from the USCS Genome Browser, complete
url: http://hgdownload.cse.ucsc.edu/goldenPath/mm9/database/knownToRefSeq.txt.gz.
When inspecting this list I noticed that mapping of RefSeq, already a transcript identifier, to
UCSC identifier was a one to many mapping and upon inspection these UCSC mapping to one
RefSeq were also annotated with the same UTRs. Consequently, using the unprocessed list of
UCSC identifier would result in several annotation of many UTRs for no identifiable reason. I
therefore kept for each RefSeq identifier only one UCSC identifier.
I used this list of UCSC identifiers together with the lists of 5’ and 3’UTRs to get the UTR
lengths. For each organ and each UTR (either 5’ or 3’) I used two reference lists of transcripts:
• all expressed transcripts
• circadian transcripts positively tested for rhythmic post-transcriptional regulation
(FDR<0.25 obtained from PA-test [179]).
C.4 RNA Binding Proteins
In Section 2.7.2 I search for rhythmically expressed RNA binding proteins (RBPs). In order to
do that I use a combination of three curated lists of RBPs in mouse:
• http://rbpdb.ccbr.utoronto.ca: a collection of experimental observations of RNA-
binding sites, both in vitro and in vivo, manually curated from primary literature by Cook
et al. [263]
• http://cisbp-rna.ccbr.utoronto.ca: a Catalog of Inferred Sequence Binding Prefer-
ences of RNA binding proteins by Ray et al. [264]
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• http://rbpmap.technion.ac.il: a database of 114 human/mouse RBPs together with
their motifs by Paz et al. [265]
This gives list of 463 RBPs in mouse. To find circadianly expressed RBPs I identify for each
RBP the transcript in liver and kidney and choose these RBPs whose mRNA abundance have
a strong circadian rhythm, i.e. FDR≤ 0.25 obtained from RAIN and Arel > 0.2. Furthermore, I
exclude all RBPs whose half-lives has been measured by Schwanhäusser et al. [213] since all of
these have a half-life are much longer than 15 hours and I expect for these RBPs that rhythms in
protein level has vanished, see Section 2.1. With that I receive 15 and 25 RBPs with a rhythmic
transcript in kidney and liver, respectively. 4 of them are rhythmic in both organs. A complete
list of these RBPs can be found in Section F.4.
C.4.1 Enrichment of RBP Binding Sites
In Section 2.7.3 I searched for RNA binding sites in the 5’ and 3’UTRs of transcripts. I then
test if RBP binding sites of specific RBPs are enriched in genes positively tested for rhythmic
postTRXreg.
To find the number of RNA binding sites for each transcript I again used the transcripts
quantification described in Section C.3 and downloaded the UTR-sequences from Ensembl
BioMart Browser (www.ensembl.org/biomart/martview) [266] accessed by ENSEMBLE Tran-
script identifier. These sequences I used in the online tool “RBPmap (Mapping Binding Sites of
RNA Binding Protein)” [265]. This tool provides a curated list of 114 human/mouse RBP bind-
ing motifs. I allowed to search for occurrence of any of these motifs in the uploaded sequences
together with options “High stringency”, which applies a very low p-value cut-off (p < 0.001).
I identified in this way RBP binding motifs in two transcript sets for each organ:
• all circadian transcripts (FDR≤ 0.25 obtained from RAIN and Arel > 0.1)
• circadian genes positively tested for rhythmic postTRXreg (FDR≤ 0.25 obtained from
PA-test).
For each transcript I annotated if a RBP binding motif of a specific RBP in the UTRs occurred.
In this way I received how many transcript UTR contained a binding site for each RBP. These
counts of binding site occurrences I used to test for enrichment of transcripts positively tested
for rhythmic postTRXreg against all circadian transcripts. The enrichment test was done using
Fisher’s Exact test implemented in R (function fisher.test).
C.5 Gene Function and Enrichment of Gene Functions
In Section 2.7.3 I also tested for gene function enrichment. For that I extracted different subsets
of genes and used them as test set and background set in the DAVID Function Annotation Tool.
I accessed gene functions via the genes’ Entrez gene ID.
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I investigated following subsets for each organ (see also text and figure in Section 2.7.3):
subset used as
all circadian genes background1 (bg1)
all genes tested for
rhythmic postTRXreg testset with bg1 / background2 (bg2)
testset1 testset with bg2
genes from testset1 + pdp btw 0 & 12 h testset with bg2
genes from testset1 + pdp btw 12 & 0 h testset with bg2
genes from testset1 + pdp btw 6 & 18 h testset with bg2
genes from testset1 + pdp btw 18 & 6 h testset with bg2
genes from testset1 + pdp btw 0 & 6 h testset with bg2
genes from testset1 + pdp btw 6 & 16 h testset with bg2
genes from testset1 + pdp btw 16 & 24 h testset with bg2
Abbreviations:
all circadian genes = all expressed genes (either mRNA or transcriptional activity) with RAIN
FDR≤ 0.25 and Arel > 0.1
testset1 = all circadian genes positivly tested for rhythmic postTRXreg (FDR≤ 0.25 from PA-
test)
pdp btw = predicted degradation phase between
C.6 Shape of Time Series
In Section 2.7.4 I investigate the shape of time series. For that I first find for the transcriptional
activity the best fit out of different lengths of Fourier series. Then I test if a fit of the transcript
abundance would work better if the fitting model has one more Fourier term than the fit of the
corresponding transcriptional activity. To compare fits I use the ANOVA package implemented
in R.
The algorithm to find the best suitable fit for the transcriptional activity is as follows:
1. Initialize number of terms: n = 1, corresponds to a cosine function∗
2. Initialize fake start p-value: pcompare = 0.1
3. Perform two linear fits:
a) Fourier series with n terms
b) Fourier series with n+ 1 terms
4. Perform ANOVA test to compare both fits, get p-value pANOVA
5. If pcomparepANOVA > 10, then best fit for transcriptional activity is a Fourier series with
order= n+ 1.
6. Else: n = n+ 1, pcompare = pANOVA, go to 3.
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∗ My first try is already an oscillating fit and with that I loose all constant time series. However,
I feared that the step from a constant to a rhythmic fit will give highly significant test-result
and any differences between fits of Fourier series with higher terms would be not as significant.
I then used the order received from the first algorithm to compare two fits for the corresponding
mRNA abundance, first a Fourier series with order from transcriptional activity fit, second a
Fourier series with order+1. The comparison was done using again the ANOVA test which
provided the in the main text reported p-values.
To test for enrichment between both tests I used again a Fisher exact test. My contingency
table I tested had the following form for each organ with x =q-value in Figure 2.14B:
q-value<x q-value≥ x Total
PA-test A B A+B
test for shape C D C+D
Total A+C B+D A+B+C+D
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Appendix D: Harmonics Generated by
Rhythmic Splicing
D.1
In Section 3.1 I investigate if rhythmic splicing can result in higher harmonics in the mRNA
abundance, i.e. mRNA with a period of 12 hours instead of 24 hours.
A pre-RNA x is rhythmically transcribed and rhythmically spliced and serves as production
for an mRNA y which is then degraded with a constant degradation rate. This is described by
the model
dx
d
t
= prod(t)− γsplic(1 +Asplic cos(ωt− φsplic)) (D.1)
dy
d
t
= kγsplic(1 +Asplic cos(ωt− φsplic))− γdeg (D.2)
I simulated the model with the parameters, if not indicated, ω = 2pi24h−1, γsplic = ln 2/0.5h−1,
k = 1h−1, γdeg = 0.5h−1. For the function describing the transcriptional activity, I tested two
periodic functions, in the main text termed cosine and “pointy” function. The equations for
both read:
prodcos(t) = (1 +Aprod cos(ωt)) (D.3)
prodpoint(t) = (1 +Aprod
1
1 + 0.8 cos(ωt)) (D.4)
In Figure D.1 prodpoint(t) for different relative amplitudes is shown.
Detection of period was done by counting maxima of the time series within 24 hours. The
simulation, analysis of simulated time series and graphical representation was done using a
Mathematica script.
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Figure D.1: The function prodpoint(t) for different relative amplitudes.
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Appendix E: Rhythmic postTRXreg in Core
Clock
E.1
In Section 3.2 I investigated a Goodwin model with rhythmic degradation rates. The Goodwin
model I used reads:
dx
d
t
= kx
Kh
Kh + zh − dx(1 +Ax cos(ωt− φx))x (E.1)
dy
d
t
= kyx− dy(1 +Ay cos(ωt− φy))y (E.2)
dz
d
t
= kzy − dz(1 +Az cos(ωt− φz))z (E.3)
For simulation I used the following parameters kx = ky = kz = 1, dx = dy = dz = 0.1, K = 1,
h = 10. If simulated this system with constant degradation rates, that is Ax = Ay = Az = 0,
all variables oscillated with a period T = 39.71. I used this period as reference and fixed the
angular frequency of the degradation rates with ω = 2piT .
I simulated the system and let either one of the degradation rates oscillate, all others were
set to constant, or in other words their relative amplitude was set to zero. I determined the
oscillation properties of each variable by following algorithms (x stands for any variable of
interest, x, y or z in the model equation):
period/phase:
1. Iterate through time points starting at t=500,
find a peak (x_t < x_t+1 & x_t+1 > x_t+2).
2. Iterate further through time points, find second peak.
3. phase = t_peak2 - t_peak1
4. period = t_peak2 - t_peak1
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magnitude:
1. M = 0
2. Iterate through time points over one period:
For each time point n: M = M + x[n]*(time[n+1]-time[n])
3. M = M/period
rel. amplitude:
1. x_max=0, x_min=1E+06
2. Iterate through time points n over one period:
For each time point n:
if x[n] < x_min: x_min = x[n]
if x[n] > x_max: x_max = x[n]
3. relAmp = 1/M * 0.5 * (x_max-x_min)
Simulation, time series analysis and graphical representation was done using a python script.
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F.1 List of Circadian Core Clock Genes
List of circadian genes used in Figure 2.3 (MGI-symbols):
Arntl, Npas2, Cry1, Cry2, Per1, Per2, Per3, Dbp, Nr1d1, Nr1d2
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F.3 List of Genes with Rhythmic Post-Transcriptional Control
F.3 List of Genes with Rhythmic Post-Transcriptional Control
List of genes with rhythmic post-transcriptional regulation found by the pa-test with FDR≤ 0.25
in Section 2.4. If the gene was found in liver or kidney the predicted degradation phase φdeg is
shown.
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MGI predicted φdeg Kidney predicted φdeg Liver
1 1190002N15Rik 2.09
2 2410002F23Rik 15.83
3 2510039O18Rik 13.98
4 Aco1 20.45
5 Aco2 23.08 18.23
6 Acot9 19.87
7 Acsl5 7.99
8 Actn1 22.64 13.43
9 Adar 11.05
10 Adk 20.82
11 Aebp1 17.36
12 Aes 23.32
13 Agpat4 17.79
14 Agps 15.83
15 Ahctf1 0.81
16 Ahcy 18.33
17 AI837181 18.92
18 Ak2 15.16
19 Akap11 10.99
20 Akr1b8 17.69
21 Alad 22.18
22 Aldh9a1 21.62
23 Alg2 3.01
24 Amacr 8.66
25 Angptl2 19.47 17.13
26 Ank3 14.76
27 Ankrd12 18.76
28 Anp32b 17.41
29 Anxa11 16.57
30 Anxa2 2.24
31 Anxa3 15.31
32 Anxa7 18.82 14.54
33 Ap1m1 22.27
34 Ap2a2 4.58 2.80
35 Ap2s1 16.47
36 Aprt 8.86
37 Arhgap28 3.30
38 Arl8a 12.65
39 Asna1 21.77
40 Atad2 20.27
41 Atp6ap1 1.46
42 Atp6v1e1 13.31
43 B230219D22Rik 12.64
44 Bag2 23.94
45 Bag3 21.16
46 Baz1b 18.13
47 BC017643 7.20
48 Becn1 21.43
49 Bgn 19.09
50 Bicd2 1.51
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MGI predicted φdeg Kidney predicted φdeg Liver
51 Bid 3.93
52 Bloc1s2 14.50
53 Cacybp 0.22
54 Cald1 6.60 5.25
55 Cand2 7.05
56 Cask 19.97
57 Casp3 13.17
58 Cbl 20.83
59 Cbx6 15.92
60 Cct3 23.77
61 Cct5 0.96 23.96
62 Cd2ap 9.36
63 Cd3eap 18.56
64 Cd9 7.47
65 Cdca8 12.56
66 Cdh11 8.01
67 Cdk5rap2 10.86
68 Cdkn2c 10.42
69 Chaf1b 15.74
70 Chchd4 15.71
71 Chka 3.42
72 Chmp2a 17.09
73 Chmp6 7.33
74 Chordc1 1.76 22.76
75 Cirbp 13.87 9.11
76 Clic4 3.63 0.09
77 Clk1 5.75
78 Clpp 19.68
79 Clpx 7.39 2.85
80 Cltb 23.02
81 Cmtm7 10.23
82 Cobll1 14.87
83 Coil 4.32
84 Col6a1 23.01 10.69
85 Comt 7.64
86 Cpne8 8.39
87 Cpsf2 5.45
88 Cpt1a 16.43 15.48
89 Crcp 18.12
90 Creld2 23.49
91 Csad 19.25
92 Cstf2t 13.43
93 Cttn 12.01
94 Cttnbp2nl 16.61
95 Cyc1 20.43
96 Cyr61 7.68
97 D1Ertd622e 17.47
98 Dab2 15.29 18.91
99 Dap3 15.46
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MGI predicted φdeg Kidney predicted φdeg Liver
100 Dazap1 13.23
101 Dbi 1.00
102 Dbn1 19.90
103 Dbr1 5.68
104 Dcakd 0.72
105 Ddx20 20.64
106 Ddx47 10.08
107 Ddx5 18.64
108 Ddx52 7.79
109 Dhfr 10.68
110 Dlst 18.00
111 Dnajb1 22.29
112 Dnajb6 16.52
113 Dnajc1 21.86
114 Dpy19l1 23.75
115 Dus3l 21.12
116 Dusp14 22.87
117 Dusp3 17.90
118 Dynll1 1.46
119 Ecm1 18.79
120 Eef1e1 2.57
121 Efhd2 16.99
122 Ehbp1 5.28
123 Ehd1 1.99
124 Eif4b 12.26
125 Elavl1 4.49
126 Emb 8.67
127 Emg1 23.57
128 Eml3 4.62
129 Eml4 0.99
130 Esd 0.02
131 Etfa 21.91
132 Evi5 2.76
133 Exoc3 9.87
134 Extl2 12.12
135 F3 10.73
136 Fadd 11.30
137 Faim 8.92
138 Fbxo21 10.69 10.83
139 Fbxo22 12.34
140 Fbxo4 8.74
141 Fdxr 16.04
142 Fis1 16.78
143 Fkbp10 17.36
144 Fkbp4 1.36 23.24
145 Fkbp5 18.71
146 Flot1 11.23
147 Foxk1 13.25
148 Foxk2 1.12
149 Fpgs 0.69
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MGI predicted φdeg Kidney predicted φdeg Liver
150 Fundc2 9.89
151 Fyn 14.18
152 Gclc 3.05
153 Gclm 4.15
154 Gga2 21.44
155 Glrx 18.05
156 Glud1 0.18
157 Glul 21.21
158 Gne 14.02
159 Gng12 13.24
160 Gnpnat1 10.85
161 Gns 20.66 15.29
162 Golgb1 12.52
163 Gopc 20.33
164 Gpd1l 17.10
165 Gsk3a 22.63 17.36
166 Gsk3b 21.58
167 Gsto1 12.06
168 Gtf2h5 20.93
169 H2-D1 17.36
170 Hdgf 0.69 17.99
171 Hdgfrp3 10.55
172 Higd2a 0.91
173 Hmg20a 12.47
174 Hmgb2 11.55 10.40
175 Hmgb3 12.48
176 Hn1 8.36
177 Hpcal1 17.11
178 Hs1bp3 11.21
179 Hsd17b7 21.34
180 Hsp90aa1 22.61
181 Hsp90ab1 22.01
182 Hsp90b1 1.55
183 Hspa14 15.43
184 Hspa4l 1.09 22.72
185 Hspa8 21.39
186 Hspb8 17.36
187 Ifit1 11.95
188 Igf2r 9.48
189 Igfbp7 20.88
190 Ilf2 11.02
191 Immt 14.66
192 Ints3 1.65
193 Iqgap1 12.75
194 Itpr1 19.60
195 Ivns1abp 16.78
196 Jmjd1c 2.93
197 Kars 9.98
198 Kdelr2 21.81
199 Khdrbs1 11.24
200 Klf13 17.45
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MGI predicted φdeg Kidney predicted φdeg Liver
201 Kpna1 2.89
202 Kpnb1 1.79
203 Lamp2 3.54
204 Lasp1 4.88
205 Leo1 3.66 1.29
206 Lgals3 11.80
207 Lima1 13.17
208 Lman2 1.57
209 Lmnb2 2.93
210 Lmo7 17.21
211 Lrrc8d 7.12
212 Luc7l2 8.58
213 Mad2l1bp 3.01
214 Man2a1 18.69
215 Maoa 12.13
216 Map2k7 10.29
217 Mapk14 21.85 19.95
218 Mapre2 19.40
219 Marcks 11.70
220 Mbnl2 18.39
221 Mcc 1.70
222 Mcfd2 22.86 22.07
223 Mcm2 18.67
224 Mdh2 19.12
225 Med19 8.53
226 Med28 7.80
227 Med8 3.30
228 Metap1 0.38
229 Mical2 6.15 2.47
230 Mnat1 12.99
231 Mocs3 13.82
232 Morc3 19.78
233 Mrpl22 8.90
234 Mrpl32 10.20
235 Mrpl50 11.11
236 Mrpl9 17.42
237 Mrps18b 17.86
238 Mrps24 12.80
239 Mrps26 16.58
240 Mrps30 5.48
241 Mrps34 12.72
242 Mrps5 13.26
243 Msh6 11.48
244 Msn 12.93
245 Mtap 22.16
246 Mtx1 15.74
247 Myadm 16.29
248 Myo1b 1.13
249 Myo5a 18.70
250 Napa 16.62
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MGI predicted φdeg Kidney predicted φdeg Liver
251 Nat10 1.63
252 Ncoa5 3.24
253 Ndufa2 20.11
254 Nedd4l 1.75
255 Nek6 6.17
256 Nin 11.13
257 Nisch 18.89
258 Noc3l 5.18
259 Npc2 13.94
260 Npr3 17.65
261 Nt5c 17.13
262 Nt5c2 16.77
263 Nubp2 19.28
264 Nucb1 8.31
265 Nudcd3 16.10
266 Nudt16l1 14.77
267 Nudt3 16.96
268 Nup62 0.31
269 Nup93 9.60
270 Ogfod1 19.60
271 Ormdl3 23.47
272 Osbpl11 1.95
273 Oxnad1 19.73
274 P4ha2 1.89 21.66
275 Pak1ip1 12.13
276 Palld 0.69
277 Pcbp4 17.47 12.24
278 Pdcl 10.26
279 Pdia6 1.18
280 Pdss2 4.91
281 Pdxk 17.71
282 Pebp1 21.21
283 Pex16 14.38
284 Pfdn2 15.19
285 Pfn1 4.24
286 Pgk1 1.90
287 Phb 19.11
288 Pik3r1 19.96
289 Plk1 13.53
290 Plod2 8.09
291 Plscr1 9.64
292 Pmpca 20.92
293 Pmvk 21.98
294 Pnp 8.30 23.61
295 Pold3 14.04
296 Pole3 14.44
297 Polr2b 19.06
298 Polr2d 8.74
299 Polr3g 23.91
137
Appendix F: Summary Tables
MGI predicted φdeg Kidney predicted φdeg Liver
300 Pon2 13.37
301 Pop4 11.70
302 Pop5 2.35
303 Por 16.99
304 Ppat 15.60
305 Ppfibp1 11.84 8.46
306 Ppm1l 20.79
307 Ppp1ca 2.81
308 Ppp1r14b 20.22
309 Ppp2r1a 7.58
310 Ppp2r1b 4.40
311 Ppp2r5e 20.04
312 Pptc7 16.20
313 Prepl 6.49
314 Prkar2a 23.00
315 Prkcd 12.48
316 Prkci 1.02
317 Prmt6 6.10
318 Prpf38a 9.32
319 Prpf38b 5.00
320 Prps1 5.50
321 Psen1 20.97
322 Psip1 5.28
323 Psma4 10.23
324 Psmc2 3.92
325 Psmc5 22.90
326 Psmd10 8.05
327 Psmd11 5.45
328 Psmd2 8.06
329 Psmd7 0.60
330 Psmd9 14.53
331 Psme3 22.56
332 Ptpn1 13.81
333 Ptpn12 1.76
334 Pura 5.86
335 Pus7 17.58
336 Qtrtd1 13.58
337 Rab1b 11.85
338 Rab21 3.33
339 Rab34 18.08 8.54
340 Rabep1 2.78
341 Rad50 14.02 5.87
342 Rai14 4.39
343 Rapgef1 15.57
344 Rapgef6 9.10
345 Rasa3 14.21 14.50
346 Rbm14 17.77
347 Rbm17 12.31
348 Rbm3 20.71
349 Rbm7 13.23
350 Rbms1 13.07
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351 Rcl1 9.78 12.21
352 Rcor1 3.52
353 Reps1 10.64
354 Rfx1 1.03
355 Rhob 16.74
356 Rhoc 10.84
357 Rpl26 22.44
358 Rpl32 20.41
359 Rps15 21.73
360 Rps25 18.14
361 Rps27a 2.57
362 Rps29 14.41
363 Rps4x 19.72
364 Rps6ka2 14.10
365 Rps6ka4 13.43
366 Rpusd4 13.84
367 Rragc 13.90
368 Rrm2 18.79
369 Rtkn 20.31
370 Samhd1 13.70
371 Scd2 1.31
372 Sdc1 23.86
373 Sec23b 20.68
374 Sephs1 9.59
375 Sept8 16.98
376 Setd7 4.91
377 Sf3b2 19.16
378 Sf3b5 15.42
379 Sfxn1 17.29
380 Sgpl1 2.42
381 Shmt1 7.06
382 Shmt2 17.42
383 Slc12a4 12.81
384 Slc16a1 3.20
385 Slc1a4 5.67
386 Slc25a13 19.38
387 Slc25a20 21.65
388 Slc25a24 11.20
389 Slc25a32 15.97
390 Slc25a4 17.16
391 Slc44a2 12.48
392 Slc6a6 14.41 3.29
393 Smarcd2 18.01
394 Smarce1 6.07
395 Snw1 13.42
396 Snx12 4.01
397 Snx3 0.32 22.91
398 Sod2 17.67
399 Spag5 22.54
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400 Spag7 14.79
401 Spast 2.84
402 Sra1 18.53
403 Srgap3 3.16
404 Stip1 0.50 23.82
405 Stx18 2.07
406 Stx5a 20.72
407 Syngr2 16.15
408 Taf9 19.12 10.02
409 Tars 3.09
410 Tbc1d15 11.07
411 Tbrg4 17.70
412 Tceb3 3.82
413 Tcp1 22.76 23.60
414 Tex10 7.17
415 Tex2 2.98
416 Timm13 18.49
417 Timm17a 12.19
418 Tmed1 10.74
419 Tmem109 19.81
420 Tmem50b 23.69
421 Tmem97 16.69
422 Top2a 11.66
423 Tor1a 17.19
424 Tor1b 15.86
425 Tor3a 10.78
426 Trappc3 12.97
427 Trappc4 11.66
428 Trappc5 21.20
429 Trim24 17.66
430 Trim65 20.91
431 Trip10 15.72
432 Trove2 2.48
433 Tsc22d1 23.91 5.83
434 Tspan4 19.75 20.56
435 Tubb2b 3.83 4.10
436 Tubb6 6.31
437 Tubg1 22.19
438 Txnrd3 9.63
439 Ube2z 0.47
440 Ubl3 17.19
441 Ubqln1 2.98 2.91
442 Ubr2 17.95
443 Ubtf 13.77
444 Upf1 19.77
445 Utp14a 8.75
446 Utp15 12.52
447 Utp6 8.72
448 Utrn 12.57
449 Vamp2 16.65 16.48
450 Vamp3 15.74
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451 Vcam1 17.41
452 Vps13a 23.26 19.33
453 Vps37c 14.51
454 Wbp2 14.98
455 Wdr33 6.01
456 Wdr6 9.94
457 Wrnip1 2.10
458 Ypel5 13.91
459 Ywhag 19.75
460 Zcchc11 14.79
461 Zcrb1 21.02
462 Zfr 23.35
463 Zmym4 9.27
F.4 RNA Binding Proteins with Rhythmic Transcript
All gene functions were taken either from OMIM (www.omim.org), Wikipedia (wikipedia.org)
or direct publications abstracts, indicated byO,W or P. I tried to find gene functions associated
with the RNA-binding. However, this was not always possible.
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MGI Organ Function
1 A1cf kid APOBEC1 complementation factor
Mammalian apolipoprotein B (APOBEC1 = A1cf) mRNA under-
goes site-specific C to U deamination, which is mediated by a multi-
component enzyme complex containing a minimal core composed of
APOBEC1 and a complementation factor encoded by this gene [267].
The gene product has three non-identical RNA recognition motifs and
belongs to the hnRNP R family of RNA-binding proteins. It has been
proposed that this complementation factor functions as an RNA-binding
subunit and docks APOBEC1 to deaminate the upstream cytidine.
Studies suggest that the protein may also be involved in other RNA
editing or RNA processing events. Its deletion results in lethality in
mice. [268] W
2 Aptx liv Aprataxin
associated with DNA single-strand breaks and their repair, see OMIM
entry for more details.
APTX efficiently repairs adenylated RNA-DNA, and acting in an RNA-
DNA damage response, promotes cellular survival and prevents S-phase
checkpoint activation in budding yeast undergoing RER. Structure-
function studies of human APTX-RNA-DNA-AMP-zinc complexes de-
fine a mechanism for detecting and reversing adenylation at RNA-DNA
junctions. This involves A-form RNA binding, proper protein folding,
and conformational changes, all of which are affected by heritable APTX
mutations in ataxia with oculomotor apraxia-1. Tumbale et al. [269]
concluded that accumulation of adenylated RNA-DNA may contribute
to neurologic disease. Garcia-Diaz et al. [270] found that most, but not
all, cell lines derived from AOA1 patient fibroblasts showed coenzyme
Q10 (CoQ10) deficiency due to reduced mRNA and protein expression of
PDSS1, the first committed enzyme of CoQ10 biosynthesis. Low PDSS1
was caused by reduced activity of a transcriptional regulatory pathway
that included APE1, NRF1, and NRF2. Knockdown of APTX or APE1
in HeLa cells recapitulated CoQ10 deficiency and other mitochondrial
abnormalities, and these abnormalities were reversed by upregulation
of NRF2. Garcia-Diaz et al. [270] concluded that mitochondrial dys-
function in APTX-depleted cells is not due to involvement of APTX in
mtDNA repair, but rather to a role for APTX in transcriptional regula-
tion of mitochondrial function. O
3 Cirbp liv/kid Cold inducible RNA binding protein
Morf et al. [168] showed that simulated body temperature cycles, but
not peripheral oscillators, controlled the rhythmic expression of cold-
inducible RNA-binding protein (CIRBP) in cultured fibroblasts. In
turn, loss-of-function experiments indicated that CIRBP was required
for high-amplitude circadian gene expression. The transcriptomewide
identification of CIRBP-bound RNAs by a biotin-streptavidin-based
crosslinking and immunoprecipitation (CLIP) procedure revealed several
transcripts encoding circadian oscillator proteins, including CLOCK.
Moreover, CLOCK accumulation was strongly reduced in CIRBP-
depleted fibroblasts. Because ectopic expression of CLOCK improved
circadian gene expression in these cells, Morf et al. [168] concluded that
CIRBP confers robustness to circadian oscillators through regulation of
CLOCK expression. O
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4 Cpeb1 liv Cytoplasmic polyadenylation element binding protein 1
CPEB1 binds the cytoplasmic polyadenylation element (CPE), a
uridine-rich sequence element within the mRNA 3-prime untrans-
lated region (UTR) involved in directing cytoplasmic polyadenyla-
tion and translational activation. CPEB1 has been implicated in
mediating both polyadenylation-dependent translation activation
and CPE-directed translational repression [271, 272] O
5 Cpeb3 liv/kid Cytoplasmic polyadenylation element binding protein 3
Using an in vitro self-selection technique, Salehi-Ashtiani et
al. [273] identified self-cleaving ribozymes associated with ol-
factory receptor OR4K15, insulin-like growth factor-1 receptor
(IGF1R), a LINE-1 retrotransposon (LRE1), and CPEB3. O
6 Cpeb4 liv Cytoplasmic polyadenylation element binding protein 4
Cytoplasmic polyadenylation elements (CPEs) are located in the
3-prime UTRs of hundreds of mRNAs involved in cell prolifera-
tion, chromosome segregation, and cell differentiation. CPEs func-
tion as docking sites for CPE-binding proteins (CPEBs), which
can either repress or activate mRNA translation. CPEB4 acti-
vates mRNA translation by adding poly(A) tails to target mRNAs
[274]O
7 Cpsf4l kid Cleavage and polyadenylation specific factor 4 like
8 Csdc2 kid Cold shock domain-containing C2
9 Dnajc17 kid DnaJ heat shock protein family (Hsp40) member C17
Members of the Heat-shock 40-kd protein family, such as
DNAJC17, are involved in transcriptional regulation [275]. O
10 Enox1 kid ecto-NOX disulfide-thiol exchanger 1
Electron transport pathways are generally associated with mito-
chondrial membranes, but non-mitochondrial pathways are also bi-
ologically significant. Plasma membrane electron transport path-
ways are involved in functions as diverse as cellular defense, intra-
cellular redox homeostasis, and control of cell growth and survival.
Members of the ecto-NOX family, such as CNOX, or ENOX1, are
involved in plasma membrane transport pathways. These enzymes
exhibit both a hydroquinone (NADH) oxidase activity and a pro-
tein disulfide-thiol interchange activity in series, with each activity
cycling every 22 to 26 minutes [276] O
11 Fus liv/kid FUS RNA binding protein
FUS is a nucleoprotein that functions in DNA and RNA
metabolism, including DNA repair, and the regulation of tran-
scription, RNA splicing, and export to the cytoplasm. Transloca-
tion of the FUS transcriptional activation domain results in fusion
proteins and has been implicated in tumorigenesis (summary by
Vance et al. [277])
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12 Igf2bp2 liv/kid Insulin-like grwoth factor2 mRNA-binding protein 2
The Diabetes Genetics Initiative of Broad Institute of Harvard
and MIT, Lund University, and Novartis Institutes for BioMedical
Research analyzed 386,731 common SNPs in 1,464 patients with
type 2 diabetes (see 125853) and 1,467 matched controls, each
characterized for measures of glucose metabolism, lipids, obesity,
and blood pressure. With collaborators Finland-United States In-
vestigation of NIDDM Genetics (FUSION) and Wellcome Trust
Case Control Consortium/United Kingdom Type 2 Diabetes Ge-
netics Consortium (WTCCC/UKT2D), this group identified and
confirmed a locus associated with type 2 diabetes in the second
intron of IGF2BP2. [278] O
13 Khdrbs3 kid KH RNA binding domain containing, signal transduction associ-
ated 3
KHDRBS3 is an RNA-binding protein involved in regulation of
alternative splicing [279]. O
14 Lsm3 liv Lsm3 protein
Sm-like proteins were identified in a variety of organisms based
on sequence homology with the Sm protein family. Sm-like pro-
teins contain the Sm sequence motif, which consists of 2 regions
separated by a linker of variable length that folds as a loop. The
Sm-like proteins are thought to form a stable heteromer present in
tri-snRNP particles, which are important for pre-mRNA splicing.
O
15 Lsm8 liv see Lsm3
16 Mbnl2 liv Muscleblind-like splicing regulator 2
MBNL2 belongs to a conserved family of RNA-binding proteins
characterized by 2 pairs of C3H-type zinc finger-related motifs.
These proteins function as target-specific regulators of pre-mRNA
splicing [280]. O
17 Parn liv Poly(A)-specific ribonuclease deadenylating nuclease
The PARN gene, which belongs to a highly conserved family of
exoribonucleases, acts by shortening mRNA poly(A) tail length
through the process of deadenylation, thus regulating gene ex-
pression [166]. O
18 Parp14 liv Poly(ADP-ribose) polymerase 14
Poly(ADP-ribosyl)ation is an immediate DNA damage-dependent
posttranslational modification of histones and other nuclear pro-
teins that contributes to the survival of injured proliferating cells.
PARP14 belongs to the superfamily of enzymes that perform this
modification [281]. O
19 Pcbp3 kid Poly(rC)-binding protein 3
The poly(rC)-binding proteins are a subfamily of KH-domain-
containing RNA-binding proteins that bind C-rich pyrimidine
tracts and play pivotal roles in a broad spectrum of posttran-
scriptional events [282]. O144
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20 Pcbp4 liv Poly(rC)-binding protein 4, see Pcbp3
21 Ppargc1a liv Peroxisome proliferator-activated receptor-gamma, coactivator 1
PPARGC1A is a coactivator of nuclear receptors and other tran-
scription factors that regulate metabolic processes, including mito-
chondrial biogenesis and respiration, hepatic gluconeogenesis, and
muscle fiber-type switching [283]. The PPARGC1 protein contains
a putative RNA-binding domain and 2 SR domains. Proteins con-
taining paired RNA-binding motifs and SR domains interact with
the C-terminal domain of RNA polymerase-2. O
22 Pspc1 liv Paraspeckle component 1
Fox et al. [284] found that PSPC1, PSPC2, and p54NRB re-
localized from paraspeckles to the perinucleolar cap region upon
transcriptional blockade. O
23 Ralyl kid Raly-like protein
24 Rbfox1 kid RNA-binding protein Fox1
Rbfox1 regulates tissue-specific splicing by binding to the element
(U)GCAUG in mRNA precursors. Depending on where it binds
relative to the regulated exon, Rbfox1 can regulate splicing posi-
tively or negatively [285]. O
25 Rbm11 kid RNA-binding motif protein 11
Tissue-specific splicing regulator. RBM11 is selectively expressed
in brain, cerebellum and testis, and to a lower extent in kidney.
[286] P
26 Rbm12b1 liv RNA-binding motif protein 12B1
27 Rbm25 liv RNA-binding motif protein 25
Rbm25 associated with multiple splicing components, including
CBP80 (NCBP1), Sm proteins, and small nuclear RNAs. Rbm25
maintained its association with mRNA after splicing, and it as-
sociated with an mRNA-derived exon product following splicing
more efficiently than a cDNA-derived exon. [287]O
28 Rbm38 kid RNA-binding motif protein 38
RNPC1 expression was induced by DNA-damaging agents in cells
expressing wildtype p53, but not in cells lacking p53 expres-
sion [288]. Overexpression of RNPC1a, but not RNPC1b, induced
cell cycle arrest in G1, and cell cycle arrest was independent of
p53 or expression of the p53 target protein p21. Both RNPC1a
and RNPC1b bound the 3-prime region of the p21 transcript, but
only RNPC1a increased p21 mRNA and protein levels. Northern
blot analysis revealed that the half-life of p21 mRNA was more
than doubled by RNPC1a expression. Shu et al. [288] concluded
that RNPC1a mediates p53-induced cell cycle arrest by stabilizing
p21 mRNA. O
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29 Rbm46 kid RNA-binding motif protein 46
Blastocyst formation represents the first lineage specification by
segregation of the trophectoderm from the inner cell mass in early
embryonic development. Rbm46 regulates trophectoderm differ-
entiation by stabilizing Cdx2 mRNA in early mouse embryos [289].
P
30 Rbm47 liv RNA-binding motif protein 47
Alternative splicing (AS) plays a critical role in cell fate transi-
tions, development, and disease. Recent studies have shown that
AS also influences pluripotency and somatic cell reprogramming.
Cieply et al. [290] profiled transcriptome-wide AS changes that
occur during reprogramming of fibroblasts to pluripotency. This
analysis revealed distinct phases of AS, including a splicing pro-
gram that is unique to transgene-independent induced pluripotent
stem cells (iPSCs). Changes in the expression of AS factors Zc-
chc24, Esrp1, Mbnl1/2, and Rbm47 were demonstrated to con-
tribute to phase-specific AS. P
31 Rbpms liv RNA-binding protein gene with multiple splicing
Using yeast 2-hybrid screens, coaffinity purification analysis of
transfected HEK293 cells, and bioinformatic analysis, Lim et
al. [291] developed an interaction network for 54 human pro-
teins involved in 23 inherited ataxias. By database analysis,
they expanded the core network to include more distantly re-
lated interacting proteins that could function as genetic modi-
fiers. ATXN1 (showed a strong direct interaction with RBPMS,
and the N-terminal portion of ATXN1 was required for interaction
with RBPMS. RBPMS was a main hub in the network and inter-
acted with many proteins, including 2 cerebellar ataxia-associated
proteins, ATN1 and QK1. O
32 Recql4 liv Recq protein-like 4
RECQL4 from HeLa cells was isolated as a stable complex with
UBR1 and UBR2, which are ubiquitin ligases of the N-end rule
pathway, Although the known role of UBR1 and UBR2 is to medi-
ate polyubiquitylation (and subsequent degradation) of their sub-
strates, the UBR1/2-bound RECQL4 was not ubiquitylated in
vivo and was a long-lived protein in HeLa cells [292].
RECQL4 siRNA knockdown human fibroblasts accumulated more
H2O2-induced DNA strand breaks than control cells, suggesting
that RECQL4 may stimulate repair of H2O2-induced DNA dam-
age [293]. O
33 Sugp2 liv splicing factor, Arginine/Serine-rich 14 (SFRS14)
SFRS14 is a member of the SURP family, proteins containing the
RNA binding motif SURP, of splicing factors. O
34 Synj2 liv Synaptojanin 2
Chuang et al. [294] found that small interfering RNA-mediated
depletion of RAC1 or SYNJ2 in 2 human glioblastoma cell lines
inhibited migration of the cells through 3-dimensional gel and rat
brain slices, and it inhibited cell migration on glioma-derived ex-
tracellular matrix. O
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35 Tab2 liv TAK1-binding protein 2
connected to NfκB regulation, see OMIM entry for more details
36 Thumpd2 kid Thump domain-containing protein 2
37 Tra2a kid Transformer 2 alpha
Tacke et al. [295] showed that human TRA2A and TRA2B pro-
teins are present in HeLa cell nuclear extracts and that they bind
efficiently and specifically to a previously characterized pre-mRNA
splicing enhancer element. Both purified proteins bind preferen-
tially to RNA sequences containing GAA repeats, characteristic of
many enhancer elements. Neither TRA2 protein functions in con-
stitutive splicing in vitro, but both activate enhancer-dependent
splicing in a sequence-specific manner and restore it after inhibi-
tion with competitor RNA. These findings indicate that mam-
malian TRA2 proteins are sequence-specific splicing activators
that are likely to participate in the control of cell-specific splic-
ing patterns. O
38 Trnau1ap liv tRNA selenocysteine 1 associated protein 1
39 Trove2 liv Trove domain family, member 2
Hung et al. [296] cataloged the Trove2-associated RNAs in hu-
man cell lines and found that among other RNAs, Trove2 bound
an RNA motif derived from endogenous Alu retroelements. Alu
transcripts were induced by type I interferon and stimulated proin-
flammatory cytokine secretion by human peripheral blood cells.
Trove2 deletion resulted in enhanced expression of Alu RNAs and
interferon-regulated genes. O
40 Zc3h12a liv Zinc finger CCCH domain-containing protein 12A
ZC3H12A is a CCCH-type zinc finger protein, whereas most mam-
malian zinc finger proteins are CCHH- or CCCC-type proteins.
The ZC3H12A gene encodes an essential RNase that controls the
stability of a set of inflammatory genes [297]. O
41 Zc3h12d liv/kid Zinc finger CCCH domain-containing protein 12D
Liang et al. ( [298] found that ZC3H12B, also known as MCPIP2,
and other MCPIP proteins, MCPIP1 (ZC3H12A), MCPIP2
(ZC3H12B), and MCPIP3 (ZC3H12C), regulate macrophage ac-
tivation. O
42 Zc3h6 liv/kid Zinc finger CCCH domain-containing protein 6
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43 Zc3hav1l liv Zinc finger CCCH-type containing, antiviral 1 like
Interchromosomal chimeric RNA molecules are often transcription
products from genomic rearrangement in cancerous cells. Fang et
al. [299] report the computational detection of an interchromoso-
mal RNA fusion between ZC3HAV1L and CHMP1A from RNA-
seq data of normal human mammary epithelial cells, and experi-
mental confirmation of the chimeric transcript in multiple human
cells and tissues. Our experimental characterization also detected
three variants of the ZC3HAV1L-CHMP1A chimeric RNA, sug-
gesting that these genes are involved in complex splicing. The
fusion sequence at the novel exon-exon boundary, and the absence
of corresponding DNA rearrangement suggest that this chimeric
RNA is likely produced by trans-splicing in human cells. P
44 Zcchc11 liv Zinc finger CCCH domain-containing protein 11
Minoda et al. [300] showed that a substantial proportion of ZC-
CHC11 translocated from the nucleus to the cytoplasm follow-
ing lipopolysaccharide (LPS) stimulation of HEK293T cells. ZC-
CHC11L coimmunoprecipitated with TIFA only following LPS
treatment, and it specifically suppressed LPS-induced NF-kappa-
B activation. Jones et al. [301] found that recombinant mouse Zc-
chc11 and endogenous human ZCCHC11 showed nucleotidyltrans-
ferase activity. ZCCHC11 did not show RNA substrate specificity
and used all RNA substrates examined. O
45 Zcrb1 liv Zinc finger CCCH domain- and RNA-bindng motif-containing pro-
tein 1
In the first step of U12-type spliceosome formation, U11 and U12
small nuclear ribonucleoproteins (snRNPs) bind U12-type pre-
mRNAs as a preformed U11/U12 di-snRNP. The U11 and U12
components recognize the 5-prime splice site and the branch site,
respectively, and together form a molecular bridge connecting both
ends of the intron. ZCRB1 is a component of the U11/U12 di-
snRNP [302]. O
46 Zfp36 liv Zinc finger protein 36-like
Galloway et al. [303] demonstrated in developing B lympho-
cytes, the RNA-binding proteins ZFP36L1 and ZFP36L2 are crit-
ical for maintaining quiescence before precursor B cell receptor
(pre-BCR) expression and for reestablishing quiescence after pre-
BCR-induced expansion. These RBPs suppress an evolutionarily
conserved posttranscriptional regulon consisting of mRNAs whose
protein products cooperatively promote transition in the S phase
of the cell cycle. O
148
Bibliography
[1] M. Beuse, R. Bartling, A. Kopmann, H. Diekmann, and M. Thoma. Effect of the dilution
rate on the mode of oscillation in continuous cultures of Saccharomyces cerevisiae. Journal
of Biotechnology, 61(1):15–31, 1998.
[2] Susan S. Golden and Shannon R. Canales. Cyanobacterial circadian clocks timing is
everything. Nature Reviews Microbiology, 1(3):191–199, 2003.
[3] Jay C Dunlap. Molecular Bases for Circadian Clocks. Cell, 96(2):271–290, 1999.
[4] Pittindrigh. Biological Rhythms. Handbook of Behavioral Neurobiology. In The Quarterly
Review of Biology, volume 4, pages 221–221. Jürgen Aschoff, 1982.
[5] J. S. Menet, J. Rodriguez, K. C. Abruzzi, and M. Rosbash. Nascent-Seq reveals novel
features of mouse circadian transcriptional regulation. eLife, 1(0):e00011–e00011, 2012.
[6] Gwendal Le Martelot, Donatella Canella, Laura Symul, Eugenia Migliavacca, Feder-
ica Gilardi, Robin Liechti, Olivier Martin, Keith Harshman, Mauro Delorenzi, Beatrice
Desvergne, Winship Herr, Bart Deplancke, Ueli Schibler, Jacques Rougemont, Nicolas
Guex, Nouria Hernandez, Felix Naef, and the CycliX consortium. Genome-Wide RNA
Polymerase II Profiles and RNA Accumulation Reveal Kinetics of Transcription and Asso-
ciated Epigenetic Changes During Diurnal Cycles. PLoS Biology, 10(11):e1001442, 2012.
[7] De Mairan. Observation botanique. e Hist. Acad. Imprimerie de Du Pont (Paris), 1729.
[8] Sutherland Simpson and J. J. Galbraith. Observations on the Normal Temperature of the
Monkey and its Diurnal Variation, and on the Effect of Changes in the Daily Routine on
this Variation. Transactions of the Royal Society of Edinburgh, 45(01):65–104, 1906.
[9] J.S. Szymanski. Die Verteilung der Ruhe- und Aktivitätsperioden bei weißen Ratten und
Tanzmäusen. Pflügers Archiv für die Gesamte Physiologie des Menschen und der Tiere,
1918.
[10] C. P. Richter. A Behavioristic Study of the Activity of the Rat. Comparative Psychology
Monographs, 1(2):56, 1922.
[11] M. S. Johnson. Activity and Distribution of Certain Wild Mice in Relation to Biotic
Communities. Journal of Mammalogy, 7(4):245, 1926.
[12] Ingeborg Beling. Über das Zeitgedächtnis der Bienen. Zeitschrift für Vergleichende Phys-
iologie, 9(2):259–338, 1929.
149
Bibliography
[13] Gustav Kramer. EXPERIMENTS ON BIRD ORIENTATION *. Ibis, 94:265–285, 1952.
[14] J. Woodland Hastings and Beatrice M. Sweeney. A persistent diurnal Rhythm of Lumi-
nescence in \emph{Gonyaulax Polyedra}. The Biological Bulletin, 115(3):440–458, 1958.
[15] Jürgen Von Aschoff and Rütger Wever. Spontanperiodik des Menschen bei Ausschluß aller
Zeitgeber. Naturwissenschaften, 49(15):337–342, 1962.
[16] D. E. Bianchi. An Endogenous Circadian Rhythm in Neurospora crassa. Journal of
General Microbiology, 35(3):437–445, 1964.
[17] A. Mitsui, S. Kumazawa, A. Takahashi, H. Ikemoto, S. Cao, and T. Arai. Strategy
by which nitrogen-fixing unicellular cyanobacteria grow photoautotrophically. Nature,
323(6090):720–722, 1986.
[18] E Bünning. Zur Kenntnis der erblichen Tagesperioizität bei den Primärblättern von Phase-
olus multiflorus. Jahrb. Wis., 1935.
[19] R. J. Konopka and S. Benzer. Clock mutants of Drosophila melanogaster. Proceedings of
the National Academy of Sciences of the United States of America, 68(9):2112–2116, 1971.
[20] P. Reddy, W. A. Zehring, D. A. Wheeler, V. Pirrotta, C. Hadfield, J. C. Hall, and M. Ros-
bash. Molecular analysis of the period locus in Drosophila melanogaster and identification
of a transcript involved in biological rhythms. Cell, 38(3):701–710, 1984.
[21] M. H. Vitaterna, D. P. King, A. M. Chang, J. M. Kornhauser, P. L. Lowrey, J. D. McDon-
ald, W. F. Dove, L. H. Pinto, F. W. Turek, and J. S. Takahashi. Mutagenesis and mapping
of a mouse gene, Clock, essential for circadian behavior. Science, 264(5159):719–725, 1994.
[22] Roberto Refinetti. Circadian physiology. Taylor & Francis Inc, 2016.
[23] V. Dvornyk, O. Vinogradova, and E. Nevo. Origin and evolution of circadian clock genes
in prokaryotes. Proceedings of the National Academy of Sciences of the United States of
America, 100(5):2495–2500, 2003.
[24] Mark A. Woelfle, Yao Xu, Ximing Qin, and Carl Hirschie Johnson. Circadian rhythms
of superhelical status of DNA in cyanobacteria. Proceedings of the National Academy of
Sciences of the United States of America, 104(47):18819–18824, 2007.
[25] Vikram Vijayan, Rick Zuzow, and Erin K. O’Shea. Oscillations in supercoiling drive cir-
cadian gene expression in cyanobacteria. Proceedings of the National Academy of Sciences
of the United States of America, 106(52):22564–22568, 2009.
[26] Stanly B. Williams. A Circadian Timing Mechanism in the Cyanobacteria. In Advances
in Microbial Physiology, volume 52, pages 229–296. Elsevier, 2006.
[27] R. A. Hut and D. G. M. Beersma. Evolution of time-keeping mechanisms: early emer-
gence and adaptation to photoperiod. Philosophical Transactions of the Royal Society B:
Biological Sciences, 366(1574):2141–2154, 2011.
150
[28] Steven A. Brown, Elzbieta Kowalska, and Robert Dallmann. (Re)inventing the Circadian
Feedback Loop. Developmental Cell, 22(3):477–487, 2012.
[29] Sarah Lück and Pål O. Westermark. Circadian mRNA expression: insights from modeling
and transcriptomics. Cellular and Molecular Life Sciences, 73:497–521, 2016.
[30] Y. Miyamoto and A. Sancar. Vitamin B2-based blue-light photoreceptors in the retino-
hypothalamic tract as the photoactive pigments for setting the circadian clock in mam-
mals. Proceedings of the National Academy of Sciences of the United States of America,
95(11):6097–6102, 1998.
[31] R. J. Thresher, M. H. Vitaterna, Y. Miyamoto, A. Kazantsev, D. S. Hsu, C. Petit, C. P.
Selby, L. Dawut, O. Smithies, J. S. Takahashi, and A. Sancar. Role of mouse cryptochrome
blue-light photoreceptor in circadian photoresponses. Science, 282(5393):1490–1494, 1998.
[32] R. Stanewsky, M. Kaneko, P. Emery, B. Beretta, K. Wager-Smith, S. A. Kay, M. Rosbash,
and J. C. Hall. The cryb mutation identifies cryptochrome as a circadian photoreceptor
in Drosophila. Cell, 95(5):681–692, 1998.
[33] P. Emery, W. V. So, M. Kaneko, J. C. Hall, and M. Rosbash. CRY, a Drosophila clock
and light-regulated cryptochrome, is a major contributor to circadian rhythm resetting
and photosensitivity. Cell, 95(5):669–679, 1998.
[34] N. Öztürk, S.-H. Song, S. Özgür, C. P. Selby, L. Morrison, C. Partch, D. Zhong, and
A. Sancar. Structure and Function of Animal Cryptochromes. Cold Spring Harbor Sym-
posia on Quantitative Biology, 72(1):119–131, 2007.
[35] Rachel S. Edgar, Edward W. Green, Yuwei Zhao, Gerben van Ooijen, Maria Olmedo, Xim-
ing Qin, Yao Xu, Min Pan, Utham K. Valekunja, Kevin A. Feeney, Elizabeth S. Maywood,
Michael H. Hastings, Nitin S. Baliga, Martha Merrow, Andrew J. Millar, Carl H. Johnson,
Charalambos P. Kyriacou, John S. O’Neill, and Akhilesh B. Reddy. Peroxiredoxins are
conserved markers of circadian rhythms. Nature, 2012.
[36] Walter Gehring and Michael Rosbash. The Coevolution of Blue-Light Photoreception and
Circadian Rhythms. Journal of Molecular Evolution, 57(0):S286–S289, 2003.
[37] E. Tauber. Clock Gene Evolution and Functional Divergence. Journal of Biological
Rhythms, 19(5):445–458, 2004.
[38] Kaspar H. von Meyenburg. Energetics of the budding cycle of Saccharomyces cerevisiae
during glucose limited aerobic growth. Archiv für Mikrobiologie, 66(4):289–303, 1969.
[39] R. R. Klevecz, J. Bolen, G. Forrest, and D. B. Murray. A genomewide oscillation in
transcription gates DNA replication and cell cycle. Proceedings of the National Academy
of Sciences of the United States of America, 101(5):1200–1205, 2004.
[40] N. Slavov and D. Botstein. Coupling among growth rate response, metabolic cycle, and
cell division cycle in yeast. Molecular Biology of the Cell, 22(12):1997–2009, 2011.
151
Bibliography
[41] Alexandros Papagiannakis, Bastian Niebel, Ernst C. Wit, and Matthias Heinemann. Au-
tonomous Metabolic Oscillations Robustly Gate the Early and Late Cell Cycle. Molecular
Cell, 65(2):285–295, 2016.
[42] Helen C. Causton, Kevin A. Feeney, Christine A. Ziegler, and John S. O’Neill. Metabolic
Cycles in Yeast Share Features Conserved among Circadian Rhythms. Current biology:
CB, 25(8):1056–1062, 2015.
[43] David Lloyd and Douglas B. Murray. Redox rhythmicity: clocks at the core of tempo-
ral coherence. BioEssays: News and Reviews in Molecular, Cellular and Developmental
Biology, 29(5):465–473, 2007.
[44] R. R. Klevecz and C. M. Li. Evolution of the clock from yeast to man by period-doubling
folds in the cellular oscillator. Cold Spring Harbor Symposia on Quantitative Biology,
72:421–429, 2007.
[45] R. K. Finn and R. E. Wilson. Fermentation Process Control, Population Dynamics of a
Continuous Propagator for Microorganisms. Journal of Agricultural and Food Chemistry,
2:66–69, 1954.
[46] Nikolai Slavov, Joanna Macinskas, Amy Caudy, and David Botstein. Metabolic cycling
without cell division cycling in respiring yeast. Proceedings of the National Academy of
Sciences of the United States of America, 108(47):19090–19095, 2011.
[47] A. J. Burnetti, M. Aydin, and N. E. Buchler. Cell Cycle Start is coupled to Entry into
the Yeast Metabolic Cycle Across Diverse Strains and Growth Rates. Molecular Biology
of the Cell, 27(1):64–74, 2016.
[48] Martin T. Küenzi and Armin Fiechter. Changes in carbohydrate composition and
trehalase-activity during the budding cycle of Saccharomyces cerevisiae. Archiv für Mikro-
biologie, 64(4):396–407, 1969.
[49] Rainer Machné and Douglas B. Murray. The Yin and Yang of Yeast Transcription: El-
ements of a Global Feedback System between Metabolism and Chromatin. PLoS ONE,
7(6):e37906, 2012.
[50] Eric E. Zhang, Andrew C. Liu, Tsuyoshi Hirota, Loren J. Miraglia, Genevieve Welch,
Pagkapol Y. Pongsawakul, Xianzhong Liu, Ann Atwood, Jon W. Huss, Jeff Janes, An-
drew I. Su, John B. Hogenesch, and Steve A. Kay. A Genome-wide RNAi Screen for
Modifiers of the Circadian Clock in Human Cells. Cell, 139(1):199–210, 2009.
[51] P. E. Hardin, J. C. Hall, and M. Rosbash. Feedback of the Drosophila period gene product
on circadian cycling of its messenger RNA levels. Nature, 343(6258):536–540, 1990.
[52] B. D. Aronson, K. A. Johnson, J. J. Loros, and J. C. Dunlap. Negative feedback defining a
circadian clock: autoregulation of the clock gene frequency. Science, 263(5153):1578–1584,
1994.
152
[53] Polly Yingshan Hsu and Stacey L. Harmer. Wheels within wheels: the plant circadian
system. Trends in Plant Science, 19(4):240–249, 2014.
[54] J. S. Griffith. Mathematics of cellular control processes. I. Negative feedback to one gene.
Journal of Theoretical Biology, 20(2):202–208, 1968.
[55] P. Rapp. Analysis of biochemical phase shift oscillators by a harmonic balancing technique.
Journal of Mathematical Biology, 3(3-4):203–224, 1976.
[56] Béla Novák and John J. Tyson. Design principles of biochemical oscillators. Nature Reviews
Molecular Cell Biology, 9(12):981–991, 2008.
[57] B. C. Goodwin. Oscillatory behavior in enzymatic control processes. Advances in Enzyme
Regulation, 3:425–438, 1965.
[58] Stefan Müller, Josef Hofbauer, Lukas Endler, Christoph Flamm, Stefanie Widder, and
Peter Schuster. A generalized model of the repressilator. Journal of Mathematical Biology,
53(6):905–937, 2006.
[59] Bharath Ananthasubramaniam and Hanspeter Herzel. Positive Feedback Promotes Oscil-
lations in Negative Feedback Loops. PLoS ONE, 9(8):e104761, 2014.
[60] Phillip L. Lowrey and Joseph S. Takahashi. MAMMALIAN CIRCADIAN BIOLOGY:
Elucidating Genome-Wide Levels of Temporal Organization. Annual Review of Genomics
and Human Genetics, 5(1):407–441, 2004.
[61] M. K. Bunger, L. D. Wilsbacher, S. M. Moran, C. Clendenin, L. A. Radcliffe, J. B.
Hogenesch, M. C. Simon, J. S. Takahashi, and C. A. Bradfield. Mop3 is an essential
component of the master circadian pacemaker in mammals. Cell, 103(7):1009–1017, 2000.
[62] Jason P DeBruyne, David R Weaver, and Steven M Reppert. CLOCK and NPAS2 have
overlapping roles in the suprachiasmatic circadian clock. Nature Neuroscience, 10(5):543–
545, 2007.
[63] K. Bae, X. Jin, E. S. Maywood, M. H. Hastings, S. M. Reppert, and D. R. Weaver.
Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. Neuron,
30(2):525–536, 2001.
[64] B. Zheng, U. Albrecht, K. Kaasik, M. Sage, W. Lu, S. Vaishnav, Q. Li, Z. S. Sun,
G. Eichele, A. Bradley, and C. C. Lee. Nonredundant roles of the mPer1 and mPer2
genes in the mammalian circadian clock. Cell, 105(5):683–694, 2001.
[65] G. T. van der Horst, M. Muijtjens, K. Kobayashi, R. Takano, S. Kanno, M. Takao,
J. de Wit, A. Verkerk, A. P. Eker, D. van Leenen, R. Buijs, D. Bootsma, J. H. Hoeijmak-
ers, and A. Yasui. Mammalian Cry1 and Cry2 are essential for maintenance of circadian
rhythms. Nature, 398(6728):627–630, 1999.
153
Bibliography
[66] M. H. Vitaterna, C. P. Selby, T. Todo, H. Niwa, C. Thompson, E. M. Fruechte, K. Hitomi,
R. J. Thresher, T. Ishikawa, J. Miyazaki, J. S. Takahashi, and A. Sancar. Differential
regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and
2. Proceedings of the National Academy of Sciences of the United States of America,
96(21):12114–12119, 1999.
[67] J. Patrick Pett, Anja Korenčič, Felix Wesener, Achim Kramer, and Hanspeter Herzel.
Feedback Loops of the Mammalian Circadian Clock Constitute Repressilator. PLOS Com-
putational Biology, 12(12):e1005266, 2016.
[68] Anja Korenčič, Grigory Bordyugov, Rok Košir, Damjana Rozman, Marko Goličnik, and
Hanspeter Herzel. The Interplay of cis-Regulatory Elements Rules Circadian Rhythms in
Mouse Liver. PLoS ONE, 7(11):e46835, 2012.
[69] M. B. Elowitz and S. Leibler. A synthetic oscillatory network of transcriptional regulators.
Nature, 403(6767):335–338, 2000.
[70] N. Koike, S.-H. Yoo, H.-C. Huang, V. Kumar, C. Lee, T.-K. Kim, and J. S. Takahashi.
Transcriptional Architecture and Chromatin Landscape of the Core Circadian Clock in
Mammals. Science, 338(6105):349–354, 2012.
[71] John S. O’Neill, Gerben van Ooijen, Laura E. Dixon, Carl Troein, Florence Corellou,
François-Yves Bouget, Akhilesh B. Reddy, and Andrew J. Millar. Circadian rhythms
persist without transcription in a eukaryote. Nature, 469(7331):554–558, 2011.
[72] Bora Zivkovic. Circadian clock without DNA–History and the power of metaphor. Ac-
cessed: 2017-01-09.
[73] Michael Menaker, Zachary C Murphy, and Michael T Sellix. Central control of peripheral
circadian oscillators. Current Opinion in Neurobiology, 23(5):741–746, 2013.
[74] Jennifer A. Mohawk, Carla B. Green, and Joseph S. Takahashi. Central an peripheral
clocks in mammals. Annual review of neuroscience, 35:445–462, 2012.
[75] Erik D. Herzog, Sara J. Aton, Rika Numano, Yoshiyuki Sakaki, and Hajime Tei. Tempo-
ral Precision in the Mammalian Circadian System: A Reliable Clock from Less Reliable
Neurons. Journal of Biological Rhythms, 19(1):35–46, 2004.
[76] Charna Dibner, Ueli Schibler, and Urs Albrecht. The Mammalian Circadian Timing Sys-
tem: Organization and Coordination of Central and Peripheral Clocks. Annual Review of
Physiology, 72(1):517–549, 2010.
[77] Natsuko Inagaki, Sato Honma, Daisuke Ono, Yusuke Tanahashi, and Ken-ichi Honma.
Separate oscillating cell groups in mouse suprachiasmatic nucleus couple photoperiodically
to the onset and end of daily activity. Proceedings of the National Academy of Sciences of
the United States of America, 104(18):7664–7669, 2007.
154
[78] Henk Tjebbe VanderLeest, Thijs Houben, Stephan Michel, Tom Deboer, Henk Albus,
Mariska J. Vansteensel, Gene D. Block, and Johanna H. Meijer. Seasonal encoding by the
circadian pacemaker of the SCN. Current Biology, 17(5):468–473, 2007.
[79] Christoph Schmal, Jihwan Myung, Hanspeter Herzel, and Grigory Bordyugov. A Theo-
retical Study on Seasonality. Frontiers in Neurology, 6, 2015.
[80] F. K. Stephan and I. Zucker. Circadian rhythms in drinking behavior and locomotor ac-
tivity of rats are eliminated by hypothalamic lesions. Proceedings of the National Academy
of Sciences of the United States of America, 69(6):1583–1586, 1972.
[81] M. N. Lehman, R. Silver, W. R. Gladstone, R. M. Kahn, M. Gibson, and E. L. Bittman.
Circadian rhythmicity restored by neural transplant. Immunocytochemical characteriza-
tion of the graft and its integration with the host brain. The Journal of Neuroscience:
The Official Journal of the Society for Neuroscience, 7(6):1626–1638, 1987.
[82] M. R. Ralph, R. G. Foster, F. C. Davis, and M. Menaker. Transplanted suprachiasmatic
nucleus determines circadian period. Science, 247(4945):975–978, 1990.
[83] F. K. Stephan, J. M. Swann, and C. L. Sisk. Entrainment of circadian rhythms by feeding
schedules in rats with suprachiasmatic lesions. Behavioral and Neural Biology, 25(4):545–
554, 1979.
[84] D. T. Krieger, H. Hauser, and L. C. Krey. Suprachiasmatic nuclear lesions do not abolish
food-shifted circadian adrenal and temperature rhythmicity. Science, 197(4301):398–399,
1977.
[85] Ozgür Tataroglu, Alec J. Davidson, Luke J. Benvenuto, and Michael Menaker. The
methamphetamine-sensitive circadian oscillator (MASCO) in mice. Journal of Biologi-
cal Rhythms, 21(3):185–194, 2006.
[86] Pinar Pezuk, Jennifer A. Mohawk, Tomoko Yoshikawa, Michael T. Sellix, and Michael
Menaker. Circadian organization is governed by extra-SCN pacemakers. Journal of Bio-
logical Rhythms, 25(6):432–441, 2010.
[87] K. Honma, S. Honma, and T. Hiroshige. Activity rhythms in the circadian domain appear
in suprachiasmatic nuclei lesioned rats given methamphetamine. Physiology & Behavior,
40(6):767–774, 1987.
[88] Francesca Damiola, Nguyet Le Minh, Nicolas Preitner, Benoît Kornmann, Fabienne
Fleury-Olela, and Ueli Schibler. Restricted feeding uncouples circadian oscillators in pe-
ripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes &
Development, 14(23):2950–2961, 2000.
[89] Jennifer A. Mohawk, Matthew L. Baer, and Michael Menaker. The methamphetamine-
sensitive circadian oscillator does not employ canonical clock genes. Proceedings of the
National Academy of Sciences of the United States of America, 106(9):3519–3524, 2009.
155
Bibliography
[90] Julie S. Pendergast, Wataru Nakamura, Rio C. Friday, Fumiyuki Hatanaka, Toru Takumi,
and Shin Yamazaki. Robust Food Anticipatory Activity in BMAL1-Deficient Mice. PLoS
ONE, 4(3):e4860, 2009.
[91] Joseph Bass and Joseph S. Takahashi. Circadian Integration of Metabolism and Energetics.
Science, 330(6009):1349–1354, 2010.
[92] Jacob Richards and Michelle L. Gumz. Advances in understanding the peripheral circadian
clocks. The FASEB Journal, 26(9):3602–3613, 2012.
[93] Satchidananda Panda. Circadian physiology of metabolism. Science, 354(6315):1008–1015,
2016.
[94] Ray Zhang, Nicholas F. Lahens, Heather I. Ballance, Michael E. Hughes, and John B.
Hogenesch. A circadian gene expression atlas in mammals: Implications for biology and
medicine. Proceedings of the National Academy of Sciences of the United States of America,
111(45):16219–16224, 2014.
[95] S. Yamazaki, R. Numano, M. Abe, A. Hida, R. Takahashi, M. Ueda, G. D. Block,
Y. Sakaki, M. Menaker, and H. Tei. Resetting central and peripheral circadian oscillators
in transgenic rats. Science, 288(5466):682–685, 2000.
[96] David K. Welsh, Seung-Hee Yoo, Andrew C. Liu, Joseph S. Takahashi, and Steve A. Kay.
Bioluminescence imaging of individual fibroblasts reveals persistent, independently phased
circadian rhythms of clock gene expression. Current Biology, 14(24):2289–2295, 2004.
[97] Emi Nagoshi, Camille Saini, Christoph Bauer, Thierry Laroche, Felix Naef, and Ueli
Schibler. Circadian gene expression in individual fibroblasts: cell-autonomous and self-
sustained oscillators pass time to daughter cells. Cell, 119(5):693–705, 2004.
[98] Laura Lande-Diner, Jacob Stewart-Ornstein, Charles J. Weitz, and Galit Lahav. Single-
cell analysis of circadian dynamics in tissue explants. Molecular Biology of the Cell,
26(22):3940–3945, 2015.
[99] Pål O. Westermark, David K. Welsh, Hitoshi Okamura, and Hanspeter Herzel. Quantifi-
cation of Circadian Rhythms in Single Cells. PLoS Computational Biology, 5(11), 2009.
[100] Ruud M. Buijs, Joke Wortel, Joop J. Van Heerikhuize, Matthijs G. P. Feenstra, Gert J.
Ter Horst, Herms J. Romijn, and Andries Kalsbeek. Anatomical and functional demon-
stration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway: Suprachi-
asmatic adrenal interaction. European Journal of Neuroscience, 11(5):1535–1544, 1999.
[101] A. Kalsbeek, S. Perreau-Lenz, and R. M. Buijs. A Network of (Autonomic) Clock Outputs.
Chronobiology International, 23(3), 2006.
[102] Cathy Cailotto, Jun Lei, Jan van der Vliet, Caroline van Heijningen, Corbert G. van Eden,
Andries Kalsbeek, Paul Pévet, and Ruud M. Buijs. Effects of Nocturnal Light on (Clock)
Gene Expression in Peripheral Organs: A Role for the Autonomic Innervation of the Liver.
PLoS ONE, 4(5):e5650, 2009.
156
[103] Inés Pineda Torra, Vladimir Tsibulsky, Franck Delaunay, Régis Saladin, Vincent Laudet,
Jean-Charles Fruchart, Vladimir Kosykh, and Bart Staels. Circadian and Glucocorticoid
Regulation of Rev-erbα Expression in Liver 1. Endocrinology, 141(10):3799–3806, 2000.
[104] Mitsugu Sujino, Keiichi Furukawa, Satoshi Koinuma, Atsuko Fujioka, Mamoru Nagano,
Masayuki Iigo, and Yasufumi Shigeyoshi. Differential Entrainment of Peripheral Clocks in
the Rat by Glucocorticoid and Feeding. Endocrinology, 153(5):2277–2286, 2012.
[105] Pinar Pezük, Jennifer A. Mohawk, Laura A. Wang, and Michael Menaker. Glucocorticoids
as Entraining Signals for Peripheral Circadian Oscillators. Endocrinology, 153(10):4775–
4783, 2012.
[106] Michael E. Hughes, Luciano DiTacchio, Kevin R. Hayes, Christopher Vollmers, S. Puli-
varthy, Julie E. Baggs, Satchidananda Panda, and John B. Hogenesch. Harmonics of
Circadian Gene Transcription in Mammals. PLoS Genetics, 5(4):e1000442, 2009.
[107] Clara Bien Peek, Daniel C. Levine, Jonathan Cedernaes, Akihiko Taguchi, Yumiko
Kobayashi, Stacy J. Tsai, Nicolle A. Bonar, Maureen R. McNulty, Kathryn Moynihan
Ramsey, and Joseph Bass. Circadian Clock Interaction with HIF1α Mediates Oxygenic
Metabolism and Anaerobic Glycolysis in Skeletal Muscle. Cell Metabolism, 25(1):86–92,
2016.
[108] R. Daniel Rudic, Peter McNamara, Anne-Maria Curtis, Raymond C. Boston, Satchi-
dananda Panda, John B. Hogenesch, and Garret A. Fitzgerald. BMAL1 and CLOCK, two
essential components of the circadian clock, are involved in glucose homeostasis. PLoS
biology, 2(11):e377, 2004.
[109] Katja A. Lamia, Kai-Florian Storch, and Charles J. Weitz. Physiological significance of a
peripheral tissue circadian clock. Proceedings of the National Academy of Sciences of the
United States of America, 105(39):15172–15177, 2008.
[110] Matthew M. Molusky, Siming Li, Di Ma, Lei Yu, and Jiandie D. Lin. Ubiquitin-Specific
Protease 2 Regulates Hepatic Gluconeogenesis and Diurnal Glucose Metabolism Through
11β-Hydroxysteroid Dehydrogenase 1. Diabetes, 61(5):1025–1035, 2012.
[111] C. B. Peek, A. H. Affinati, K. M. Ramsey, H.-Y. Kuo, W. Yu, L. A. Sena, O. Ilkayeva,
B. Marcheva, Y. Kobayashi, C. Omura, D. C. Levine, D. J. Bacsik, D. Gius, C. B. Newgard,
E. Goetzman, N. S. Chandel, J. M. Denu, M. Mrksich, and J. Bass. Circadian Clock NAD+
Cycle Drives Mitochondrial Oxidative Metabolism in Mice. Science, 342(6158):1243417–
1243417, 2013.
[112] Joshua J Gooley. Circadian regulation of lipid metabolism. Proceedings of the Nutrition
Society, 75(04):440–450, 2016.
[113] David Jacobi, Sihao Liu, Kristopher Burkewitz, Nora Kory, Nelson H. Knudsen, Ryan K.
Alexander, Ugur Unluturk, Xiaobo Li, Xiaohui Kong, Alexander L. Hyde, Matthew R.
Gangl, William B. Mair, and Chih-Hao Lee. Hepatic Bmal1 Regulates Rhythmic Mito-
chondrial Dynamics and Promotes Metabolic Fitness. Cell Metabolism, 22(4), 2015.
157
Bibliography
[114] Olga Cela, Rosella Scrima, Valerio Pazienza, Giuseppe Merla, Giorgia Benegiamo, Bar-
tolomeo Augello, Sabino Fugetto, Marta Menga, Rosa Rubino, Luise Fuhr, Angela Relogio,
Claudia Piccoli, Gianluigi Mazzoccoli, and Nazzareno Capitanio. Clock genes-dependent
acetylation of complex I sets rhythmic activity of mitochondrial OxPhos. Biochimica et
Biophysica Acta - Molecular Cell Research, 1863(4):596–606, 2016.
[115] Adi Neufeld-Cohen, Maria S. Robles, Rona Aviram, Gal Manella, Yaarit Adamovich, Ben-
jamin Ladeuix, Dana Nir, Liat Rousso-Noori, Yael Kuperman, Marina Golik, Matthias
Mann, and Gad Asher. Circadian control of oscillations in mitochondrial rate-limiting en-
zymes and nutrient utilization by PERIOD proteins. Proceedings of the National Academy
of Sciences of the United States of America, 113(12):E1673–E1682, 2016.
[116] Benedikt Westermann. Bioenergetic role of mitochondrial fusion and fission. Biochimica
et Biophysica Acta - Bioenergetics, 1817(10):1833–1838, 2012.
[117] S. Yamazaki, Y. Ishida, and S. Inouye. Circadian rhythms of adenosine triphosphate
contents in the suprachiasmatic nucleus, anterior hypothalamic area and caudate putamen
of the rat–negative correlation with electrical activity. Brain Research, 664(1-2):237–240,
1994.
[118] Steven A. Brown. Circadian Metabolism: From Mechanisms to Metabolomics and
Medicine. Trends in Endocrinology & Metabolism, 27(6):415–426, 2016.
[119] Uma M. Sachdeva and Craig B. Thompson. Diurnal rhythms of autophagy: implications
for cell biology and human disease. Autophagy, 4(5):581–589, 2008.
[120] Marrit Putker and John Stuart O’Neill. Reciprocal Control of the Circadian Clock and
Cellular Redox State - a Critical Appraisal. Molecules and Cells, 39(1):6–19, 2016.
[121] Adam R. Wende, Martin E. Young, John Chatham, Jianhua Zhang, Namakkal S. Ra-
jasekaran, and Victor M. Darley-Usmar. Redox biology and the interface between bioener-
getics, autophagy and circadian control of metabolism. Free Radical Biology and Medicine,
100:94–107, 2016.
[122] Di Ma, Satchidananda Panda, and Jiandie D Lin. Temporal orchestration of circadian
autophagy rhythm by C/EBP[beta]. EMBO Journal, 30:4642–4651, 2011.
[123] Selma Masri, Marlene Cervantes, and Paolo Sassone-Corsi. The circadian clock and cell
cycle: interconnected biological circuits. Current Opinion in Cell Biology, 25(6):730–734,
2013.
[124] J. Bieler, R. Cannavo, K. Gustafson, C. Gobet, D. Gatfield, and F. Naef. Robust synchro-
nization of coupled circadian and cell cycle oscillators in single mammalian cells. Molecular
Systems Biology, 10(7):739–739, 2014.
[125] K-F Storch, O Lipan, I Leykin, N Viswanathan, F C Davis, W H Wong, and C J Weitz.
Extensive and divergent circadian gene expression in liver and heart. Nature, 417(6884):78–
83, 2002.
158
[126] S Panda, M P Antoch, B H Miller, A I Su, A B Schook, M Straume, P G Schultz, S A
Kay, J S Takahashi, and J B Hogenesch. Coordinated transcription of key pathways in
the mouse by the circadian clock. Cell, 109(3):307–320, 2002.
[127] Brooke H. Miller, Erin L. McDearmon, Satchidananda Panda, Kevin R. Hayes, Jie Zhang,
Jessica L. Andrews, Marina P. Antoch, John R. Walker, Karyn A. Esser, John B. Ho-
genesch, and Joseph S. Takahashi. Circadian and CLOCK-controlled regulation of the
mouse transcriptome and cell proliferation. Proceedings of the National Academy of Sci-
ences of the United States of America, 104(9):3342–3347, 2007.
[128] Gwendal Le Martelot, Thierry Claudel, David Gatfield, Olivier Schaad, Benoît Kornmann,
Giuseppe Lo Sasso, Antonio Moschetta, and Ueli Schibler. REV-ERBalpha participates in
circadian SREBP signaling and bile acid homeostasis. PLoS biology, 7(9):e1000181, 2009.
[129] Christopher Vollmers, Shubhroz Gill, Luciano DiTacchio, Sandhya R. Pulivarthy, Hiep D.
Le, and Satchidananda Panda. Time of feeding and the intrinsic circadian clock drive
rhythms in hepatic gene expression. Proceedings of the National Academy of Sciences of
the United States of America, 106(50):21453–21458, 2009.
[130] K. L. Eckel-Mahan, V. R. Patel, R. P. Mohney, K. S. Vignola, P. Baldi, and P. Sassone-
Corsi. Coordination of the transcriptome and metabolome by the circadian clock. Proceed-
ings of the National Academy of Sciences of the United States of America, 109(14):5541–
5546, 2012.
[131] Han Cho, Xuan Zhao, Megumi Hatori, Ruth T. Yu, Grant D. Barish, Michael T. Lam,
Ling-Wa Chong, Luciano DiTacchio, Annette R. Atkins, Christopher K. Glass, Christopher
Liddle, Johan Auwerx, Michael Downes, Satchidananda Panda, and Ronald M. Evans.
Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β.
Nature, 485(7396):123–127, 2012.
[132] Selma Masri, Vishal R. Patel, Kristin L. Eckel-Mahan, Shahaf Peleg, Ignasi Forne, An-
dreas G. Ladurner, Pierre Baldi, Axel Imhof, and Paolo Sassone-Corsi. Circadian acety-
lome reveals regulation of mitochondrial metabolic pathways. Proceedings of the National
Academy of Sciences of the United States of America, 110(9):3339–3344, 2013.
[133] Kristin L. Eckel-Mahan, Vishal R. Patel, Sara de Mateo, Ricardo Orozco-Solis, Nicholas J.
Ceglia, Saurabh Sahar, Sherry A. Dilag-Penilla, Kenneth A. Dyar, Pierre Baldi, and Paolo
Sassone-Corsi. Reprogramming of the Circadian Clock by Nutritional Challenge. Cell,
155(7):1464–1478, 2013.
[134] Akhilesh B. Reddy, Natasha A. Karp, Elizabeth S. Maywood, Elizabeth A. Sage, Michael
Deery, John S. O’Neill, Gabriel K.Y. Wong, Jo Chesham, Mark Odell, Kathryn S. Lil-
ley, Charalambos P. Kyriacou, and Michael H. Hastings. Circadian Orchestration of the
Hepatic Proteome. Current Biology, 16(11):1107–1115, 2006.
[135] D. Mauvoisin, J. Wang, C. Jouffe, E. Martin, F. Atger, P. Waridel, M. Quadroni, F. Ga-
chon, and F. Naef. Circadian clock-dependent and -independent rhythmic proteomes
159
Bibliography
implement distinct diurnal functions in mouse liver. Proceedings of the National Academy
of Sciences of the United States of America, 111(1):167–172, 2014.
[136] Maria S. Robles, Jürgen Cox, and Matthias Mann. In-Vivo Quantitative Proteomics Re-
veals a Key Contribution of Post-Transcriptional Mechanisms to the Circadian Regulation
of Liver Metabolism. PLoS Genetics, 10(1):e1004047, 2014.
[137] Jingkui Wang, Daniel Mauvoisin, Eva Martin, Florian Atger, Antonio Nùñes Galindo, Loïc
Dayon, Federico Sizzano, Alessio Palini, Martin Kussmann, Patrice Waridel, Manfredo
Quadroni, Vjekoslav Dulić, Felix Naef, and Frédéric Gachon. Nuclear Proteomics Uncovers
Diurnal Regulatory Landscapes in Mouse Liver. Cell Metabolism, 2016.
[138] Megumi Hatori, Christopher Vollmers, Amir Zarrinpar, Luciano DiTacchio, Eric A.
Bushong, Shubhroz Gill, Mathias Leblanc, Amandine Chaix, Matthew Joens, James A.J.
Fitzpatrick, Mark H. Ellisman, and Satchidananda Panda. Time-Restricted Feeding with-
out Reducing Caloric Intake Prevents Metabolic Diseases in Mice Fed a High-Fat Diet.
Cell Metabolism, 15(6):848–860, 2012.
[139] Jean-Michel Fustin, Masao Doi, Hiroyuki Yamada, Rie Komatsu, Shigeki Shimba, and
Hitoshi Okamura. Rhythmic Nucleotide Synthesis in the Liver: Temporal Segregation of
Metabolites. Cell Reports, 1(4):341–349, 2012.
[140] Koichi Fujisawa, Taro Takami, Yoshitaka Kimoto, Toshihiko Matsumoto, Naoki Ya-
mamoto, Shuji Terai, and Isao Sakaida. Circadian variations in the liver metabolites
of medaka (Oryzias latipes). Scientific Reports, 6:20916, 2016.
[141] Melanie Tran, Zhihong Yang, Suthat Liangpunsakul, and Li Wang. Metabolomics Analysis
Revealed Distinct Cyclic Changes of Metabolites Altered by Chronic Ethanol-Plus-Binge
and Shp Deficiency. Alcoholism: Clinical and Experimental Research, 40(12):2548–2556,
2016.
[142] Hans Reinke and Gad Asher. Circadian Clock Control of Liver Metabolic Functions.
Gastroenterology, 150(3):574–580, 2016.
[143] M. G. Koopman, G. C. Koomen, R. T. Krediet, E. A. de Moor, F. J. Hoek, and L. Arisz.
Circadian rhythm of glomerular filtration rate in normal individuals. Clinical Science
(London, England: 1979), 77(1):105–111, 1989.
[144] M. Pons, O. Forpomès, S. Espagnet, and J. Cambar. Relationship between circadian
changes in renal hemodynamics and circadian changes in urinary glycosaminoglycan ex-
cretion in normal rats. Chronobiology International, 13(5):349–358, 1996.
[145] L. R. Stow and M. L. Gumz. The Circadian Clock in the Kidney. Journal of the American
Society of Nephrology, 22(4):598–604, 2011.
[146] Mohammad Saifur Rohman, Noriaki Emoto, Hidemi Nonaka, Ryusuke Okura, Masataka
Nishimura, Kazuhiro Yagita, Gijsbertus T.J. Van Der Horst, Masafumi Matsuo, Hitoshi
160
Okamura, and Mitsuhiro Yokoyama. Circadian clock genes directly regulate expression
of the Na+/H+ exchanger NHE3 in the kidney. Kidney International, 67(4):1410–1419,
2005.
[147] A. M. Zuber, G. Centeno, S. Pradervand, S. Nikolaeva, L. Maquelin, L. Cardinaux,
O. Bonny, and D. Firsov. Molecular clock is involved in predictive circadian adjustment
of renal function. Proceedings of the National Academy of Sciences of the United States of
America, 106(38):16523–16528, 2009.
[148] Michelle L. Gumz, Lisa R. Stow, I. Jeanette Lynch, Megan M. Greenlee, Alicia Rudin,
Brian D. Cain, David R. Weaver, and Charles S. Wingo. The circadian clock protein
Period 1 regulates expression of the renal epithelial sodium channel in mice. Journal of
Clinical Investigation, 119(8):2423–2434, 2009.
[149] K. Solocinski and M. L. Gumz. The Circadian Clock in the Regulation of Renal Rhythms.
Journal of Biological Rhythms, 30(6):470–486, 2015.
[150] Melissa J. Moore. From birth to death: the complex lives of eukaryotic mRNAs. Science,
309(5740):1514–1518, 2005.
[151] Stefanie Gerstberger, Markus Hafner, and Thomas Tuschl. A census of human RNA-
binding proteins. Nature Reviews Genetics, 15(12):829–845, 2014.
[152] Eric Londin, Phillipe Loher, Aristeidis G. Telonis, Kevin Quann, Peter Clark, Yi Jing,
Eleftheria Hatzimichael, Yohei Kirino, Shozo Honda, Michelle Lally, Bharat Ramrat-
nam, Clay E. S. Comstock, Karen E. Knudsen, Leonard Gomella, George L. Spaeth, Lisa
Hark, L. Jay Katz, Agnieszka Witkiewicz, Abdolmohamad Rostami, Sergio A. Jimenez,
Michael A. Hollingsworth, Jen Jen Yeh, Chad A. Shaw, Steven E. McKenzie, Paul Bray,
Peter T. Nelson, Simona Zupo, Katrien Van Roosbroeck, Michael J. Keating, George A.
Calin, Charles Yeo, Masaya Jimbo, Joseph Cozzitorto, Jonathan R. Brody, Kathleen Del-
grosso, John S. Mattick, Paolo Fortina, and Isidore Rigoutsos. Analysis of 13 cell types
reveals evidence for the expression of numerous novel primate- and tissue-specific microR-
NAs. Proceedings of the National Academy of Sciences of the United States of America,
112(10):E1106–E1115, 2015.
[153] Jacek Krol, Inga Loedige, and Witold Filipowicz. The widespread regulation of microRNA
biogenesis, function and decay. Nature Reviews Genetics, 11(9):597–610, 2010.
[154] Julia Berretta and Antonin Morillon. Pervasive transcription constitutes a new level of
eukaryotic genome regulation. EMBO Reports, 10(9):973–982, 2009.
[155] B. G. Robinson, D. M. Frim, W. J. Schwartz, and J. A. Majzoub. Vasopressin mRNA
in the suprachiasmatic nuclei: daily regulation of polyadenylate tail length. Science,
241(4863):342–344, 1988.
[156] W.V. So and M. Rosbash. Post-transcriptional regulation contributes to Drosophila clock
gene mRNA cycling. EMBO Journal, 16(23):7146–7155, 1997.
161
Bibliography
[157] Y. Cheng, B. Gvakharia, and P. E. Hardin. Two alternatively spliced transcripts from the
Drosophila period gene rescue rhythms having different molecular and behavioral charac-
teristics. Molecular and Cellular Biology, 18(11):6505–6514, 1998.
[158] John Majercak, David Sidote, Paul E. Hardin, and Isaac Edery. How a Circadian Clock
Adapts to Seasonal Decreases in Temperature and Day Length. Neuron, 24(1):219–230,
1999.
[159] E. Kwak. Essential Role of 3’-Untranslated Region-mediated mRNA Decay in Circadian
Oscillations of Mouse Period3 mRNA. Journal of Biological Chemistry, 281(28):19100–
19106, 2006.
[160] K.-C. Woo, T.-D. Kim, K.-H. Lee, D.-Y. Kim, W. Kim, K.-Y. Lee, and K.-T. Kim. Mouse
period 2 mRNA circadian oscillation is modulated by PTB-mediated rhythmic mRNA
degradation. Nucleic Acids Research, 37(1):26–37, 2009.
[161] K.-C. Woo, D.-C. Ha, K.-H. Lee, D.-Y. Kim, T.-D. Kim, and K.-T. Kim. Circadian Am-
plitude of Cryptochrome 1 Is Modulated by mRNA Stability Regulation via Cytoplasmic
hnRNP D Oscillation. Molecular and Cellular Biology, 30(1):197–205, 2010.
[162] S. Kojima, K. Matsumoto, M. Hirose, M. Shimada, M. Nagano, Y. Shigeyoshi, S.-i.
Hoshino, K. Ui-Tei, K. Saigo, C. B. Green, Y. Sakaki, and H. Tei. LARK activates post-
transcriptional expression of an essential mammalian clock protein, PERIOD1. Proceedings
of the National Academy of Sciences of the United States of America, 104(6):1859–1864,
2007.
[163] M. Andrea Markus and Brian J. Morris. RBM4: A multifunctional RNA-binding protein.
The International Journal of Biochemistry & Cell Biology, 41(4):740–743, 2009.
[164] Carla B. Green and Joseph C. Besharse. Identification of a novel vertebrate circadian clock-
regulated gene encoding the protein nocturnin. Proceedings of the National Academy of
Sciences of the United States of America, 93(25):14884–14888, 1996.
[165] Y. Wang, D. L. Osterbur, P. L. Megaw, G. Tosini, C. Fukuhara, C. B. Green, and J. C.
Besharse. Rhythmic expression of Nocturnin mRNA in multiple tissues of the mouse.
BMC Developmental Biology, 1:9, 2001.
[166] Alan R. Godwin, Shihoko Kojima, Carla B. Green, and Jeffrey Wilusz. Kiss your tail good-
bye: The role of PARN, Nocturnin, and Angel deadenylases in mRNA biology. Biochimica
et Biophysica Acta - Gene Regulatory Mechanisms, 1829(6-7):571–579, 2013.
[167] Jeremy J. Stubblefield, Jérémy Terrien, and Carla B. Green. Nocturnin: at the crossroads
of clocks and metabolism. Trends in Endocrinology and Metabolism, 23(7):326–333, 2012.
[168] J. Morf, G. Rey, K. Schneider, M. Stratmann, J. Fujita, F. Naef, and U. Schibler. Cold-
Inducible RNA-Binding Protein Modulates Circadian Gene Expression Posttranscription-
ally. Science, 338(6105):379–383, 2012.
162
[169] Yuting Liu, Wenchao Hu, Yasuhiro Murakawa, Jingwen Yin, Gang Wang, Markus
Landthaler, and Jun Yan. Cold-induced RNA-binding proteins regulate circadian gene
expression by controlling alternative polyadenylation. Scientific Reports, 3, 2013.
[170] Ivana Gotic, Saeed Omidi, Fabienne Fleury-Olela, Nacho Molina, Felix Naef, and Ueli
Schibler. Temperature regulates splicing efficiency of the cold-inducible RNA-binding
protein gene Cirbp. Genes & Development, 30(17):2005–2017, 2016.
[171] D. Gatfield, G. Le Martelot, C. E. Vejnar, D. Gerlach, O. Schaad, F. Fleury-Olela,
A.-L. Ruskeepaa, M. Oresic, C. C. Esau, E. M. Zdobnov, and U. Schibler. Integra-
tion of microRNA miR-122 in hepatic circadian gene expression. Genes & Development,
23(11):1313–1326, 2009.
[172] Mariana Lagos-Quintana, Reinhard Rauhut, Abdullah Yalcin, Jutta Meyer, Winfried
Lendeckel, and Thomas Tuschl. Identification of Tissue-Specific MicroRNAs from Mouse.
Current Biology, 12(9):735–739, 2002.
[173] Jan Krützfeldt, Nikolaus Rajewsky, Ravi Braich, Kallanthottathil G. Rajeev, Thomas
Tuschl, Muthiah Manoharan, and Markus Stoffel. Silencing of microRNAs in vivo with
’antagomirs’. Nature, 438(7068):685–689, 2005.
[174] Christine Esau, Scott Davis, Susan F. Murray, Xing Xian Yu, Sanjay K. Pandey, Michael
Pear, Lynnetta Watts, Sheri L. Booten, Mark Graham, Robert McKay, Amuthakannan
Subramaniam, Stephanie Propp, Bridget A. Lollo, Susan Freier, C. Frank Bennett, Sanjay
Bhanot, and Brett P. Monia. miR-122 regulation of lipid metabolism revealed by in vivo
antisense targeting. Cell Metabolism, 3(2):87–98, 2006.
[175] Haifang Wang, Zenghua Fan, Meng Zhao, Juan Li, Minghua Lu, Wei Liu, Hao Ying,
Mofang Liu, and Jun Yan. Oscillating primary transcripts harbor miRNAs with circadian
functions. Scientific Reports, 6:21598, 2016.
[176] Sadanand Vodala, Stefan Pescatore, Joseph Rodriguez, Marita Buescher, Ya-Wen Chen,
Ruifen Weng, Stephen M. Cohen, and Michael Rosbash. The Oscillating miRNA 959-964
Cluster Impacts Drosophila Feeding Time and Other Circadian Outputs. Cell Metabolism,
16(5):601–612, 2012.
[177] Ngoc-Hien Du, Alaaddin Bulak Arpat, Mara De Matos, and David Gatfield. MicroRNAs
shape circadian hepatic gene expression on a transcriptome-wide scale. eLife, 3, 2014.
[178] J. Hausser, A. P. Syed, N. Selevsek, E. van Nimwegen, L. Jaskiewicz, R. Aebersold, and
M. Zavolan. Timescales and bottlenecks in miRNA-dependent gene regulation. Molecular
Systems Biology, 9(1):711–711, 2014.
[179] Sarah Lück, Kevin Thurley, Paul F. Thaben, and Pål O. Westermark. Rhythmic Degra-
dation Explains and Unifies Circadian Transcriptome and Proteome Data. Cell Reports,
9(2):741–751, 2014.
163
Bibliography
[180] Manon Torres, Denis Becquet, Marie-Pierre Blanchard, Séverine Guillen, Bénédicte Boyer,
Mathias Moreno, Jean-Louis Franc, and Anne-Marie Fran¸sois Bellan. Circadian RNA
expression elicited by 3’-UTR IRAlu-paraspeckle associated elements. eLife, 5, 2016.
[181] Christine M. Clemson, John N. Hutchinson, Sergio A. Sara, Alexander W. Ensminger,
Archa H. Fox, Andrew Chess, and Jeanne B. Lawrence. An Architectural Role for a
Nuclear Noncoding RNA: NEAT1 RNA Is Essential for the Structure of Paraspeckles.
Molecular Cell, 33(6):717–726, 2009.
[182] Yasnory TF Sasaki and Tetsuro Hirose. How to build a paraspeckle. Genome Biology,
10(7):227, 2009.
[183] Ling-Ling Chen and Gordon G. Carmichael. Gene regulation by SINES and inosines:
biological consequences of A-to-I editing of Alu element inverted repeats. Cell Cycle,
7(21):3294–3301, 2008.
[184] Eric T. Wang, Rickard Sandberg, Shujun Luo, Irina Khrebtukova, Lu Zhang, Christine
Mayr, Stephen F. Kingsmore, Gary P. Schroth, and Christopher B. Burge. Alternative
isoform regulation in human tissue transcriptomes. Nature, 456(7221):470–476, 2008.
[185] Stefan Mockenhaupt and Eugene V. Makeyev. Non-coding functions of alternative pre-
mRNA splicing in development. Seminars in Cell & Developmental Biology, 47-48:32–39,
2015.
[186] Nicholas J. McGlincy, Amandine Valomon, Johanna E. Chesham, Elizabeth S. Maywood,
Michael H. Hastings, and Jernej Ule. Regulation of alternative splicing by the circadian
clock and food related cues. Genome Biology, 13(6):R54, 2012.
[187] Nicole L. Garneau, Jeffrey Wilusz, and Carol J. Wilusz. The highways and byways of
mRNA decay. Nature Reviews Molecular Cell Biology, 8(2):113–126, 2007.
[188] Xiaokan Zhang, Anders Virtanen, and Frida E Kleiman. To polyadenylate or to deadeny-
late. Cell Cycle, 9(22):4437–4449, 2010.
[189] Shihoko Kojima, Elaine L. Sher-Chen, and Carla B. Green. Circadian control of mRNA
polyadenylation dynamics regulates rhythmic protein expression. Genes & Development,
26(24):2724–2736, 2012.
[190] Shihoko Kojima, Kerry L. Gendreau, Elaine L. Sher-Chen, Peng Gao, and Carla B. Green.
Changes in poly(A) tail length dynamics from the loss of the circadian deadenylase Noc-
turnin. Scientific Reports, 5:17059, 2015.
[191] Dan Dominissini, Sharon Moshitch-Moshkovitz, Schraga Schwartz, Mali Salmon-Divon,
Lior Ungar, Sivan Osenberg, Karen Cesarkas, Jasmine Jacob-Hirsch, Ninette Amariglio,
Martin Kupiec, Rotem Sorek, and Gideon Rechavi. Topology of the human and mouse
m6a RNA methylomes revealed by m6a-seq. Nature, 485(7397):201–206, 2012.
164
[192] Jean-Michel Fustin, Masao Doi, Yoshiaki Yamaguchi, Hayashi Hida, Shinichi Nishimura,
Minoru Yoshida, Takayuki Isagawa, Masaki Suimye Morioka, Hideaki Kakeya, Ichiro Man-
abe, and Hitoshi Okamura. RNA-Methylation-Dependent RNA Processing Controls the
Speed of the Circadian Clock. Cell, 155(4):793–806, 2013.
[193] Francesco Ferrari, Artyom A Alekseyenko, Peter J Park, and Mitzi I Kuroda. Transcrip-
tional control of a whole chromosome: emerging models for dosage compensation. Nature
Structural & Molecular Biology, 21(2):118–125, 2014.
[194] Dimos Gaidatzis, Lukas Burger, Maria Florescu, and Michael B Stadler. Analysis
of intronic and exonic reads in RNA-seq data characterizes transcriptional and post-
transcriptional regulation. Nature Biotechnology, 33(7):722–729, 2015.
[195] Peter J. Park. ChIP-seq: advantages and challenges of a maturing technology. Nature
Reviews. Genetics, 10(10):669–680, 2009.
[196] Nikolay V. Rozhkov. Global Run-On Sequencing (GRO-seq) Library Preparation from
Drosophila Ovaries. Methods in Molecular Biology, 1328:217–230, 2015.
[197] Y. L. Khodor, J. Rodriguez, K. C. Abruzzi, C.-H. A. Tang, M. T. Marr, and M. Rosbash.
Nascent-seq indicates widespread cotranscriptional pre-mRNA splicing in Drosophila.
Genes & Development, 25(23):2502–2512, 2011.
[198] Mattia Brugiolo, Lydia Herzel, and Karla M Neugebauer. Counting on co-transcriptional
splicing. F1000Prime Reports, 5, 2013.
[199] J. Rodriguez, C.-H. A. Tang, Y. L. Khodor, S. Vodala, J. S. Menet, and M. Rosbash.
Nascent-Seq analysis of Drosophila cycling gene expression. Proceedings of the National
Academy of Sciences of the United States of America, 110(4):E275–E284, 2013.
[200] P. F. Thaben and P. O. Westermark. Detecting Rhythms in Time Series with RAIN.
Journal of Biological Rhythms, 29(6):391–400, 2014.
[201] Halberg. Circadian System Phase - An Aspect of Temporal Morphology; Procedures and
Illustrative Examples. In The Cellular Aspects of Biorhythms, pages 20–48. Mayersbach,
H.v., 1965.
[202] Martin Straume. DNA Microarray Time Series Analysis: Automated Statistical Assess-
ment of Circadian Rhythms in Gene Expression Patterning. In Methods in Enzymology,
volume 383, pages 149–166. Elsevier, 2004.
[203] S. Wichert, K. Fokianos, and K. Strimmer. Identifying periodically expressed transcripts
in microarray time series data. Bioinformatics, 20(1):5–20, 2004.
[204] M. E. Hughes, J. B. Hogenesch, and K. Kornacker. JTK_cycle: An Efficient Nonparamet-
ric Algorithm for Detecting Rhythmic Components in Genome-Scale Data Sets. Journal
of Biological Rhythms, 25(5):372–380, 2010.
165
Bibliography
[205] Herman Wijnen, Felix Naef, and Michael W. Young. Molecular and Statistical Tools for
Circadian Transcript Profiling. In Methods in Enzymology, volume 393, pages 341–365.
Elsevier, 2005.
[206] Yoav Benjamini and Yosef Hochberg. Controlling the False Discovery Rate: A Practical
and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society,
57(1):289–300, 1995.
[207] L. J. Core, J. J. Waterfall, and J. T. Lis. Nascent RNA Sequencing Reveals Widespread
Pausing and Divergent Initiation at Human Promoters. Science, 322(5909):1845–1848,
2008.
[208] Keren Bahar Halpern, Sivan Tanami, Shanie Landen, Michal Chapal, Liran Szlak, Anat
Hutzler, Anna Nizhberg, and Shalev Itzkovitz. Bursty Gene Expression in the Intact
Mammalian Liver. Molecular Cell, 58(1):147–156, 2015.
[209] Jarnail Singh and Richard A Padgett. Rates of in situ transcription and splicing in large
human genes. Nature Structural & Molecular Biology, 16(11):1128–1133, 2009.
[210] E. Wahle. Purification and characterization of a mammalian polyadenylate polymerase
involved in the 3’ end processing of messenger RNA precursors. The Journal of Biological
Chemistry, 266(5):3131–3139, 1991.
[211] Marlene Oeffinger and Daniel Zenklusen. To the pore and through the pore: A story of
mRNA export kinetics. Biochimica et Biophysica Acta - Gene Regulatory Mechanisms,
1819(6):494–506, 2012.
[212] C. C. Friedel, L. Dolken, Z. Ruzsics, U. H. Koszinowski, and R. Zimmer. Conserved
principles of mammalian transcriptional regulation revealed by RNA half-life. Nucleic
Acids Research, 37(17):e115–e115, 2009.
[213] Björn Schwanhäusser, Dorothea Busse, Na Li, Gunnar Dittmar, Johannes Schuchhardt,
Jana Wolf, Wei Chen, and Matthias Selbach. Global quantification of mammalian gene
expression control. Nature, 473(7347):337–342, 2011.
[214] Shanrong Zhao, Wai-Ping Fung-Leung, Anton Bittner, Karen Ngo, and Xuejun Liu. Com-
parison of RNA-Seq and Microarray in Transcriptome Profiling of Activated T Cells. PLoS
ONE, 9(1):e78644, 2014.
[215] T. W. Anderson. An introduction to multivariate statistical analysis. Wiley series in
probability and statistics. Wiley-Interscience, Hoboken, N.J, 3rd ed edition, 2003.
[216] Florian Atger, Cédric Gobet, Julien Marquis, Eva Martin, Jingkui Wang, Benjamin Weger,
Grégory Lefebvre, Patrick Descombes, Felix Naef, and Frédéric Gachon. Circadian and
feeding rhythms differentially affect rhythmic mRNA transcription and translation in
mouse liver. Proceedings of the National Academy of Sciences of the United States of
America, 112(47):E6579–E6588, 2015.
166
[217] Ionita Ghiran. Project description: Impact of circadian rhythm in obtaining ref-
erence profiles of exRNAs in healthy in healthy individuals. http://exrna.org/
projects/impact-circadian-rhythm-obtaining-reference-profiles-exrnas.
-healthy-healthy-individuals/. Accessed: 2017-01-07.
[218] R. Sandberg, J. R. Neilson, A. Sarma, P. A. Sharp, and C. B. Burge. Proliferating Cells
Express mRNAs with Shortened 3’ Untranslated Regions and Fewer MicroRNA Target
Sites. Science, 320(5883):1643–1647, 2008.
[219] T. Kadowaki, M. Hitomi, S. Chen, and A. M. Tartakoff. Nuclear mRNA accumulation
causes nucleolar fragmentation in yeast mtr2 mutant. Molecular Biology of the Cell,
5(11):1253–1263, 1994.
[220] D. Weil, S. Boutain, A. Audibert, and F. Dautry. Mature mRNAs accumulated in the
nucleus are neither the molecules in transit to the cytoplasm nor constitute a stockpile for
gene expression. RNA , 6(7):962–975, 2000.
[221] Janusz Niedojadło, Konrad Dełeńko, and Katarzyna Niedojadło. Regulation of poly(A)
RNA retention in the nucleus as a survival strategy of plants during hypoxia. RNA Biology,
13(5):531–543, 2016.
[222] Jack D. Keene. RNA regulons: coordination of post-transcriptional events. Nature Reviews
Genetics, 8(7):533–543, 2007.
[223] Da Wei Huang, Brad T Sherman, and Richard A Lempicki. Systematic and integra-
tive analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols,
4(1):44–57, 2008.
[224] D. W. Huang, B. T. Sherman, and R. A. Lempicki. Bioinformatics enrichment tools: paths
toward the comprehensive functional analysis of large gene lists. Nucleic Acids Research,
37(1):1–13, 2009.
[225] Li Wang and Rui Yi. 3’UTRs take a long shot in the brain. BioEssays : news and reviews
in molecular, cellular and developmental biology, 36(1):39–45, 2014.
[226] Xiao Li, Gerald Quon, Howard D. Lipshitz, and Quaid Morris. Predicting in vivo binding
sites of RNA-binding proteins using mRNA secondary structure. RNA, 16(6):1096–1107,
2010.
[227] Michael E. Hughes, Hee-Kyung Hong, Jason L. Chong, Alejandra A. Indacochea, Samuel S.
Lee, Michael Han, Joseph S. Takahashi, and John B. Hogenesch. Brain-Specific Rescue
of Clock Reveals System-Driven Transcriptional Rhythms in Peripheral Tissue. PLoS
Genetics, 8(7):e1002835, 2012.
[228] Gaspard Cretenet, Mikaël Le Clech, and Frédéric Gachon. Circadian Clock-Coordinated
12 Hr Period Rhythmic Activation of the IRE1α Pathway Controls Lipid Metabolism in
Mouse Liver. Cell Metabolism, 11(1):47–57, 2010.
167
Bibliography
[229] Pål O. Westermark and Hanspeter Herzel. Mechanism for 12 Hr Rhythm Generation by
the Circadian Clock. Cell Reports, 3(4):1228–1238, 2013.
[230] Martin J Hicks, Chin-Rang Yang, Matthew V Kotlajich, and Klemens J Hertel. Linking
Splicing to Pol II Transcription Stabilizes Pre-mRNAs and Influences Splicing Patterns.
PLoS Biology, 4(6):e147, 2006.
[231] Gad Asher, David Gatfield, Markus Stratmann, Hans Reinke, Charna Dibner, Florian
Kreppel, Raul Mostoslavsky, Frederick W. Alt, and Ueli Schibler. SIRT1 Regulates Cir-
cadian Clock Gene Expression through PER2 Deacetylation. Cell, 134(2):317–328, 2008.
[232] K. A. Lamia, U. M. Sachdeva, L. DiTacchio, E. C. Williams, J. G. Alvarez, D. F. Egan,
D. S. Vasquez, H. Juguilon, S. Panda, R. J. Shaw, C. B. Thompson, and R. M. Evans.
AMPK Regulates the Circadian Clock by Cryptochrome Phosphorylation and Degrada-
tion. Science, 326(5951):437–440, 2009.
[233] John J. Tyson and Béla Novák. Functional Motifs in Biochemical Reaction Networks.
Annual Review of Physical Chemistry, 61(1):219–240, 2010.
[234] P. Ruoff, M. Vinsjevik, C. Monnerjahn, and L. Rensing. The Goodwin oscillator: on the
importance of degradation reactions in the circadian clock. Journal of Biological Rhythms,
14(6):469–479, 1999.
[235] Paul François, Nicolas Despierre, and Eric D. Siggia. Adaptive Temperature Compensation
in Circadian Oscillations. PLoS Computational Biology, 8(7):e1002585, 2012.
[236] Peter Ruoff and Ludger Rensing. The Temperature-Compensated Goodwin Model Sim-
ulates Many Circadian Clock Properties. Journal of Theoretical Biology, 179(4):275–285,
1996.
[237] Zhang Cheng, Feng Liu, Xiao-Peng Zhang, and Wei Wang. Reversible Phosphorylation
Subserves Robust Circadian Rhythms by Creating a Switch in Inactivating the Positive
Element. Biophysical Journal, 97(11):2867–2875, 2009.
[238] Treenut Saithong, Kevin J. Painter, and Andrew J. Millar. The Contributions of Inter-
locking Loops and Extensive Nonlinearity to the Properties of Circadian Clock Models.
PLoS ONE, 5(11):e13867, 2010.
[239] Angela Relógio, Pål O. Westermark, Thomas Wallach, Katja Schellenberg, Achim Kramer,
and Hanspeter Herzel. Tuning the Mammalian Circadian Clock: Robust Synergy of Two
Loops. PLoS Computational Biology, 7(12):e1002309, 2011.
[240] Aurore Woller, Hélène Duez, Bart Staels, and Marc Lefranc. A Mathematical Model of
the Liver Circadian Clock Linking Feeding and Fasting Cycles to Clock Function. Cell
Reports, 17(4):1087–1097, 2016.
[241] A. G. McKendrick and M. Kesava Pai. XLV.-The Rate of Multiplication of Micro-
organisms: A Mathematical Study. Proceedings of the Royal Society of Edinburgh, 31:649–
653, 1912.
168
[242] A. G. McKendrick. Applications of Mathematics to Medical Problems. Proceedings of the
Edinburgh Mathematical Society, 44:98, 1925.
[243] H. von Foerster. Some Remarks on Changing Populations. In The Kinetics of Cellular
Proliferation, pages 382–407, 1959.
[244] B. S. Berlett and E. R. Stadtman. Protein Oxidation in Aging, Disease, and Oxidative
Stress. Journal of Biological Chemistry, 272(33):20313–20316, 1997.
[245] Audrey Desvergne, Nicolas Ugarte, Sabrina Radjei, Monique Gareil, Isabelle Petropoulos,
and Bertrand Friguet. Circadian modulation of proteasome activity and accumulation of
oxidized protein in human embryonic kidney HEK 293 cells and primary dermal fibroblasts.
Free Radical Biology and Medicine, 94:195–207, 2016.
[246] Tobias Jung, Nicolle Bader, and Tilman Grune. Oxidized proteins: Intracellular dis-
tribution and recognition by the proteasome. Archives of Biochemistry and Biophysics,
462(2):231–237, 2007.
[247] George Brawerman. The Role of the Poly(A) Sequence in Mammalian Messenger RN.
Critical Reviews in Biochemistry, 10(1):1–38, 1981.
[248] Aaron C. Goldstrohm and Marvin Wickens. Multifunctional deadenylase complexes di-
versify mRNA control. Nature Reviews Molecular Cell Biology, 9(4):337–344, 2008.
[249] Jong-Eun Park, Hyerim Yi, Yoosik Kim, Hyeshik Chang, and V. Narry Kim. Regulation
of Poly(A) Tail and Translation during the Somatic Cell Cycle. Molecular Cell, 62(3):462–
471, 2016.
[250] Mandy Jeske, Claudia Temme, and Elmar Wahle. Assaying mRNA Deadenylation In
Vitro. In Joanna Rorbach and Agnieszka J. Bobrowicz, editors, Polyadenylation, volume
1125, pages 297–311. Humana Press, Totowa, NJ, 2014.
[251] Claudia Temme and Elmar Wahle. Assaying mRNA Deadenylation In Vivo. In Joanna
Rorbach and Agnieszka J. Bobrowicz, editors, Polyadenylation, volume 1125, pages 313–
324. Humana Press, Totowa, NJ, 2014.
[252] Hyeshik Chang, Jaechul Lim, Minju Ha, and V. Narry Kim. TAIL-seq: Genome-wide De-
termination of Poly(A) Tail Length and 3’ End Modifications. Molecular Cell, 53(6):1044–
1052, 2014.
[253] Alexander O. Subtelny, Stephen W. Eichhorn, Grace R. Chen, Hazel Sive, and David P.
Bartel. Poly(A)-tail profiling reveals an embryonic switch in translational control. Nature,
508(7494):66–71, 2014.
[254] M. Barahona and J. Dattani. Stochastic models of gene transcription with upstream
drives: Exact solution and sample path characterisation, 2016.
[255] G. J. Boender, A. A. de Koeijer, and E. A. J. Fischer. Derivation of a Floquet Formalism
within a Natural Framework. Acta Biotheoretica, 60(3):303–317, 2012.
169
Bibliography
[256] Il’ja N. Bronštejn, Konstantin A. Semendjaev, Gerhard Musiol, Heiner Mühlig, and I. N.
Bronstein, editors. Taschenbuch der Mathematik. Deutsch, Frankfurt am Main, 7., vollst.
überarb. und erg. aufl edition, 2008.
[257] H. S. Carslaw. Introduction to the theory of Fourier’s series and integrals. MacMillan and
Co., 1921.
[258] F. Halberg, Y. L. Tong, and E. A. Johnson. Circadian System Phase - An Aspect of
Temporal Morphology; Procedures and Illustrative Examples. In H. von Mayersbach, edi-
tor, The Cellular Aspects of Biorhythms, pages 20–48. Springer Berlin Heidelberg, Berlin,
Heidelberg, 1967.
[259] Natalie Gilks, Nancy Kedersha, Maranatha Ayodele, Lily Shen, Georg Stoecklin, Laura M.
Dember, and Paul Anderson. Stress granule assembly is mediated by prion-like aggregation
of TIA-1. Molecular Biology of the Cell, 15(12):5383–5398, 2004.
[260] Ben Langmead and Steven L Salzberg. Fast gapped-read alignment with Bowtie 2. Nature
Methods, 9(4):357–359, 2012.
[261] Michael Lawrence, Wolfgang Huber, Hervé Pagès, Patrick Aboyoun, Marc Carlson, Robert
Gentleman, Martin T. Morgan, and Vincent J. Carey. Software for Computing and An-
notating Genomic Ranges. PLoS Computational Biology, 9(8):e1003118, 2013.
[262] Lioudmila V. Sharova, Alexei A. Sharov, Timur Nedorezov, Yulan Piao, Nabeebi Shaik,
and Minoru S. H. Ko. Database for mRNA half-life of 19 977 genes obtained by DNA
microarray analysis of pluripotent and differentiating mouse embryonic stem cells. DNA
research: an international journal for rapid publication of reports on genes and genomes,
16(1):45–58, 2009.
[263] K. B. Cook, H. Kazan, K. Zuberi, Q. Morris, and T. R. Hughes. RBPDB: a database of
RNA-binding specificities. Nucleic Acids Research, 39(Database):D301–D308, 2011.
[264] Debashish Ray, Hilal Kazan, Kate B. Cook, Matthew T. Weirauch, Hamed S. Najafabadi,
Xiao Li, Serge Gueroussov, Mihai Albu, Hong Zheng, Ally Yang, Hong Na, Manuel Irimia,
Leah H. Matzat, Ryan K. Dale, Sarah A. Smith, Christopher A. Yarosh, Seth M. Kelly,
Behnam Nabet, Desirea Mecenas, Weimin Li, Rakesh S. Laishram, Mei Qiao, Howard D.
Lipshitz, Fabio Piano, Anita H. Corbett, Russ P. Carstens, Brendan J. Frey, Richard A.
Anderson, Kristen W. Lynch, Luiz O. F. Penalva, Elissa P. Lei, Andrew G. Fraser, Ben-
jamin J. Blencowe, Quaid D. Morris, and Timothy R. Hughes. A compendium of RNA-
binding motifs for decoding gene regulation. Nature, 499(7457):172–177, 2013.
[265] I. Paz, I. Kosti, M. Ares, M. Cline, and Y. Mandel-Gutfreund. RBPmap: a web server for
mapping binding sites of RNA-binding proteins. Nucleic Acids Research, 42(W1):W361–
W367, 2014.
[266] Andrew Yates, Wasiu Akanni, M. Ridwan Amode, Daniel Barrell, Konstantinos Billis,
Denise Carvalho-Silva, Carla Cummins, Peter Clapham, Stephen Fitzgerald, Laurent Gil,
170
Carlos García Girón, Leo Gordon, Thibaut Hourlier, Sarah E. Hunt, Sophie H. Janacek,
Nathan Johnson, Thomas Juettemann, Stephen Keenan, Ilias Lavidas, Fergal J. Martin,
Thomas Maurel, William McLaren, Daniel N. Murphy, Rishi Nag, Michael Nuhn, Anne
Parker, Mateus Patricio, Miguel Pignatelli, Matthew Rahtz, Harpreet Singh Riat, Daniel
Sheppard, Kieron Taylor, Anja Thormann, Alessandro Vullo, Steven P. Wilder, Amonida
Zadissa, Ewan Birney, Jennifer Harrow, Matthieu Muffato, Emily Perry, Magali Ruffier,
Giulietta Spudich, Stephen J. Trevanion, Fiona Cunningham, Bronwen L. Aken, Daniel R.
Zerbino, and Paul Flicek. Ensembl 2016. Nucleic Acids Research, 44(D1):D710–D716,
2016.
[267] J. O. Henderson, V. Blanc, and N. O. Davidson. Isolation, characterization and develop-
mental regulation of the human apobec-1 complementation factor (ACF) gene. Biochimica
Et Biophysica Acta, 1522(1):22–30, 2001.
[268] Valerie Blanc, Jeffrey O. Henderson, Elizabeth P. Newberry, Susan Kennedy, Jianyang
Luo, and Nicholas O. Davidson. Targeted Deletion of the Murine apobec-1 Complemen-
tation Factor (acf) Gene Results in Embryonic Lethality. Molecular and Cellular Biology,
25(16):7260–7269, 2005.
[269] Percy Tumbale, Jessica S. Williams, Matthew J. Schellenberg, Thomas A. Kunkel, and
R. Scott Williams. Aprataxin resolves adenylated RNA-DNA junctions to maintain
genome integrity. Nature, 506(7486):111–115, 2014.
[270] Beatriz Garcia-Diaz, Emanuele Barca, Andrea Balreira, Luis C. Lopez, Saba Tadesse,
Sindhu Krishna, Ali Naini, Caterina Mariotti, Barbara Castellotti, and Catarina M.
Quinzii. Lack of aprataxin impairs mitochondrial functions via downregulation of the
APE1/NRF1/NRF2 pathway. Human Molecular Genetics, 24(16):4516–4529, 2015.
[271] J. F. Welk, A. Charlesworth, G. D. Smith, and A. M. MacNicol. Identification and char-
acterization of the gene encoding human cytoplasmic polyadenylation element binding
protein. Gene, 263(1-2):113–120, 2001.
[272] R. Mendez and J. D. Richter. Translational control by CPEB: a means to the end. Nature
Reviews. Molecular Cell Biology, 2(7):521–529, 2001.
[273] Kourosh Salehi-Ashtiani, Andrej Lupłák, Alexander Litovchick, and Jack W. Szosłak. A
genomewide search for ribozymes reveals an HDV-like sequence in the human CPEB3
gene. Science, 313(5794):1788–1792, 2006.
[274] Elena Ortiz-Zapater, David Pineda, Neus Martínez-Bosch, Gonzalo Fernández-Miranda,
Mar Iglesias, Francesc Alameda, Mireia Moreno, Carolina Eliscovich, Eduardo Eyras,
Francisco X. Real, Raúl Méndez, and Pilar Navarro. Key contribution of CPEB4-mediated
translational control to cancer progression. Nature Medicine, 18(1):83–90, 2011.
[275] Elena Amendola, Remo Sanges, Antonella Galvan, Nina Dathan, Giacomo Manenti,
Giuseppe Ferrandino, Francesca Maria Alvino, Tina Di Palma, Marzia Scarfò, Mariastella
Zannini, Tommaso A. Dragani, Mario De Felice, and Roberto Di Lauro. A locus on mouse
171
Bibliography
chromosome 2 is involved in susceptibility to congenital hypothyroidism and contains an
essential gene expressed in thyroid. Endocrinology, 151(4):1948–1958, 2010.
[276] Debbie-Jane G. Scarlett, Patries M. Herst, and Michael V. Berridge. Multiple proteins
with single activities or a single protein with multiple activities: the conundrum of cell
surface NADH oxidoreductases. Biochimica Et Biophysica Acta, 1708(1):108–119, 2005.
[277] Caroline Vance, Boris Rogelj, Tibor Hortobágyi, Kurt J. De Vos, Agnes Lumi Nishimura,
Jemeen Sreedharan, Xun Hu, Bradley Smith, Deborah Ruddy, Paul Wright, Jeban Gane-
salingam, Kelly L. Williams, Vineeta Tripathi, Safa Al-Saraj, Ammar Al-Chalabi, P. Nigel
Leigh, Ian P. Blair, Garth Nicholson, Jackie de Belleroche, Jean-Marc Gallo, Christo-
pher C. Miller, and Christopher E. Shaw. Mutations in FUS, an RNA processing protein,
cause familial amyotrophic lateral sclerosis type 6. Science, 323(5918):1208–1211, 2009.
[278] Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and
Novartis Institutes of BioMedical Research, Richa Saxena, Benjamin F. Voight, Valeriya
Lyssenko, Noël P. Burtt, Paul I. W. de Bakker, Hong Chen, Jeffrey J. Roix, Sekar Kathire-
san, Joel N. Hirschhorn, Mark J. Daly, Thomas E. Hughes, Leif Groop, David Altshuler,
Peter Almgren, Jose C. Florez, Joanne Meyer, Kristin Ardlie, Kristina Bengtsson Boström,
Bo Isomaa, Guillaume Lettre, Ulf Lindblad, Helen N. Lyon, Olle Melander, Christo-
pher Newton-Cheh, Peter Nilsson, Marju Orho-Melander, Lennart Råstam, Elizabeth K.
Speliotes, Marja-Riitta Taskinen, Tiinamaija Tuomi, Candace Guiducci, Anna Berglund,
Joyce Carlson, Lauren Gianniny, Rachel Hackett, Liselotte Hall, Johan Holmkvist, Esa
Laurila, Marketa Sjögren, Maria Sterner, Aarti Surti, Margareta Svensson, Malin Svens-
son, Ryan Tewhey, Brendan Blumenstiel, Melissa Parkin, Matthew Defelice, Rachel Barry,
Wendy Brodeur, Jody Camarata, Nancy Chia, Mary Fava, John Gibbons, Bob Handsaker,
Claire Healy, Kieu Nguyen, Casey Gates, Carrie Sougnez, Diane Gage, Marcia Nizzari,
Stacey B. Gabriel, Gung-Wei Chirn, Qicheng Ma, Hemang Parikh, Delwood Richardson,
Darrell Ricke, and Shaun Purcell. Genome-wide association analysis identifies loci for type
2 diabetes and triglyceride levels. Science, 316(5829):1331–1336, 2007.
[279] Lisa Traunmüller, Andrea M. Gomez, Thi-Minh Nguyen, and Peter Scheiffele. Control of
neuronal synapse specification by a highly dedicated alternative splicing program. Science,
352(6288):982–986, 2016.
[280] Thai H. Ho, Nicolas Charlet-B, Michael G. Poulos, Gopal Singh, Maurice S. Swanson,
and Thomas A. Cooper. Muscleblind proteins regulate alternative splicing. The EMBO
journal, 23(15):3103–3112, 2004.
[281] Jean-Christophe Amé, Catherine Spenlehauer, and Gilbert de Murcia. The PARP super-
family. BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology,
26(8):882–893, 2004.
[282] Alexander N. Chkheidze and Stephen A. Liebhaber. A novel set of nuclear localization
signals determine distributions of the alphaCP RNA-binding proteins. Molecular and
Cellular Biology, 23(23):8405–8415, 2003.
172
[283] Jiandie Lin, Pei-Hsuan Wu, Paul T. Tarr, Katrin S. Lindenberg, Julie St-Pierre, Chen-Yu
Zhang, Vamsi K. Mootha, Sibylle Jäger, Claudia R. Vianna, Richard M. Reznick, Libin
Cui, Monia Manieri, Mi X. Donovan, Zhidan Wu, Marcus P. Cooper, Melina C. Fan,
Lindsay M. Rohas, Ann Marie Zavacki, Saverio Cinti, Gerald I. Shulman, Bradford B.
Lowell, Dimitri Krainc, and Bruce M. Spiegelman. Defects in adaptive energy metabolism
with CNS-linked hyperactivity in PGC-1alpha null mice. Cell, 119(1):121–135, 2004.
[284] Archa H. Fox, Yun Wah Lam, Anthony K. L. Leung, Carol E. Lyon, Jens Andersen,
Matthias Mann, and Angus I. Lamond. Paraspeckles: a novel nuclear domain. Current
Biology, 12(1):13–25, 2002.
[285] Kazuhiro Fukumura, Ayako Kato, Yui Jin, Takashi Ideue, Tetsuro Hirose, Naoyuki
Kataoka, Toshinobu Fujiwara, Hiroshi Sakamoto, and Kunio Inoue. Tissue-specific splic-
ing regulator Fox-1 induces exon skipping by interfering E complex formation on the
downstream intron of human F1gamma gene. Nucleic Acids Research, 35(16):5303–5311,
2007.
[286] Simona Pedrotti, Roberta Busà, Claudia Compagnucci, and Claudio Sette. The RNA
recognition motif protein RBM11 is a novel tissue-specific splicing regulator. Nucleic
Acids Research, 40(3):1021–1032, 2012.
[287] Puri Fortes, Dasa Longman, Susan McCracken, Joanna Y. Ip, Raymond Poot, Iain W.
Mattaj, Javier F. Cáceres, and Benjamin J. Blencowe. Identification and characterization
of RED120: a conserved PWI domain protein with links to splicing and 3’-end formation.
FEBS letters, 581(16):3087–3097, 2007.
[288] Limin Shu, Wensheng Yan, and Xinbin Chen. RNPC1, an RNA-binding protein and a
target of the p53 family, is required for maintaining the stability of the basal and stress-
induced p21 transcript. Genes & Development, 20(21):2961–2972, 2006.
[289] Chenchen Wang, Yuanfan Chen, Hongkui Deng, Shaorong Gao, and Lingsong Li. Rbm46
regulates trophectoderm differentiation by stabilizing Cdx2 mRNA in early mouse em-
bryos. Stem Cells and Development, 24(7):904–915, 2015.
[290] Benjamin Cieply, Juw Won Park, Angela Nakauka-Ddamba, Thomas W. Bebee, Yang
Guo, Xuequn Shang, Christopher J. Lengner, Yi Xing, and Russ P. Carstens. Multipha-
sic and Dynamic Changes in Alternative Splicing during Induction of Pluripotency Are
Coordinated by Numerous RNA-Binding Proteins. Cell Reports, 15(2):247–255, 2016.
[291] Janghoo Lim, Tong Hao, Chad Shaw, Akash J. Patel, Gábor Szabó, Jean-Fran¸cois Rual,
C. Joseph Fisk, Ning Li, Alex Smolyar, David E. Hill, Albert-László Barabási, Marc Vidal,
and Huda Y. Zoghbi. A protein-protein interaction network for human inherited ataxias
and disorders of Purkinje cell degeneration. Cell, 125(4):801–814, 2006.
[292] Jinhu Yin, Yong Tae Kwon, Alexander Varshavsky, and Weidong Wang. RECQL4, mu-
tated in the Rothmund-Thomson and RAPADILINO syndromes, interacts with ubiqui-
tin ligases UBR1 and UBR2 of the N-end rule pathway. Human Molecular Genetics,
13(20):2421–2430, 2004.
173
Bibliography
[293] Shepherd H. Schurman, Mohammad Hedayati, ZhengMing Wang, Dharmendra K. Singh,
Elzbieta Speina, Yongqing Zhang, Kevin Becker, Margaret Macris, Patrick Sung, David M.
Wilson, Deborah L. Croteau, and Vilhelm A. Bohr. Direct and indirect roles of RECQL4 in
modulating base excision repair capacity. Human Molecular Genetics, 18(18):3470–3483,
2009.
[294] Ya-Yu Chuang, Nhan L. Tran, Nicole Rusk, Mitsutoshi Nakada, Michael E. Berens, and
Marc Symons. Role of synaptojanin 2 in glioma cell migration and invasion. Cancer
Research, 64(22):8271–8275, 2004.
[295] R. Tacke, M. Tohyama, S. Ogawa, and J. L. Manley. Human Tra2 proteins are sequence-
specific activators of pre-mRNA splicing. Cell, 93(1):139–148, 1998.
[296] T. Hung, G. A. Pratt, B. Sundararaman, M. J. Townsend, C. Chaivorapol, T. Bhangale,
R. R. Graham, W. Ortmann, L. A. Criswell, G. W. Yeo, and T. W. Behrens. The Ro60
autoantigen binds endogenous retroelements and regulates inflammatory gene expression.
Science, 350(6259):455–459, 2015.
[297] Kazufumi Matsushita, Osamu Takeuchi, Daron M. Standley, Yutaro Kumagai, Tatsukata
Kawagoe, Tohru Miyake, Takashi Satoh, Hiroki Kato, Tohru Tsujimura, Haruki Naka-
mura, and Shizuo Akira. Zc3h12a is an RNase essential for controlling immune responses
by regulating mRNA decay. Nature, 458(7242):1185–1190, 2009.
[298] Jian Liang, Jing Wang, Asim Azfer, Wenjun Song, Gail Tromp, Pappachan E. Kolat-
tukudy, and Mingui Fu. A novel CCCH-zinc finger protein family regulates proinflamma-
tory activation of macrophages. The Journal of Biological Chemistry, 283(10):6337–6346,
2008.
[299] Wenwen Fang, Yong Wei, Yibin Kang, and Laura F. Landweber. Detection of a common
chimeric transcript between human chromosomes 7 and 16. Biology Direct, 7:49, 2012.
[300] Yasumasa Minoda, Kazuko Saeki, Daisuke Aki, Hiromi Takaki, Takahito Sanada, Keiko
Koga, Takashi Kobayashi, Giichi Takaesu, and Akihiko Yoshimura. A novel Zinc finger
protein, ZCCHC11, interacts with TIFA and modulates TLR signaling. Biochemical and
Biophysical Research Communications, 344(3):1023–1030, 2006.
[301] Matthew R. Jones, Lee J. Quinton, Matthew T. Blahna, Joel R. Neilson, Suneng Fu,
Alexander R. Ivanov, Dieter A. Wolf, and Joseph P. Mizgerd. Zcchc11-dependent uridy-
lation of microRNA directs cytokine expression. Nature Cell Biology, 11(9):1157–1163,
2009.
[302] HaoranWang, Mary X. Gao, Linda Li, Bin Wang, Naohiro Hori, and Kenzo Sato. Isolation,
expression, and characterization of the human ZCRB1 gene mapped to 12q12. Genomics,
89(1):59–69, 2007.
[303] Alison Galloway, Alexander Saveliev, Sebastian Ł ukasiak, Daniel J. Hodson, Daniel Bol-
land, Kathryn Balmanno, Helena Ahlfors, Elisa Monzón-Casanova, Sara Ciullini Man-
nurita, Lewis S. Bell, Simon Andrews, Manuel D. Díaz-Muñoz, Simon J. Cook, Anne
174
Corcoran, and Martin Turner. RNA-binding proteins ZFP36l1 and ZFP36l2 promote cell
quiescence. Science, 352(6284):453–459, 2016.
175

List of Figures
1.1 Two models of the core negative feedback loop in the circadian clock. . . . . . . . 5
1.2 Overview of the main post-transcriptional gene regulation pathways in eukaryotes. 10
1.3 Definition and depiction of rhythmic properties. . . . . . . . . . . . . . . . . . . . 18
2.1 Time matters for oscillations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
2.2 Characteristics of circadian gene expression in liver and kidney. . . . . . . . . . . 27
2.3 Genes expressed both in kidney and liver. . . . . . . . . . . . . . . . . . . . . . . 29
2.4 Test for agreement of model prediction Equation 2.5, 2.6 and data in 2 stages:
Principle and first test stage for kidney. . . . . . . . . . . . . . . . . . . . . . . . 31
2.5 Test for agreement of model prediction Equation 2.5, 2.6 and data in 2 stages:
Second test-stage considering also mRNA half-lives for kidney. . . . . . . . . . . 34
2.6 How many genes are under rhythmic PTR? . . . . . . . . . . . . . . . . . . . . .
2.7 A model describing rhythmic production and rhythmic degradation and its solution. 41
2.8 Conclusions drawn from model solution: rhythmicity properties of the rates. . . . 43
2.9 Conclusions drawn from model solution: influence of half-lives. . . . . . . . . . . 45
2.10 Illustration of predicting an unknown degradation rate with given mRNA abun-
dance and transcriptional activity. . . . . . . . . . . . . . . . . . . . . . . . . . . 47
2.11 UTRs of circadian genes are longer in liver than in kidney. . . . . . . . . . . . . . 52
2.12 Rhythmic PTR is organ specific. . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
2.13 Rhythmic degradation alters the shape of mRNA time series. . . . . . . . . . . . 56
2.14 Hits in genes with a different Fourier series fit for transcriptional activity and
RNA abundance are enriched in genes with rhythmic PTR. . . . . . . . . . . . . 58
3.1 Rhythmic splicing can produce 12 hour rhythms. . . . . . . . . . . . . . . . . . . 64
3.2 Goodwin model with oscillating degradation rates as example for rhythmically
degraded core clock genes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
3.3 Systematic analysis of rhythmic degradation in all degradation rates for Goodwin
model. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
3.4 A PDE describing damage accumulation of molecules. . . . . . . . . . . . . . . . 71
3.5 Different numerical simulations of the PDE Equation 3.6 . . . . . . . . . . . . . . 73
3.6 Rhythms of production are conserved in long-lived proteins. . . . . . . . . . . . . 75
3.7 Prediction of deadenylation rates. . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
A.1 Definition of the function arctan 2(y, x). . . . . . . . . . . . . . . . . . . . . . . . 89
A.2 Numerical simulation and analytical approximation of the model. . . . . . . . . . 93
A.3 Function with non-sinusoidal shape . . . . . . . . . . . . . . . . . . . . . . . . . 95
177
LIST OF FIGURES
A.4 Validation of the Fourier approximation. Production/degradation term: cosine. . 96
A.5 Validation of the Fourier approximation. Production/degradation term: non-
sinoidal. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
A.6 Validation of the Fourier approximation for an unknown degradation rhythm at
varying half-lives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
A.7 Validation of the Fourier approximation for an unknown degradation rhythm at
varying phases and relative amplitudes. . . . . . . . . . . . . . . . . . . . . . . . 99
B.1 Illustration of the model Equation B.17. . . . . . . . . . . . . . . . . . . . . . . . 107
B.2 The damage dependence of v(t, d) (Equation B.25) for different parameter values. 110
C.1 Proportion of genes which are classified as circadian. . . . . . . . . . . . . . . . . 116
D.1 The function prodpoint(t) for different relative amplitudes. . . . . . . . . . . . . . 126
178
Danke!
First and foremost, I would like to thank my supervisor, Pål Westermark, for his guidance
and his support, the inspiring conversations and the freedom he provided to follow my own
way. Second, I would like to thank all the people who broadened my view with regards to
science and, specifically, biology: Hanspeter Herzel, who often brought with his experience new
aspects into the conversations, Rainer Machné, who taught me at least one quarter of my biology
knowledge during long breakfast conversations, Carla Green, who gave me the oppurtunity to
fulfill a scientific dream and study mitochondria, and last but not least Achim Kramer and
his group, in whose journal club I learned to read Westernblots and other experimental data. I
thank the Institute for Theoretical Biology to provide a nuturious, yet enjoyable environment for
conducting and discussing research. A special mention goes to Andreas Hantschmann, Tiziano
Zito, Rike-Benjamin Schuppner, Elvira Lauterbach and Karin Winkelhöfer for helping with
computers, keys, contracts and so on.
I thank Pål, Hanspeter and Felix Naef for taking their time and evaluating this thesis, and
Peter Hammerstein and Leonie Ringrose for being part of my commitee.
Apart from this scientific input I would like to deeply thank my family and my friends for
their support and endless encouragement, especially Theresa, Kiri (thank you for reading all
this!), Neta, Franzi and Grisha.
And finally, I thank Rainer for his endless patience, the critical comments on this thesis, the
title (!) and last, but not least for his love.
179

Selbständigkeitserklärung
Ich erkläre, dass ich die vorliegende Arbeit selbständig und nur unter Verwendung der angegebe-
nen Literatur und Hilfsmittel angefertigt habe.
Berlin, den 11.01.2017 Sarah Lück
181
